id	sid	tid	token	lemma	pos
ajlm-1434	1	1	abstract	abstract	ADJ
ajlm-1434	1	2	introduction	introduction	NOUN
ajlm-1434	1	3	methods	method	NOUN
ajlm-1434	1	4	results	result	VERB
ajlm-1434	1	5	discussion	discussion	NOUN
ajlm-1434	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1434	1	7	references	reference	NOUN
ajlm-1434	1	8	about	about	ADP
ajlm-1434	1	9	the	the	DET
ajlm-1434	1	10	author(s	author(s	NOUN
ajlm-1434	1	11	)	)	PUNCT
ajlm-1434	1	12	foluke	foluke	PROPN
ajlm-1434	1	13	a.	a.	PROPN
ajlm-1434	1	14	fasola	fasola	PROPN
ajlm-1434	1	15	department	department	PROPN
ajlm-1434	1	16	of	of	ADP
ajlm-1434	1	17	haematology	haematology	PROPN
ajlm-1434	1	18	,	,	PUNCT
ajlm-1434	1	19	college	college	NOUN
ajlm-1434	1	20	of	of	ADP
ajlm-1434	1	21	medicine	medicine	NOUN
ajlm-1434	1	22	,	,	PUNCT
ajlm-1434	1	23	university	university	NOUN
ajlm-1434	1	24	of	of	ADP
ajlm-1434	1	25	ibadan	ibadan	PROPN
ajlm-1434	1	26	,	,	PUNCT
ajlm-1434	1	27	ibadan	ibadan	PROPN
ajlm-1434	1	28	,	,	PUNCT
ajlm-1434	1	29	nigeria	nigeria	PROPN
ajlm-1434	1	30	department	department	PROPN
ajlm-1434	1	31	of	of	ADP
ajlm-1434	1	32	haematology	haematology	PROPN
ajlm-1434	1	33	,	,	PUNCT
ajlm-1434	1	34	university	university	NOUN
ajlm-1434	1	35	college	college	NOUN
ajlm-1434	1	36	hospital	hospital	NOUN
ajlm-1434	1	37	,	,	PUNCT
ajlm-1434	1	38	ibadan	ibadan	PROPN
ajlm-1434	1	39	,	,	PUNCT
ajlm-1434	1	40	nigeria	nigeria	PROPN
ajlm-1434	1	41	adeola	adeola	PROPN
ajlm-1434	1	42	a.	a.	PROPN
ajlm-1434	1	43	fowotade	fowotade	PROPN
ajlm-1434	1	44	department	department	PROPN
ajlm-1434	1	45	of	of	ADP
ajlm-1434	1	46	medical	medical	ADJ
ajlm-1434	1	47	microbiology	microbiology	NOUN
ajlm-1434	1	48	&	&	CCONJ
ajlm-1434	1	49	parasitology	parasitology	NOUN
ajlm-1434	1	50	,	,	PUNCT
ajlm-1434	1	51	college	college	NOUN
ajlm-1434	1	52	of	of	ADP
ajlm-1434	1	53	medicine	medicine	NOUN
ajlm-1434	1	54	,	,	PUNCT
ajlm-1434	1	55	university	university	NOUN
ajlm-1434	1	56	of	of	ADP
ajlm-1434	1	57	ibadan	ibadan	PROPN
ajlm-1434	1	58	,	,	PUNCT
ajlm-1434	1	59	ibadan	ibadan	PROPN
ajlm-1434	1	60	,	,	PUNCT
ajlm-1434	1	61	nigeria	nigeria	PROPN
ajlm-1434	1	62	adedayo	adedayo	PROPN
ajlm-1434	1	63	o.	o.	PROPN
ajlm-1434	1	64	faneye	faneye	PROPN
ajlm-1434	1	65	department	department	PROPN
ajlm-1434	1	66	of	of	ADP
ajlm-1434	1	67	virology	virology	NOUN
ajlm-1434	1	68	,	,	PUNCT
ajlm-1434	1	69	college	college	NOUN
ajlm-1434	1	70	of	of	ADP
ajlm-1434	1	71	medicine	medicine	NOUN
ajlm-1434	1	72	,	,	PUNCT
ajlm-1434	1	73	university	university	NOUN
ajlm-1434	1	74	of	of	ADP
ajlm-1434	1	75	ibadan	ibadan	PROPN
ajlm-1434	1	76	,	,	PUNCT
ajlm-1434	1	77	ibadan	ibadan	PROPN
ajlm-1434	1	78	,	,	PUNCT
ajlm-1434	1	79	nigeria	nigeria	PROPN
ajlm-1434	1	80	adeyeni	adeyeni	PROPN
ajlm-1434	1	81	adeleke	adeleke	PROPN
ajlm-1434	1	82	department	department	PROPN
ajlm-1434	1	83	of	of	ADP
ajlm-1434	1	84	haematology	haematology	PROPN
ajlm-1434	1	85	,	,	PUNCT
ajlm-1434	1	86	college	college	NOUN
ajlm-1434	1	87	of	of	ADP
ajlm-1434	1	88	medicine	medicine	NOUN
ajlm-1434	1	89	,	,	PUNCT
ajlm-1434	1	90	university	university	NOUN
ajlm-1434	1	91	of	of	ADP
ajlm-1434	1	92	ibadan	ibadan	PROPN
ajlm-1434	1	93	,	,	PUNCT
ajlm-1434	1	94	ibadan	ibadan	PROPN
ajlm-1434	1	95	,	,	PUNCT
ajlm-1434	1	96	nigeria	nigeria	PROPN
ajlm-1434	1	97	citation	citation	PROPN
ajlm-1434	1	98	fasola	fasola	PROPN
ajlm-1434	1	99	fa	fa	PROPN
ajlm-1434	1	100	,	,	PUNCT
ajlm-1434	1	101	fowotade	fowotade	VERB
ajlm-1434	1	102	aa	aa	NOUN
ajlm-1434	1	103	,	,	PUNCT
ajlm-1434	1	104	faneye	faneye	NOUN
ajlm-1434	1	105	ao	ao	PROPN
ajlm-1434	1	106	,	,	PUNCT
ajlm-1434	1	107	adeleke	adeleke	ADJ
ajlm-1434	1	108	a.	a.	NOUN
ajlm-1434	1	109	prevalence	prevalence	NOUN
ajlm-1434	1	110	of	of	ADP
ajlm-1434	1	111	hepatitis	hepatitis	PROPN
ajlm-1434	1	112	b	b	PROPN
ajlm-1434	1	113	virus	virus	NOUN
ajlm-1434	1	114	core	core	NOUN
ajlm-1434	1	115	antibodies	antibodie	VERB
ajlm-1434	1	116	among	among	ADP
ajlm-1434	1	117	blood	blood	NOUN
ajlm-1434	1	118	donors	donor	NOUN
ajlm-1434	1	119	in	in	ADP
ajlm-1434	1	120	nigeria	nigeria	PROPN
ajlm-1434	1	121	:	:	PUNCT
ajlm-1434	1	122	implications	implication	NOUN
ajlm-1434	1	123	for	for	ADP
ajlm-1434	1	124	blood	blood	NOUN
ajlm-1434	1	125	safety	safety	NOUN
ajlm-1434	1	126	.	.	PUNCT
ajlm-1434	2	1	afr	afr	PROPN
ajlm-1434	2	2	j	j	PROPN
ajlm-1434	2	3	lab	lab	PROPN
ajlm-1434	2	4	med	med	PROPN
ajlm-1434	2	5	.	.	PUNCT
ajlm-1434	3	1	2022;11(1	2022;11(1	NUM
ajlm-1434	3	2	)	)	PUNCT
ajlm-1434	3	3	,	,	PUNCT
ajlm-1434	3	4	a1434	a1434	PROPN
ajlm-1434	3	5	.	.	PUNCT
ajlm-1434	4	1	https://doi.org/10.4102/ajlm.v11i1.1434	https://doi.org/10.4102/ajlm.v11i1.1434	X
ajlm-1434	4	2	original	original	ADJ
ajlm-1434	4	3	research	research	NOUN
ajlm-1434	4	4	prevalence	prevalence	NOUN
ajlm-1434	4	5	of	of	ADP
ajlm-1434	4	6	hepatitis	hepatitis	PROPN
ajlm-1434	4	7	b	b	PROPN
ajlm-1434	4	8	virus	virus	NOUN
ajlm-1434	4	9	core	core	NOUN
ajlm-1434	4	10	antibodies	antibodie	VERB
ajlm-1434	4	11	among	among	ADP
ajlm-1434	4	12	blood	blood	NOUN
ajlm-1434	4	13	donors	donor	NOUN
ajlm-1434	4	14	in	in	ADP
ajlm-1434	4	15	nigeria	nigeria	PROPN
ajlm-1434	4	16	:	:	PUNCT
ajlm-1434	4	17	implications	implication	NOUN
ajlm-1434	4	18	for	for	ADP
ajlm-1434	4	19	blood	blood	NOUN
ajlm-1434	4	20	safety	safety	NOUN
ajlm-1434	4	21	foluke	foluke	PROPN
ajlm-1434	4	22	a.	a.	PROPN
ajlm-1434	4	23	fasola	fasola	PROPN
ajlm-1434	4	24	,	,	PUNCT
ajlm-1434	4	25	adeola	adeola	PROPN
ajlm-1434	4	26	a.	a.	PROPN
ajlm-1434	4	27	fowotade	fowotade	PROPN
ajlm-1434	4	28	,	,	PUNCT
ajlm-1434	4	29	adedayo	adedayo	PROPN
ajlm-1434	4	30	o.	o.	PROPN
ajlm-1434	4	31	faneye	faneye	PROPN
ajlm-1434	4	32	,	,	PUNCT
ajlm-1434	4	33	adeyeni	adeyeni	ADJ
ajlm-1434	4	34	adeleke	adeleke	PROPN
ajlm-1434	4	35	received	receive	VERB
ajlm-1434	4	36	:	:	PUNCT
ajlm-1434	4	37	23	23	NUM
ajlm-1434	4	38	oct	oct	NOUN
ajlm-1434	4	39	.	.	PROPN
ajlm-1434	4	40	2020	2020	NUM
ajlm-1434	4	41	;	;	PUNCT
ajlm-1434	4	42	accepted	accept	VERB
ajlm-1434	4	43	:	:	PUNCT
ajlm-1434	4	44	20	20	NUM
ajlm-1434	4	45	apr	apr	NOUN
ajlm-1434	4	46	.	.	PUNCT
ajlm-1434	4	47	2022	2022	NUM
ajlm-1434	4	48	;	;	PUNCT
ajlm-1434	4	49	published	publish	VERB
ajlm-1434	4	50	:	:	PUNCT
ajlm-1434	4	51	26	26	NUM
ajlm-1434	4	52	july	july	PROPN
ajlm-1434	4	53	2022	2022	NUM
ajlm-1434	4	54	copyright	copyright	NOUN
ajlm-1434	4	55	:	:	PUNCT
ajlm-1434	4	56	©	©	PROPN
ajlm-1434	4	57	2022	2022	NUM
ajlm-1434	4	58	.	.	PUNCT
ajlm-1434	5	1	the	the	DET
ajlm-1434	5	2	author(s	author(s	PROPN
ajlm-1434	5	3	)	)	PUNCT
ajlm-1434	5	4	.	.	PUNCT
ajlm-1434	6	1	licensee	licensee	NOUN
ajlm-1434	6	2	:	:	PUNCT
ajlm-1434	6	3	aosis	aosis	NOUN
ajlm-1434	6	4	.	.	PUNCT
ajlm-1434	7	1	this	this	PRON
ajlm-1434	7	2	is	be	AUX
ajlm-1434	7	3	an	an	DET
ajlm-1434	7	4	open	open	ADJ
ajlm-1434	7	5	access	access	NOUN
ajlm-1434	7	6	article	article	NOUN
ajlm-1434	7	7	distributed	distribute	VERB
ajlm-1434	7	8	under	under	ADP
ajlm-1434	7	9	the	the	DET
ajlm-1434	7	10	terms	term	NOUN
ajlm-1434	7	11	of	of	ADP
ajlm-1434	7	12	the	the	DET
ajlm-1434	7	13	creative	creative	ADJ
ajlm-1434	7	14	commons	common	NOUN
ajlm-1434	7	15	attribution	attribution	NOUN
ajlm-1434	7	16	license	license	NOUN
ajlm-1434	7	17	,	,	PUNCT
ajlm-1434	7	18	which	which	PRON
ajlm-1434	7	19	permits	permit	VERB
ajlm-1434	7	20	unrestricted	unrestricted	ADJ
ajlm-1434	7	21	use	use	NOUN
ajlm-1434	7	22	,	,	PUNCT
ajlm-1434	7	23	distribution	distribution	NOUN
ajlm-1434	7	24	,	,	PUNCT
ajlm-1434	7	25	and	and	CCONJ
ajlm-1434	7	26	reproduction	reproduction	NOUN
ajlm-1434	7	27	in	in	ADP
ajlm-1434	7	28	any	any	DET
ajlm-1434	7	29	medium	medium	NOUN
ajlm-1434	7	30	,	,	PUNCT
ajlm-1434	7	31	provided	provide	VERB
ajlm-1434	7	32	the	the	DET
ajlm-1434	7	33	original	original	ADJ
ajlm-1434	7	34	work	work	NOUN
ajlm-1434	7	35	is	be	AUX
ajlm-1434	7	36	properly	properly	ADV
ajlm-1434	7	37	cited	cite	VERB
ajlm-1434	7	38	.	.	PUNCT
ajlm-1434	8	1	abstract	abstract	ADJ
ajlm-1434	8	2	background	background	NOUN
ajlm-1434	8	3	:	:	PUNCT
ajlm-1434	8	4	anti	anti	ADJ
ajlm-1434	8	5	-	-	ADJ
ajlm-1434	8	6	hepatitis	hepatitis	ADJ
ajlm-1434	8	7	b	b	NOUN
ajlm-1434	8	8	core	core	NOUN
ajlm-1434	8	9	antibody	antibody	NOUN
ajlm-1434	8	10	(	(	PUNCT
ajlm-1434	8	11	anti	anti	ADJ
ajlm-1434	8	12	-	-	ADJ
ajlm-1434	8	13	hbc	hbc	ADJ
ajlm-1434	8	14	)	)	PUNCT
ajlm-1434	8	15	testing	testing	NOUN
ajlm-1434	8	16	improves	improve	VERB
ajlm-1434	8	17	transfusion	transfusion	NOUN
ajlm-1434	8	18	safety	safety	NOUN
ajlm-1434	8	19	by	by	ADP
ajlm-1434	8	20	detecting	detect	VERB
ajlm-1434	8	21	past	past	NOUN
ajlm-1434	8	22	and	and	CCONJ
ajlm-1434	8	23	current	current	ADJ
ajlm-1434	8	24	hepatitis	hepatitis	PROPN
ajlm-1434	8	25	b	b	PROPN
ajlm-1434	8	26	virus	virus	NOUN
ajlm-1434	8	27	(	(	PUNCT
ajlm-1434	8	28	hbv	hbv	NOUN
ajlm-1434	8	29	)	)	PUNCT
ajlm-1434	8	30	infection	infection	NOUN
ajlm-1434	8	31	while	while	SCONJ
ajlm-1434	8	32	detecting	detect	VERB
ajlm-1434	8	33	hepatitis	hepatitis	PROPN
ajlm-1434	8	34	b	b	PROPN
ajlm-1434	8	35	surface	surface	NOUN
ajlm-1434	8	36	antigen	antigen	NOUN
ajlm-1434	8	37	(	(	PUNCT
ajlm-1434	8	38	hbsag	hbsag	NOUN
ajlm-1434	8	39	)	)	PUNCT
ajlm-1434	8	40	in	in	ADP
ajlm-1434	8	41	serology	serology	NOUN
ajlm-1434	8	42	-	-	PUNCT
ajlm-1434	8	43	negative	negative	ADJ
ajlm-1434	8	44	hbv	hbv	NOUN
ajlm-1434	8	45	infection	infection	NOUN
ajlm-1434	8	46	.	.	PUNCT
ajlm-1434	9	1	however	however	ADV
ajlm-1434	9	2	,	,	PUNCT
ajlm-1434	9	3	occult	occult	NOUN
ajlm-1434	9	4	hbv	hbv	NOUN
ajlm-1434	9	5	infection	infection	NOUN
ajlm-1434	9	6	(	(	PUNCT
ajlm-1434	9	7	obi	obi	PROPN
ajlm-1434	9	8	)	)	PUNCT
ajlm-1434	9	9	(	(	PUNCT
ajlm-1434	9	10	serum	serum	NOUN
ajlm-1434	9	11	or	or	CCONJ
ajlm-1434	9	12	liver	liver	NOUN
ajlm-1434	9	13	hbv	hbv	NOUN
ajlm-1434	9	14	dna	dna	NOUN
ajlm-1434	9	15	-	-	PUNCT
ajlm-1434	9	16	positive	positive	ADJ
ajlm-1434	9	17	but	but	CCONJ
ajlm-1434	9	18	hbsag	hbsag	ADJ
ajlm-1434	9	19	-	-	PUNCT
ajlm-1434	9	20	negative	negative	ADJ
ajlm-1434	9	21	)	)	PUNCT
ajlm-1434	9	22	remains	remain	VERB
ajlm-1434	9	23	unaddressed	unaddresse	VERB
ajlm-1434	9	24	among	among	ADP
ajlm-1434	9	25	replacement	replacement	NOUN
ajlm-1434	9	26	blood	blood	NOUN
ajlm-1434	9	27	donors	donor	NOUN
ajlm-1434	9	28	–	–	PUNCT
ajlm-1434	9	29	family	family	NOUN
ajlm-1434	9	30	members	member	NOUN
ajlm-1434	9	31	or	or	CCONJ
ajlm-1434	9	32	friends	friend	NOUN
ajlm-1434	9	33	who	who	PRON
ajlm-1434	9	34	donate	donate	VERB
ajlm-1434	9	35	to	to	PART
ajlm-1434	9	36	replace	replace	VERB
ajlm-1434	9	37	blood	blood	NOUN
ajlm-1434	9	38	transfused	transfuse	VERB
ajlm-1434	9	39	to	to	ADP
ajlm-1434	9	40	a	a	DET
ajlm-1434	9	41	relative	relative	NOUN
ajlm-1434	9	42	.	.	PUNCT
ajlm-1434	10	1	objective	objective	NOUN
ajlm-1434	10	2	:	:	PUNCT
ajlm-1434	10	3	this	this	DET
ajlm-1434	10	4	study	study	NOUN
ajlm-1434	10	5	assessed	assess	VERB
ajlm-1434	10	6	risk	risk	NOUN
ajlm-1434	10	7	factors	factor	NOUN
ajlm-1434	10	8	for	for	ADP
ajlm-1434	10	9	a	a	DET
ajlm-1434	10	10	positive	positive	ADJ
ajlm-1434	10	11	anti	anti	ADJ
ajlm-1434	10	12	-	-	ADJ
ajlm-1434	10	13	hbc	hbc	ADJ
ajlm-1434	10	14	test	test	NOUN
ajlm-1434	10	15	among	among	ADP
ajlm-1434	10	16	donors	donor	NOUN
ajlm-1434	10	17	with	with	ADP
ajlm-1434	10	18	obi	obi	PROPN
ajlm-1434	10	19	and	and	CCONJ
ajlm-1434	10	20	determined	determine	VERB
ajlm-1434	10	21	the	the	DET
ajlm-1434	10	22	anti	anti	ADJ
ajlm-1434	10	23	-	-	ADJ
ajlm-1434	10	24	hbc	hbc	ADJ
ajlm-1434	10	25	-	-	PUNCT
ajlm-1434	10	26	positive	positive	ADJ
ajlm-1434	10	27	status	status	NOUN
ajlm-1434	10	28	of	of	ADP
ajlm-1434	10	29	replacement	replacement	NOUN
ajlm-1434	10	30	donors	donor	NOUN
ajlm-1434	10	31	.	.	PUNCT
ajlm-1434	11	1	methods	method	NOUN
ajlm-1434	11	2	:	:	PUNCT
ajlm-1434	11	3	the	the	DET
ajlm-1434	11	4	study	study	NOUN
ajlm-1434	11	5	was	be	AUX
ajlm-1434	11	6	conducted	conduct	VERB
ajlm-1434	11	7	at	at	ADP
ajlm-1434	11	8	the	the	DET
ajlm-1434	11	9	university	university	NOUN
ajlm-1434	11	10	college	college	PROPN
ajlm-1434	11	11	hospital	hospital	PROPN
ajlm-1434	11	12	blood	blood	PROPN
ajlm-1434	11	13	bank	bank	PROPN
ajlm-1434	11	14	,	,	PUNCT
ajlm-1434	11	15	ibadan	ibadan	PROPN
ajlm-1434	11	16	,	,	PUNCT
ajlm-1434	11	17	nigeria	nigeria	PROPN
ajlm-1434	11	18	,	,	PUNCT
ajlm-1434	11	19	using	use	VERB
ajlm-1434	11	20	blood	blood	NOUN
ajlm-1434	11	21	samples	sample	NOUN
ajlm-1434	11	22	collected	collect	VERB
ajlm-1434	11	23	from	from	ADP
ajlm-1434	11	24	blood	blood	NOUN
ajlm-1434	11	25	donors	donor	NOUN
ajlm-1434	11	26	between	between	ADP
ajlm-1434	11	27	april	april	PROPN
ajlm-1434	11	28	2019	2019	NUM
ajlm-1434	11	29	and	and	CCONJ
ajlm-1434	11	30	may	may	PROPN
ajlm-1434	11	31	2019	2019	NUM
ajlm-1434	11	32	.	.	PUNCT
ajlm-1434	12	1	donors	donor	NOUN
ajlm-1434	12	2	were	be	AUX
ajlm-1434	12	3	screened	screen	VERB
ajlm-1434	12	4	for	for	ADP
ajlm-1434	12	5	hbsag	hbsag	NOUN
ajlm-1434	12	6	by	by	ADP
ajlm-1434	12	7	rapid	rapid	ADJ
ajlm-1434	12	8	diagnostic	diagnostic	ADJ
ajlm-1434	12	9	test	test	NOUN
ajlm-1434	12	10	(	(	PUNCT
ajlm-1434	12	11	rdt	rdt	PROPN
ajlm-1434	12	12	)	)	PUNCT
ajlm-1434	12	13	and	and	CCONJ
ajlm-1434	12	14	enzyme	enzyme	NOUN
ajlm-1434	12	15	-	-	PUNCT
ajlm-1434	12	16	linked	link	VERB
ajlm-1434	12	17	immunosorbent	immunosorbent	NOUN
ajlm-1434	12	18	assay	assay	PROPN
ajlm-1434	12	19	(	(	PUNCT
ajlm-1434	12	20	elisa	elisa	NOUN
ajlm-1434	12	21	)	)	PUNCT
ajlm-1434	12	22	and	and	CCONJ
ajlm-1434	12	23	anti	anti	ADJ
ajlm-1434	12	24	-	-	NOUN
ajlm-1434	12	25	hbc	hbc	NOUN
ajlm-1434	12	26	by	by	ADP
ajlm-1434	12	27	elisa	elisa	PROPN
ajlm-1434	12	28	,	,	PUNCT
ajlm-1434	12	29	while	while	SCONJ
ajlm-1434	12	30	hbv	hbv	PROPN
ajlm-1434	12	31	dna	dna	PROPN
ajlm-1434	12	32	was	be	AUX
ajlm-1434	12	33	detected	detect	VERB
ajlm-1434	12	34	using	use	VERB
ajlm-1434	12	35	a	a	DET
ajlm-1434	12	36	semi	semi	ADJ
ajlm-1434	12	37	-	-	ADJ
ajlm-1434	12	38	nested	nested	ADJ
ajlm-1434	12	39	polymerase	polymerase	NOUN
ajlm-1434	12	40	chain	chain	NOUN
ajlm-1434	12	41	reaction	reaction	NOUN
ajlm-1434	12	42	.	.	PUNCT
ajlm-1434	13	1	results	result	NOUN
ajlm-1434	13	2	:	:	PUNCT
ajlm-1434	13	3	of	of	ADP
ajlm-1434	13	4	the	the	DET
ajlm-1434	13	5	274	274	NUM
ajlm-1434	13	6	participants	participant	NOUN
ajlm-1434	13	7	,	,	PUNCT
ajlm-1434	13	8	15	15	NUM
ajlm-1434	13	9	(	(	PUNCT
ajlm-1434	13	10	5.5	5.5	NUM
ajlm-1434	13	11	%	%	NOUN
ajlm-1434	13	12	)	)	PUNCT
ajlm-1434	13	13	were	be	AUX
ajlm-1434	13	14	hbsag	hbsag	ADJ
ajlm-1434	13	15	-	-	PUNCT
ajlm-1434	13	16	positive	positive	ADJ
ajlm-1434	13	17	by	by	ADP
ajlm-1434	13	18	rdt	rdt	PROPN
ajlm-1434	13	19	and	and	CCONJ
ajlm-1434	13	20	36	36	NUM
ajlm-1434	13	21	(	(	PUNCT
ajlm-1434	13	22	13.1	13.1	NUM
ajlm-1434	13	23	%	%	NOUN
ajlm-1434	13	24	)	)	PUNCT
ajlm-1434	13	25	by	by	ADP
ajlm-1434	13	26	elisa	elisa	NOUN
ajlm-1434	13	27	,	,	PUNCT
ajlm-1434	13	28	while	while	SCONJ
ajlm-1434	13	29	133	133	NUM
ajlm-1434	13	30	(	(	PUNCT
ajlm-1434	13	31	48.5	48.5	NUM
ajlm-1434	13	32	%	%	NOUN
ajlm-1434	13	33	)	)	PUNCT
ajlm-1434	13	34	were	be	AUX
ajlm-1434	13	35	anti	anti	ADJ
ajlm-1434	13	36	-	-	ADJ
ajlm-1434	13	37	hbc	hbc	ADJ
ajlm-1434	13	38	positive	positive	NOUN
ajlm-1434	13	39	.	.	PUNCT
ajlm-1434	14	1	out	out	ADP
ajlm-1434	14	2	of	of	ADP
ajlm-1434	14	3	232	232	NUM
ajlm-1434	14	4	hbsag	hbsag	ADJ
ajlm-1434	14	5	-	-	PUNCT
ajlm-1434	14	6	negative	negative	ADJ
ajlm-1434	14	7	donors	donor	NOUN
ajlm-1434	14	8	,	,	PUNCT
ajlm-1434	14	9	107	107	NUM
ajlm-1434	14	10	(	(	PUNCT
ajlm-1434	14	11	46.1	46.1	NUM
ajlm-1434	14	12	%	%	NOUN
ajlm-1434	14	13	)	)	PUNCT
ajlm-1434	14	14	were	be	AUX
ajlm-1434	14	15	anti	anti	ADJ
ajlm-1434	14	16	-	-	ADJ
ajlm-1434	14	17	hbc	hbc	ADJ
ajlm-1434	14	18	positive	positive	NOUN
ajlm-1434	14	19	.	.	PUNCT
ajlm-1434	15	1	of	of	ADP
ajlm-1434	15	2	the	the	DET
ajlm-1434	15	3	107	107	NUM
ajlm-1434	15	4	hbsag	hbsag	ADJ
ajlm-1434	15	5	-	-	PUNCT
ajlm-1434	15	6	negative	negative	ADJ
ajlm-1434	15	7	but	but	CCONJ
ajlm-1434	15	8	anti	anti	ADJ
ajlm-1434	15	9	-	-	ADJ
ajlm-1434	15	10	hbc	hbc	ADJ
ajlm-1434	15	11	-	-	PUNCT
ajlm-1434	15	12	positive	positive	ADJ
ajlm-1434	15	13	samples	sample	NOUN
ajlm-1434	15	14	,	,	PUNCT
ajlm-1434	15	15	only	only	ADV
ajlm-1434	15	16	one	one	NUM
ajlm-1434	15	17	(	(	PUNCT
ajlm-1434	15	18	0.93	0.93	NUM
ajlm-1434	15	19	%	%	NOUN
ajlm-1434	15	20	)	)	PUNCT
ajlm-1434	15	21	was	be	AUX
ajlm-1434	15	22	hbv	hbv	NOUN
ajlm-1434	15	23	dna	dna	NOUN
ajlm-1434	15	24	-	-	PUNCT
ajlm-1434	15	25	positive	positive	ADJ
ajlm-1434	15	26	.	.	PUNCT
ajlm-1434	16	1	the	the	DET
ajlm-1434	16	2	hbv	hbv	NOUN
ajlm-1434	16	3	dna	dna	PROPN
ajlm-1434	16	4	-	-	PUNCT
ajlm-1434	16	5	positive	positive	ADJ
ajlm-1434	16	6	donor	donor	NOUN
ajlm-1434	16	7	was	be	AUX
ajlm-1434	16	8	hbsag	hbsag	NOUN
ajlm-1434	16	9	-	-	PUNCT
ajlm-1434	16	10	negative	negative	ADJ
ajlm-1434	16	11	by	by	ADP
ajlm-1434	16	12	both	both	CCONJ
ajlm-1434	16	13	rdt	rdt	PROPN
ajlm-1434	16	14	and	and	CCONJ
ajlm-1434	16	15	elisa	elisa	NOUN
ajlm-1434	16	16	tests	test	NOUN
ajlm-1434	16	17	.	.	PUNCT
ajlm-1434	17	1	conclusion	conclusion	NOUN
ajlm-1434	17	2	:	:	PUNCT
ajlm-1434	17	3	this	this	DET
ajlm-1434	17	4	study	study	NOUN
ajlm-1434	17	5	establishes	establish	VERB
ajlm-1434	17	6	a	a	DET
ajlm-1434	17	7	potential	potential	ADJ
ajlm-1434	17	8	risk	risk	NOUN
ajlm-1434	17	9	for	for	ADP
ajlm-1434	17	10	hbv	hbv	NOUN
ajlm-1434	17	11	transmission	transmission	NOUN
ajlm-1434	17	12	from	from	ADP
ajlm-1434	17	13	isolated	isolated	ADJ
ajlm-1434	17	14	anti	anti	ADJ
ajlm-1434	17	15	-	-	ADJ
ajlm-1434	17	16	hbc	hbc	ADJ
ajlm-1434	17	17	-	-	PUNCT
ajlm-1434	17	18	positive	positive	ADJ
ajlm-1434	17	19	donors	donor	NOUN
ajlm-1434	17	20	to	to	ADP
ajlm-1434	17	21	blood	blood	NOUN
ajlm-1434	17	22	recipients	recipient	NOUN
ajlm-1434	17	23	.	.	PUNCT
ajlm-1434	18	1	hbc	hbc	PROPN
ajlm-1434	18	2	immunoglobulin	immunoglobulin	NOUN
ajlm-1434	18	3	(	(	PUNCT
ajlm-1434	18	4	antibody	antibody	NOUN
ajlm-1434	18	5	)	)	PUNCT
ajlm-1434	18	6	m	m	AUX
ajlm-1434	18	7	testing	test	VERB
ajlm-1434	18	8	to	to	PART
ajlm-1434	18	9	identify	identify	VERB
ajlm-1434	18	10	blood	blood	NOUN
ajlm-1434	18	11	units	unit	NOUN
ajlm-1434	18	12	requiring	require	VERB
ajlm-1434	18	13	further	far	ADV
ajlm-1434	18	14	screening	screen	VERB
ajlm-1434	18	15	with	with	ADP
ajlm-1434	18	16	polymerase	polymerase	NOUN
ajlm-1434	18	17	chain	chain	NOUN
ajlm-1434	18	18	reaction	reaction	NOUN
ajlm-1434	18	19	to	to	PART
ajlm-1434	18	20	detect	detect	VERB
ajlm-1434	18	21	obi	obi	NOUN
ajlm-1434	18	22	can	can	AUX
ajlm-1434	18	23	prevent	prevent	VERB
ajlm-1434	18	24	hbv	hbv	NOUN
ajlm-1434	18	25	transmission	transmission	NOUN
ajlm-1434	18	26	through	through	ADP
ajlm-1434	18	27	blood	blood	NOUN
ajlm-1434	18	28	transfusion	transfusion	NOUN
ajlm-1434	18	29	.	.	PUNCT
ajlm-1434	19	1	keywords	keyword	NOUN
ajlm-1434	19	2	:	:	PUNCT
ajlm-1434	19	3	anti	anti	ADJ
ajlm-1434	19	4	-	-	ADJ
ajlm-1434	19	5	hbc	hbc	ADJ
ajlm-1434	19	6	antibodies	antibodie	VERB
ajlm-1434	19	7	;	;	PUNCT
ajlm-1434	20	1	donors	donor	NOUN
ajlm-1434	20	2	;	;	PUNCT
ajlm-1434	20	3	blood	blood	NOUN
ajlm-1434	20	4	safety	safety	NOUN
ajlm-1434	20	5	;	;	PUNCT
ajlm-1434	20	6	hbv	hbv	PROPN
ajlm-1434	20	7	dna	dna	PROPN
ajlm-1434	20	8	;	;	PUNCT
ajlm-1434	20	9	occult	occult	NOUN
ajlm-1434	20	10	hbv	hbv	NOUN
ajlm-1434	20	11	.	.	PUNCT
ajlm-1434	21	1	introduction	introduction	NOUN
ajlm-1434	21	2	blood	blood	NOUN
ajlm-1434	21	3	transfusion	transfusion	NOUN
ajlm-1434	21	4	is	be	AUX
ajlm-1434	21	5	an	an	DET
ajlm-1434	21	6	indispensable	indispensable	ADJ
ajlm-1434	21	7	life	life	NOUN
ajlm-1434	21	8	-	-	PUNCT
ajlm-1434	21	9	saving	save	VERB
ajlm-1434	21	10	therapy	therapy	NOUN
ajlm-1434	21	11	for	for	ADP
ajlm-1434	21	12	patient	patient	ADJ
ajlm-1434	21	13	management	management	NOUN
ajlm-1434	21	14	;	;	PUNCT
ajlm-1434	21	15	however	however	ADV
ajlm-1434	21	16	,	,	PUNCT
ajlm-1434	21	17	one	one	NUM
ajlm-1434	21	18	of	of	ADP
ajlm-1434	21	19	its	its	PRON
ajlm-1434	21	20	adverse	adverse	ADJ
ajlm-1434	21	21	effects	effect	NOUN
ajlm-1434	21	22	is	be	AUX
ajlm-1434	21	23	the	the	DET
ajlm-1434	21	24	potential	potential	NOUN
ajlm-1434	21	25	for	for	ADP
ajlm-1434	21	26	transmitting	transmit	VERB
ajlm-1434	21	27	infections	infection	NOUN
ajlm-1434	21	28	.	.	PUNCT
ajlm-1434	22	1	hepatitis	hepatitis	PROPN
ajlm-1434	22	2	b	b	PROPN
ajlm-1434	22	3	virus	virus	NOUN
ajlm-1434	22	4	(	(	PUNCT
ajlm-1434	22	5	hbv	hbv	NOUN
ajlm-1434	22	6	)	)	PUNCT
ajlm-1434	22	7	is	be	AUX
ajlm-1434	22	8	the	the	DET
ajlm-1434	22	9	most	most	ADV
ajlm-1434	22	10	frequent	frequent	ADJ
ajlm-1434	22	11	transfusion	transfusion	NOUN
ajlm-1434	22	12	-	-	PUNCT
ajlm-1434	22	13	transmitted	transmit	VERB
ajlm-1434	22	14	viral	viral	ADJ
ajlm-1434	22	15	infection.1	infection.1	NOUN
ajlm-1434	22	16	in	in	ADP
ajlm-1434	22	17	sub	sub	ADJ
ajlm-1434	22	18	-	-	ADJ
ajlm-1434	22	19	saharan	saharan	ADJ
ajlm-1434	22	20	africa	africa	PROPN
ajlm-1434	22	21	,	,	PUNCT
ajlm-1434	22	22	the	the	DET
ajlm-1434	22	23	median	median	ADJ
ajlm-1434	22	24	risk	risk	NOUN
ajlm-1434	22	25	of	of	ADP
ajlm-1434	22	26	hbv	hbv	NOUN
ajlm-1434	22	27	infection	infection	NOUN
ajlm-1434	22	28	following	follow	VERB
ajlm-1434	22	29	blood	blood	NOUN
ajlm-1434	22	30	transfusion	transfusion	NOUN
ajlm-1434	22	31	is	be	AUX
ajlm-1434	22	32	4.3/1000	4.3/1000	NUM
ajlm-1434	22	33	units2	units2	NOUN
ajlm-1434	22	34	and	and	CCONJ
ajlm-1434	22	35	the	the	DET
ajlm-1434	22	36	risk	risk	NOUN
ajlm-1434	22	37	from	from	ADP
ajlm-1434	22	38	blood	blood	NOUN
ajlm-1434	22	39	screened	screen	VERB
ajlm-1434	22	40	by	by	ADP
ajlm-1434	22	41	enzyme	enzyme	NOUN
ajlm-1434	22	42	immunoassay	immunoassay	NOUN
ajlm-1434	22	43	for	for	ADP
ajlm-1434	22	44	recipients	recipient	NOUN
ajlm-1434	22	45	younger	young	ADJ
ajlm-1434	22	46	than	than	ADP
ajlm-1434	22	47	ten	ten	NUM
ajlm-1434	22	48	years	year	NOUN
ajlm-1434	22	49	old	old	ADJ
ajlm-1434	22	50	is	be	AUX
ajlm-1434	22	51	1:326.3	1:326.3	NUM
ajlm-1434	22	52	due	due	ADP
ajlm-1434	22	53	to	to	ADP
ajlm-1434	22	54	its	its	PRON
ajlm-1434	22	55	public	public	ADJ
ajlm-1434	22	56	health	health	NOUN
ajlm-1434	22	57	burden	burden	NOUN
ajlm-1434	22	58	,	,	PUNCT
ajlm-1434	22	59	tackling	tackle	VERB
ajlm-1434	22	60	hbv	hbv	NOUN
ajlm-1434	22	61	is	be	AUX
ajlm-1434	22	62	a	a	DET
ajlm-1434	22	63	global	global	ADJ
ajlm-1434	22	64	health	health	NOUN
ajlm-1434	22	65	strategy	strategy	NOUN
ajlm-1434	22	66	for	for	ADP
ajlm-1434	22	67	achieving	achieve	VERB
ajlm-1434	22	68	the	the	DET
ajlm-1434	22	69	2030	2030	NUM
ajlm-1434	22	70	agenda	agenda	NOUN
ajlm-1434	22	71	for	for	ADP
ajlm-1434	22	72	sustainable	sustainable	ADJ
ajlm-1434	22	73	development.4	development.4	PROPN
ajlm-1434	22	74	when	when	SCONJ
ajlm-1434	22	75	an	an	DET
ajlm-1434	22	76	individual	individual	NOUN
ajlm-1434	22	77	has	have	VERB
ajlm-1434	22	78	an	an	DET
ajlm-1434	22	79	acute	acute	ADJ
ajlm-1434	22	80	-	-	PUNCT
ajlm-1434	22	81	phase	phase	NOUN
ajlm-1434	22	82	infection	infection	NOUN
ajlm-1434	22	83	,	,	PUNCT
ajlm-1434	22	84	the	the	DET
ajlm-1434	22	85	first	first	ADJ
ajlm-1434	22	86	viral	viral	ADJ
ajlm-1434	22	87	antigen	antigen	NOUN
ajlm-1434	22	88	to	to	PART
ajlm-1434	22	89	appear	appear	VERB
ajlm-1434	22	90	in	in	ADP
ajlm-1434	22	91	the	the	DET
ajlm-1434	22	92	blood	blood	NOUN
ajlm-1434	22	93	is	be	AUX
ajlm-1434	22	94	hepatitis	hepatitis	PROPN
ajlm-1434	22	95	b	b	PROPN
ajlm-1434	22	96	surface	surface	NOUN
ajlm-1434	22	97	antigen	antigen	NOUN
ajlm-1434	22	98	(	(	PUNCT
ajlm-1434	22	99	hbsag	hbsag	NOUN
ajlm-1434	22	100	)	)	PUNCT
ajlm-1434	22	101	,	,	PUNCT
ajlm-1434	22	102	which	which	PRON
ajlm-1434	22	103	persists	persist	VERB
ajlm-1434	22	104	even	even	ADV
ajlm-1434	22	105	in	in	ADP
ajlm-1434	22	106	the	the	DET
ajlm-1434	22	107	chronic	chronic	ADJ
ajlm-1434	22	108	phase	phase	NOUN
ajlm-1434	22	109	but	but	CCONJ
ajlm-1434	22	110	is	be	AUX
ajlm-1434	22	111	undetectable	undetectable	ADJ
ajlm-1434	22	112	when	when	SCONJ
ajlm-1434	22	113	the	the	DET
ajlm-1434	22	114	virus	virus	NOUN
ajlm-1434	22	115	is	be	AUX
ajlm-1434	22	116	cleared	clear	VERB
ajlm-1434	22	117	from	from	ADP
ajlm-1434	22	118	the	the	DET
ajlm-1434	22	119	blood	blood	NOUN
ajlm-1434	22	120	.	.	PUNCT
ajlm-1434	23	1	thus	thus	ADV
ajlm-1434	23	2	,	,	PUNCT
ajlm-1434	23	3	hbsag	hbsag	NOUN
ajlm-1434	23	4	is	be	AUX
ajlm-1434	23	5	the	the	DET
ajlm-1434	23	6	hbv	hbv	NOUN
ajlm-1434	23	7	infection	infection	NOUN
ajlm-1434	23	8	detection	detection	NOUN
ajlm-1434	23	9	marker	marker	NOUN
ajlm-1434	23	10	.	.	PUNCT
ajlm-1434	24	1	the	the	DET
ajlm-1434	24	2	hbv	hbv	NOUN
ajlm-1434	24	3	genome	genome	NOUN
ajlm-1434	24	4	is	be	AUX
ajlm-1434	24	5	enclosed	enclose	VERB
ajlm-1434	24	6	within	within	ADP
ajlm-1434	24	7	a	a	DET
ajlm-1434	24	8	‘	'	PUNCT
ajlm-1434	24	9	core	core	NOUN
ajlm-1434	24	10	particle	particle	NOUN
ajlm-1434	24	11	’	'	PUNCT
ajlm-1434	24	12	made	make	VERB
ajlm-1434	24	13	of	of	ADP
ajlm-1434	24	14	hepatitis	hepatitis	PROPN
ajlm-1434	24	15	b	b	NOUN
ajlm-1434	24	16	core	core	NOUN
ajlm-1434	24	17	protein	protein	NOUN
ajlm-1434	24	18	or	or	CCONJ
ajlm-1434	24	19	antigen	antigen	NOUN
ajlm-1434	24	20	(	(	PUNCT
ajlm-1434	24	21	hbc	hbc	PROPN
ajlm-1434	24	22	)	)	PUNCT
ajlm-1434	24	23	.	.	PUNCT
ajlm-1434	25	1	while	while	SCONJ
ajlm-1434	25	2	the	the	DET
ajlm-1434	25	3	host	host	NOUN
ajlm-1434	25	4	is	be	AUX
ajlm-1434	25	5	clearing	clear	VERB
ajlm-1434	25	6	the	the	DET
ajlm-1434	25	7	hbsag	hbsag	NOUN
ajlm-1434	25	8	by	by	ADP
ajlm-1434	25	9	developing	develop	VERB
ajlm-1434	25	10	hbsag	hbsag	ADJ
ajlm-1434	25	11	antibodies	antibody	NOUN
ajlm-1434	25	12	(	(	PUNCT
ajlm-1434	25	13	anti	anti	ADJ
ajlm-1434	25	14	-	-	ADJ
ajlm-1434	25	15	hbs	hbs	ADJ
ajlm-1434	25	16	)	)	PUNCT
ajlm-1434	25	17	,	,	PUNCT
ajlm-1434	25	18	the	the	DET
ajlm-1434	25	19	host	host	NOUN
ajlm-1434	25	20	also	also	ADV
ajlm-1434	25	21	produces	produce	VERB
ajlm-1434	25	22	hbc	hbc	PROPN
ajlm-1434	25	23	immunoglobulin	immunoglobulin	NOUN
ajlm-1434	25	24	(	(	PUNCT
ajlm-1434	25	25	antibody	antibody	NOUN
ajlm-1434	25	26	)	)	PUNCT
ajlm-1434	25	27	m.	m.	NOUN
ajlm-1434	25	28	during	during	ADP
ajlm-1434	25	29	this	this	DET
ajlm-1434	25	30	period	period	NOUN
ajlm-1434	25	31	,	,	PUNCT
ajlm-1434	25	32	known	know	VERB
ajlm-1434	25	33	as	as	ADP
ajlm-1434	25	34	the	the	DET
ajlm-1434	25	35	‘	'	PUNCT
ajlm-1434	25	36	window	window	NOUN
ajlm-1434	25	37	period	period	NOUN
ajlm-1434	25	38	’	'	PUNCT
ajlm-1434	25	39	,	,	PUNCT
ajlm-1434	25	40	the	the	DET
ajlm-1434	25	41	host	host	NOUN
ajlm-1434	25	42	is	be	AUX
ajlm-1434	25	43	infectious	infectious	ADJ
ajlm-1434	25	44	,	,	PUNCT
ajlm-1434	25	45	and	and	CCONJ
ajlm-1434	25	46	the	the	DET
ajlm-1434	25	47	serological	serological	ADJ
ajlm-1434	25	48	marker	marker	NOUN
ajlm-1434	25	49	for	for	ADP
ajlm-1434	25	50	infection	infection	NOUN
ajlm-1434	25	51	is	be	AUX
ajlm-1434	25	52	anti	anti	ADJ
ajlm-1434	25	53	-	-	ADJ
ajlm-1434	25	54	hbcigm,5	hbcigm,5	ADJ
ajlm-1434	25	55	as	as	SCONJ
ajlm-1434	25	56	the	the	DET
ajlm-1434	25	57	period	period	NOUN
ajlm-1434	25	58	is	be	AUX
ajlm-1434	25	59	associated	associate	VERB
ajlm-1434	25	60	with	with	ADP
ajlm-1434	25	61	undetectable	undetectable	ADJ
ajlm-1434	25	62	levels	level	NOUN
ajlm-1434	25	63	of	of	ADP
ajlm-1434	25	64	both	both	CCONJ
ajlm-1434	25	65	hbsag	hbsag	NOUN
ajlm-1434	25	66	and	and	CCONJ
ajlm-1434	25	67	anti	anti	ADJ
ajlm-1434	25	68	-	-	ADJ
ajlm-1434	25	69	hbsag	hbsag	ADJ
ajlm-1434	25	70	.	.	PUNCT
ajlm-1434	26	1	blood	blood	NOUN
ajlm-1434	26	2	donors	donor	NOUN
ajlm-1434	26	3	at	at	ADP
ajlm-1434	26	4	this	this	DET
ajlm-1434	26	5	infection	infection	NOUN
ajlm-1434	26	6	stage	stage	NOUN
ajlm-1434	26	7	(	(	PUNCT
ajlm-1434	26	8	tail	tail	NOUN
ajlm-1434	26	9	end	end	NOUN
ajlm-1434	26	10	carriers	carrier	NOUN
ajlm-1434	26	11	)	)	PUNCT
ajlm-1434	26	12	can	can	AUX
ajlm-1434	26	13	transmit	transmit	VERB
ajlm-1434	26	14	hbv.6	hbv.6	NOUN
ajlm-1434	26	15	progression	progression	NOUN
ajlm-1434	26	16	of	of	ADP
ajlm-1434	26	17	hbv	hbv	NOUN
ajlm-1434	26	18	infection	infection	NOUN
ajlm-1434	26	19	to	to	ADP
ajlm-1434	26	20	the	the	DET
ajlm-1434	26	21	chronic	chronic	ADJ
ajlm-1434	26	22	state	state	NOUN
ajlm-1434	26	23	is	be	AUX
ajlm-1434	26	24	associated	associate	VERB
ajlm-1434	26	25	with	with	ADP
ajlm-1434	26	26	the	the	DET
ajlm-1434	26	27	presence	presence	NOUN
ajlm-1434	26	28	of	of	ADP
ajlm-1434	26	29	both	both	DET
ajlm-1434	26	30	immunoglobin	immunoglobin	PROPN
ajlm-1434	26	31	g	g	PROPN
ajlm-1434	26	32	(	(	PUNCT
ajlm-1434	26	33	igg	igg	PROPN
ajlm-1434	26	34	)	)	PUNCT
ajlm-1434	26	35	and	and	CCONJ
ajlm-1434	26	36	immunoglobin	immunoglobin	PROPN
ajlm-1434	26	37	m	m	PROPN
ajlm-1434	26	38	(	(	PUNCT
ajlm-1434	26	39	igm	igm	PROPN
ajlm-1434	26	40	)	)	PUNCT
ajlm-1434	26	41	anti	anti	NOUN
ajlm-1434	26	42	-	-	NOUN
ajlm-1434	26	43	hbc	hbc	NOUN
ajlm-1434	26	44	against	against	ADP
ajlm-1434	26	45	hbc	hbc	PROPN
ajlm-1434	26	46	.	.	PUNCT
ajlm-1434	27	1	the	the	DET
ajlm-1434	27	2	natural	natural	ADJ
ajlm-1434	27	3	course	course	NOUN
ajlm-1434	27	4	of	of	ADP
ajlm-1434	27	5	infection	infection	NOUN
ajlm-1434	27	6	in	in	ADP
ajlm-1434	27	7	persons	person	NOUN
ajlm-1434	27	8	with	with	ADP
ajlm-1434	27	9	chronic	chronic	ADJ
ajlm-1434	27	10	hbv	hbv	NOUN
ajlm-1434	27	11	infection	infection	NOUN
ajlm-1434	27	12	could	could	AUX
ajlm-1434	27	13	terminate	terminate	VERB
ajlm-1434	27	14	as	as	ADP
ajlm-1434	27	15	‘	'	PUNCT
ajlm-1434	27	16	inactive	inactive	ADJ
ajlm-1434	27	17	carriers	carrier	NOUN
ajlm-1434	27	18	’	'	PUNCT
ajlm-1434	27	19	with	with	ADP
ajlm-1434	27	20	occult	occult	NOUN
ajlm-1434	27	21	hbv	hbv	NOUN
ajlm-1434	27	22	infection	infection	NOUN
ajlm-1434	27	23	(	(	PUNCT
ajlm-1434	27	24	obi	obi	PROPN
ajlm-1434	27	25	)	)	PUNCT
ajlm-1434	27	26	,	,	PUNCT
ajlm-1434	27	27	defined	define	VERB
ajlm-1434	27	28	as	as	ADP
ajlm-1434	27	29	the	the	DET
ajlm-1434	27	30	existence	existence	NOUN
ajlm-1434	27	31	of	of	ADP
ajlm-1434	27	32	low	low	ADJ
ajlm-1434	27	33	-	-	PUNCT
ajlm-1434	27	34	level	level	NOUN
ajlm-1434	27	35	hbv	hbv	NOUN
ajlm-1434	27	36	dna	dna	NOUN
ajlm-1434	27	37	in	in	ADP
ajlm-1434	27	38	the	the	DET
ajlm-1434	27	39	serum	serum	NOUN
ajlm-1434	27	40	(	(	PUNCT
ajlm-1434	27	41	<	<	X
ajlm-1434	27	42	200	200	NUM
ajlm-1434	27	43	iu	iu	NOUN
ajlm-1434	27	44	/	/	SYM
ajlm-1434	27	45	ml	ml	NOUN
ajlm-1434	27	46	)	)	PUNCT
ajlm-1434	27	47	,	,	PUNCT
ajlm-1434	27	48	cells	cell	NOUN
ajlm-1434	27	49	of	of	ADP
ajlm-1434	27	50	the	the	DET
ajlm-1434	27	51	lymphatic	lymphatic	ADJ
ajlm-1434	27	52	(	(	PUNCT
ajlm-1434	27	53	immune	immune	NOUN
ajlm-1434	27	54	)	)	PUNCT
ajlm-1434	27	55	system	system	NOUN
ajlm-1434	27	56	,	,	PUNCT
ajlm-1434	27	57	or	or	CCONJ
ajlm-1434	27	58	hepatic	hepatic	ADJ
ajlm-1434	27	59	tissue	tissue	NOUN
ajlm-1434	27	60	of	of	ADP
ajlm-1434	27	61	patients	patient	NOUN
ajlm-1434	27	62	with	with	ADP
ajlm-1434	27	63	serological	serological	ADJ
ajlm-1434	27	64	markers	marker	NOUN
ajlm-1434	27	65	of	of	ADP
ajlm-1434	27	66	the	the	DET
ajlm-1434	27	67	previous	previous	ADJ
ajlm-1434	27	68	infection	infection	NOUN
ajlm-1434	27	69	(	(	PUNCT
ajlm-1434	27	70	anti	anti	ADJ
ajlm-1434	27	71	-	-	ADJ
ajlm-1434	27	72	hbc	hbc	ADJ
ajlm-1434	27	73	or	or	CCONJ
ajlm-1434	27	74	anti	anti	ADJ
ajlm-1434	27	75	-	-	ADJ
ajlm-1434	27	76	hbs	hbs	ADJ
ajlm-1434	27	77	positive	positive	NOUN
ajlm-1434	27	78	)	)	PUNCT
ajlm-1434	27	79	and	and	CCONJ
ajlm-1434	27	80	the	the	DET
ajlm-1434	27	81	absence	absence	NOUN
ajlm-1434	27	82	of	of	ADP
ajlm-1434	27	83	serum	serum	NOUN
ajlm-1434	27	84	hbsag.7,8	hbsag.7,8	PROPN
ajlm-1434	27	85	hence	hence	ADV
ajlm-1434	27	86	,	,	PUNCT
ajlm-1434	27	87	positive	positive	ADJ
ajlm-1434	27	88	anti	anti	ADJ
ajlm-1434	27	89	-	-	ADJ
ajlm-1434	27	90	hbc	hbc	ADJ
ajlm-1434	27	91	is	be	AUX
ajlm-1434	27	92	considered	consider	VERB
ajlm-1434	27	93	a	a	DET
ajlm-1434	27	94	key	key	ADJ
ajlm-1434	27	95	obi	obi	NOUN
ajlm-1434	27	96	marker.9	marker.9	ADP
ajlm-1434	27	97	most	most	ADJ
ajlm-1434	27	98	blood	blood	NOUN
ajlm-1434	27	99	bank	bank	NOUN
ajlm-1434	27	100	screening	screen	VERB
ajlm-1434	27	101	panels	panel	NOUN
ajlm-1434	27	102	consist	consist	VERB
ajlm-1434	27	103	of	of	ADP
ajlm-1434	27	104	hbsag	hbsag	NOUN
ajlm-1434	27	105	and	and	CCONJ
ajlm-1434	27	106	anti	anti	ADJ
ajlm-1434	27	107	-	-	ADJ
ajlm-1434	27	108	hbc	hbc	ADJ
ajlm-1434	27	109	total	total	NOUN
ajlm-1434	27	110	(	(	PUNCT
ajlm-1434	27	111	igm	igm	NOUN
ajlm-1434	27	112	+	+	X
ajlm-1434	27	113	igg).10	igg).10	ADJ
ajlm-1434	27	114	the	the	DET
ajlm-1434	27	115	anti	anti	ADJ
ajlm-1434	27	116	-	-	ADJ
ajlm-1434	27	117	hbc	hbc	ADJ
ajlm-1434	27	118	total	total	NOUN
ajlm-1434	27	119	(	(	PUNCT
ajlm-1434	27	120	igm	igm	PROPN
ajlm-1434	27	121	+	+	CCONJ
ajlm-1434	27	122	igg	igg	PROPN
ajlm-1434	27	123	)	)	PUNCT
ajlm-1434	27	124	is	be	AUX
ajlm-1434	27	125	used	use	VERB
ajlm-1434	27	126	to	to	PART
ajlm-1434	27	127	detect	detect	VERB
ajlm-1434	27	128	both	both	PRON
ajlm-1434	27	129	previous	previous	ADJ
ajlm-1434	27	130	and	and	CCONJ
ajlm-1434	27	131	current	current	ADJ
ajlm-1434	27	132	hbv	hbv	NOUN
ajlm-1434	27	133	infection	infection	NOUN
ajlm-1434	27	134	.	.	PUNCT
ajlm-1434	28	1	the	the	DET
ajlm-1434	28	2	hbsag	hbsag	NOUN
ajlm-1434	28	3	,	,	PUNCT
ajlm-1434	28	4	anti	anti	ADJ
ajlm-1434	28	5	-	-	NOUN
ajlm-1434	28	6	hbc	hbc	ADJ
ajlm-1434	28	7	,	,	PUNCT
ajlm-1434	28	8	and	and	CCONJ
ajlm-1434	28	9	hbv	hbv	NOUN
ajlm-1434	28	10	nucleic	nucleic	ADJ
ajlm-1434	28	11	acid	acid	NOUN
ajlm-1434	28	12	tests	test	NOUN
ajlm-1434	28	13	(	(	PUNCT
ajlm-1434	28	14	nat	nat	NOUN
ajlm-1434	28	15	)	)	PUNCT
ajlm-1434	28	16	are	be	AUX
ajlm-1434	28	17	often	often	ADV
ajlm-1434	28	18	used	use	VERB
ajlm-1434	28	19	in	in	ADP
ajlm-1434	28	20	blood	blood	NOUN
ajlm-1434	28	21	banks	bank	NOUN
ajlm-1434	28	22	in	in	ADP
ajlm-1434	28	23	high	high	ADJ
ajlm-1434	28	24	-	-	PUNCT
ajlm-1434	28	25	income	income	NOUN
ajlm-1434	28	26	countries	country	NOUN
ajlm-1434	28	27	to	to	PART
ajlm-1434	28	28	detect	detect	VERB
ajlm-1434	28	29	infection	infection	NOUN
ajlm-1434	28	30	,	,	PUNCT
ajlm-1434	28	31	during	during	ADP
ajlm-1434	28	32	the	the	DET
ajlm-1434	28	33	window	window	NOUN
ajlm-1434	28	34	period	period	NOUN
ajlm-1434	28	35	,	,	PUNCT
ajlm-1434	28	36	obi	obi	PROPN
ajlm-1434	28	37	,	,	PUNCT
ajlm-1434	28	38	and	and	CCONJ
ajlm-1434	28	39	genetic	genetic	ADJ
ajlm-1434	28	40	and	and	CCONJ
ajlm-1434	28	41	antigenic	antigenic	ADJ
ajlm-1434	28	42	viral	viral	ADJ
ajlm-1434	28	43	variants	variant	NOUN
ajlm-1434	28	44	,	,	PUNCT
ajlm-1434	28	45	thus	thus	ADV
ajlm-1434	28	46	ensuring	ensure	VERB
ajlm-1434	28	47	optimal	optimal	ADJ
ajlm-1434	28	48	blood	blood	NOUN
ajlm-1434	28	49	safety	safety	NOUN
ajlm-1434	28	50	levels	level	NOUN
ajlm-1434	28	51	.	.	PUNCT
ajlm-1434	29	1	a	a	DET
ajlm-1434	29	2	substantial	substantial	ADJ
ajlm-1434	29	3	percentage	percentage	NOUN
ajlm-1434	29	4	of	of	ADP
ajlm-1434	29	5	blood	blood	NOUN
ajlm-1434	29	6	recipients	recipient	NOUN
ajlm-1434	29	7	are	be	AUX
ajlm-1434	29	8	likely	likely	ADJ
ajlm-1434	29	9	to	to	PART
ajlm-1434	29	10	be	be	AUX
ajlm-1434	29	11	the	the	DET
ajlm-1434	29	12	immunosuppressed	immunosuppressed	ADJ
ajlm-1434	29	13	,	,	PUNCT
ajlm-1434	29	14	women	woman	NOUN
ajlm-1434	29	15	,	,	PUNCT
ajlm-1434	29	16	and	and	CCONJ
ajlm-1434	29	17	children.11	children.11	VERB
ajlm-1434	29	18	transfusion	transfusion	NOUN
ajlm-1434	29	19	of	of	ADP
ajlm-1434	29	20	blood	blood	NOUN
ajlm-1434	29	21	from	from	ADP
ajlm-1434	29	22	obi	obi	NOUN
ajlm-1434	29	23	donors	donor	NOUN
ajlm-1434	29	24	to	to	ADP
ajlm-1434	29	25	pregnant	pregnant	ADJ
ajlm-1434	29	26	women	woman	NOUN
ajlm-1434	29	27	can	can	AUX
ajlm-1434	29	28	increase	increase	VERB
ajlm-1434	29	29	vertical	vertical	ADJ
ajlm-1434	29	30	transmission	transmission	NOUN
ajlm-1434	29	31	of	of	ADP
ajlm-1434	29	32	viral	viral	ADJ
ajlm-1434	29	33	hepatitis	hepatitis	NOUN
ajlm-1434	29	34	.	.	PUNCT
ajlm-1434	30	1	vertically	vertically	ADV
ajlm-1434	30	2	infected	infect	VERB
ajlm-1434	30	3	babies	baby	NOUN
ajlm-1434	30	4	are	be	AUX
ajlm-1434	30	5	prone	prone	ADJ
ajlm-1434	30	6	to	to	ADP
ajlm-1434	30	7	long	long	ADJ
ajlm-1434	30	8	-	-	PUNCT
ajlm-1434	30	9	term	term	NOUN
ajlm-1434	30	10	complications	complication	NOUN
ajlm-1434	30	11	of	of	ADP
ajlm-1434	30	12	hbv	hbv	NOUN
ajlm-1434	30	13	infection	infection	NOUN
ajlm-1434	30	14	,	,	PUNCT
ajlm-1434	30	15	such	such	ADJ
ajlm-1434	30	16	as	as	ADP
ajlm-1434	30	17	liver	liver	NOUN
ajlm-1434	30	18	disease	disease	NOUN
ajlm-1434	30	19	.	.	PUNCT
ajlm-1434	31	1	sadly	sadly	ADV
ajlm-1434	31	2	,	,	PUNCT
ajlm-1434	31	3	the	the	DET
ajlm-1434	31	4	university	university	NOUN
ajlm-1434	31	5	college	college	NOUN
ajlm-1434	31	6	hospital	hospital	NOUN
ajlm-1434	31	7	(	(	PUNCT
ajlm-1434	31	8	uch	uch	ADJ
ajlm-1434	31	9	)	)	PUNCT
ajlm-1434	31	10	blood	blood	NOUN
ajlm-1434	31	11	bank	bank	NOUN
ajlm-1434	31	12	in	in	ADP
ajlm-1434	31	13	ibadan	ibadan	PROPN
ajlm-1434	31	14	,	,	PUNCT
ajlm-1434	31	15	nigeria	nigeria	PROPN
ajlm-1434	31	16	,	,	PUNCT
ajlm-1434	31	17	can	can	AUX
ajlm-1434	31	18	not	not	PART
ajlm-1434	31	19	detect	detect	VERB
ajlm-1434	31	20	hbv	hbv	NOUN
ajlm-1434	31	21	infection	infection	NOUN
ajlm-1434	31	22	in	in	ADP
ajlm-1434	31	23	blood	blood	NOUN
ajlm-1434	31	24	donors	donor	NOUN
ajlm-1434	31	25	with	with	ADP
ajlm-1434	31	26	undetectable	undetectable	ADJ
ajlm-1434	31	27	hbsag	hbsag	NOUN
ajlm-1434	31	28	.	.	PUNCT
ajlm-1434	32	1	in	in	ADP
ajlm-1434	32	2	the	the	DET
ajlm-1434	32	3	uch	uch	ADJ
ajlm-1434	32	4	blood	blood	NOUN
ajlm-1434	32	5	bank	bank	NOUN
ajlm-1434	32	6	,	,	PUNCT
ajlm-1434	32	7	as	as	ADP
ajlm-1434	32	8	in	in	ADP
ajlm-1434	32	9	many	many	ADJ
ajlm-1434	32	10	developing	develop	VERB
ajlm-1434	32	11	countries	country	NOUN
ajlm-1434	32	12	,	,	PUNCT
ajlm-1434	32	13	most	most	ADJ
ajlm-1434	32	14	blood	blood	NOUN
ajlm-1434	32	15	units	unit	NOUN
ajlm-1434	32	16	are	be	AUX
ajlm-1434	32	17	from	from	ADP
ajlm-1434	32	18	replacement	replacement	NOUN
ajlm-1434	32	19	donors	donor	NOUN
ajlm-1434	32	20	,	,	PUNCT
ajlm-1434	32	21	against	against	ADP
ajlm-1434	32	22	the	the	DET
ajlm-1434	32	23	recommended	recommend	VERB
ajlm-1434	32	24	voluntary	voluntary	ADJ
ajlm-1434	32	25	blood	blood	NOUN
ajlm-1434	32	26	donors	donor	NOUN
ajlm-1434	32	27	for	for	ADP
ajlm-1434	32	28	safe	safe	ADJ
ajlm-1434	32	29	blood	blood	NOUN
ajlm-1434	32	30	supply	supply	NOUN
ajlm-1434	32	31	.	.	PUNCT
ajlm-1434	33	1	replacement	replacement	NOUN
ajlm-1434	33	2	blood	blood	NOUN
ajlm-1434	33	3	donors	donor	NOUN
ajlm-1434	33	4	are	be	AUX
ajlm-1434	33	5	family	family	NOUN
ajlm-1434	33	6	members	member	NOUN
ajlm-1434	33	7	or	or	CCONJ
ajlm-1434	33	8	friends	friend	NOUN
ajlm-1434	33	9	who	who	PRON
ajlm-1434	33	10	donate	donate	VERB
ajlm-1434	33	11	blood	blood	NOUN
ajlm-1434	33	12	to	to	PART
ajlm-1434	33	13	replace	replace	VERB
ajlm-1434	33	14	blood	blood	NOUN
ajlm-1434	33	15	transfused	transfuse	VERB
ajlm-1434	33	16	relatives	relative	NOUN
ajlm-1434	33	17	,	,	PUNCT
ajlm-1434	33	18	in	in	ADP
ajlm-1434	33	19	our	our	PRON
ajlm-1434	33	20	setting	set	VERB
ajlm-1434	33	21	pregnant	pregnant	ADJ
ajlm-1434	33	22	relatives	relative	NOUN
ajlm-1434	33	23	.	.	PUNCT
ajlm-1434	34	1	thus	thus	ADV
ajlm-1434	34	2	,	,	PUNCT
ajlm-1434	34	3	the	the	DET
ajlm-1434	34	4	inability	inability	NOUN
ajlm-1434	34	5	to	to	PART
ajlm-1434	34	6	detect	detect	VERB
ajlm-1434	34	7	hbv	hbv	NOUN
ajlm-1434	34	8	infection	infection	NOUN
ajlm-1434	34	9	in	in	ADP
ajlm-1434	34	10	blood	blood	NOUN
ajlm-1434	34	11	donors	donor	NOUN
ajlm-1434	34	12	with	with	ADP
ajlm-1434	34	13	undetectable	undetectable	ADJ
ajlm-1434	34	14	hbsag	hbsag	NOUN
ajlm-1434	34	15	implies	imply	VERB
ajlm-1434	34	16	a	a	DET
ajlm-1434	34	17	possible	possible	ADJ
ajlm-1434	34	18	risk	risk	NOUN
ajlm-1434	34	19	of	of	ADP
ajlm-1434	34	20	post	post	ADJ
ajlm-1434	34	21	-	-	ADJ
ajlm-1434	34	22	transfusion	transfusion	ADJ
ajlm-1434	34	23	hepatitis	hepatitis	NOUN
ajlm-1434	34	24	from	from	ADP
ajlm-1434	34	25	anti	anti	ADJ
ajlm-1434	34	26	-	-	ADJ
ajlm-1434	34	27	hbc	hbc	ADJ
ajlm-1434	34	28	-	-	PUNCT
ajlm-1434	34	29	positive	positive	ADJ
ajlm-1434	34	30	individuals	individual	NOUN
ajlm-1434	34	31	.	.	PUNCT
ajlm-1434	35	1	therefore	therefore	ADV
ajlm-1434	35	2	,	,	PUNCT
ajlm-1434	35	3	it	it	PRON
ajlm-1434	35	4	is	be	AUX
ajlm-1434	35	5	imperative	imperative	ADJ
ajlm-1434	35	6	to	to	PART
ajlm-1434	35	7	determine	determine	VERB
ajlm-1434	35	8	the	the	DET
ajlm-1434	35	9	anti	anti	ADJ
ajlm-1434	35	10	-	-	ADJ
ajlm-1434	35	11	hbc	hbc	ADJ
ajlm-1434	35	12	positivity	positivity	NOUN
ajlm-1434	35	13	status	status	NOUN
ajlm-1434	35	14	of	of	ADP
ajlm-1434	35	15	replacement	replacement	NOUN
ajlm-1434	35	16	donors	donor	NOUN
ajlm-1434	35	17	who	who	PRON
ajlm-1434	35	18	constitute	constitute	VERB
ajlm-1434	35	19	the	the	DET
ajlm-1434	35	20	most	most	ADV
ajlm-1434	35	21	significant	significant	ADJ
ajlm-1434	35	22	proportion	proportion	NOUN
ajlm-1434	35	23	of	of	ADP
ajlm-1434	35	24	our	our	PRON
ajlm-1434	35	25	blood	blood	NOUN
ajlm-1434	35	26	donors5,10	donors5,10	NOUN
ajlm-1434	35	27	as	as	ADP
ajlm-1434	35	28	with	with	ADP
ajlm-1434	35	29	nigerian	nigerian	ADJ
ajlm-1434	35	30	hospital	hospital	NOUN
ajlm-1434	35	31	-	-	PUNCT
ajlm-1434	35	32	based	base	VERB
ajlm-1434	35	33	blood	blood	NOUN
ajlm-1434	35	34	banks.12	banks.12	ADP
ajlm-1434	35	35	anti	anti	ADJ
ajlm-1434	35	36	-	-	ADJ
ajlm-1434	35	37	hepatitis	hepatitis	ADJ
ajlm-1434	35	38	b	b	NOUN
ajlm-1434	35	39	core	core	NOUN
ajlm-1434	35	40	antibody	antibody	NOUN
ajlm-1434	35	41	tests	test	NOUN
ajlm-1434	35	42	and	and	CCONJ
ajlm-1434	35	43	nat	nat	NOUN
ajlm-1434	35	44	are	be	AUX
ajlm-1434	35	45	excluded	exclude	VERB
ajlm-1434	35	46	in	in	ADP
ajlm-1434	35	47	our	our	PRON
ajlm-1434	35	48	blood	blood	NOUN
ajlm-1434	35	49	donor	donor	NOUN
ajlm-1434	35	50	algorithm	algorithm	NOUN
ajlm-1434	35	51	;	;	PUNCT
ajlm-1434	35	52	therefore	therefore	ADV
ajlm-1434	35	53	,	,	PUNCT
ajlm-1434	35	54	this	this	DET
ajlm-1434	35	55	study	study	NOUN
ajlm-1434	35	56	aimed	aim	VERB
ajlm-1434	35	57	to	to	PART
ajlm-1434	35	58	assess	assess	VERB
ajlm-1434	35	59	the	the	DET
ajlm-1434	35	60	risk	risk	NOUN
ajlm-1434	35	61	factors	factor	NOUN
ajlm-1434	35	62	for	for	ADP
ajlm-1434	35	63	positive	positive	ADJ
ajlm-1434	35	64	anti	anti	ADJ
ajlm-1434	35	65	-	-	NOUN
ajlm-1434	35	66	hbc	hbc	NOUN
ajlm-1434	35	67	in	in	ADP
ajlm-1434	35	68	donors	donor	NOUN
ajlm-1434	35	69	and	and	CCONJ
ajlm-1434	35	70	the	the	DET
ajlm-1434	35	71	anti	anti	ADJ
ajlm-1434	35	72	-	-	ADJ
ajlm-1434	35	73	hbc	hbc	ADJ
ajlm-1434	35	74	status	status	NOUN
ajlm-1434	35	75	of	of	ADP
ajlm-1434	35	76	replacement	replacement	NOUN
ajlm-1434	35	77	donors	donor	NOUN
ajlm-1434	35	78	to	to	PART
ajlm-1434	35	79	improve	improve	VERB
ajlm-1434	35	80	blood	blood	NOUN
ajlm-1434	35	81	safety	safety	NOUN
ajlm-1434	35	82	.	.	PUNCT
ajlm-1434	36	1	methods	method	NOUN
ajlm-1434	36	2	ethical	ethical	ADJ
ajlm-1434	36	3	considerations	consideration	NOUN
ajlm-1434	36	4	the	the	DET
ajlm-1434	36	5	university	university	NOUN
ajlm-1434	36	6	of	of	ADP
ajlm-1434	36	7	ibadan	ibadan	PROPN
ajlm-1434	36	8	/	/	SYM
ajlm-1434	36	9	university	university	PROPN
ajlm-1434	36	10	college	college	NOUN
ajlm-1434	36	11	hospital	hospital	NOUN
ajlm-1434	36	12	(	(	PUNCT
ajlm-1434	36	13	ui	ui	NOUN
ajlm-1434	36	14	/	/	SYM
ajlm-1434	36	15	uch	uch	NOUN
ajlm-1434	36	16	)	)	PUNCT
ajlm-1434	36	17	ethics	ethic	NOUN
ajlm-1434	36	18	review	review	NOUN
ajlm-1434	36	19	team	team	NOUN
ajlm-1434	36	20	approved	approve	VERB
ajlm-1434	36	21	this	this	DET
ajlm-1434	36	22	research	research	NOUN
ajlm-1434	36	23	(	(	PUNCT
ajlm-1434	36	24	19/0204	19/0204	NUM
ajlm-1434	36	25	)	)	PUNCT
ajlm-1434	36	26	.	.	PUNCT
ajlm-1434	37	1	all	all	DET
ajlm-1434	37	2	recruited	recruit	VERB
ajlm-1434	37	3	participants	participant	NOUN
ajlm-1434	37	4	gave	give	VERB
ajlm-1434	37	5	written	write	VERB
ajlm-1434	37	6	informed	informed	ADJ
ajlm-1434	37	7	consent	consent	NOUN
ajlm-1434	37	8	.	.	PUNCT
ajlm-1434	38	1	the	the	DET
ajlm-1434	38	2	confidentiality	confidentiality	NOUN
ajlm-1434	38	3	of	of	ADP
ajlm-1434	38	4	participants	participant	NOUN
ajlm-1434	38	5	was	be	AUX
ajlm-1434	38	6	maintained	maintain	VERB
ajlm-1434	38	7	by	by	ADP
ajlm-1434	38	8	coding	code	VERB
ajlm-1434	38	9	the	the	DET
ajlm-1434	38	10	samples	sample	NOUN
ajlm-1434	38	11	,	,	PUNCT
ajlm-1434	38	12	and	and	CCONJ
ajlm-1434	38	13	only	only	ADV
ajlm-1434	38	14	authorised	authorise	VERB
ajlm-1434	38	15	personnel	personnel	NOUN
ajlm-1434	38	16	had	have	VERB
ajlm-1434	38	17	access	access	NOUN
ajlm-1434	38	18	to	to	ADP
ajlm-1434	38	19	participants	participant	NOUN
ajlm-1434	38	20	’	'	PUNCT
ajlm-1434	38	21	identities	identity	NOUN
ajlm-1434	38	22	.	.	PUNCT
ajlm-1434	39	1	study	study	NOUN
ajlm-1434	39	2	location	location	NOUN
ajlm-1434	39	3	and	and	CCONJ
ajlm-1434	39	4	participants	participant	NOUN
ajlm-1434	39	5	the	the	DET
ajlm-1434	39	6	research	research	NOUN
ajlm-1434	39	7	was	be	AUX
ajlm-1434	39	8	conducted	conduct	VERB
ajlm-1434	39	9	at	at	ADP
ajlm-1434	39	10	the	the	DET
ajlm-1434	39	11	blood	blood	NOUN
ajlm-1434	39	12	bank	bank	NOUN
ajlm-1434	39	13	of	of	ADP
ajlm-1434	39	14	uch	uch	NOUN
ajlm-1434	39	15	in	in	ADP
ajlm-1434	39	16	ibadan	ibadan	PROPN
ajlm-1434	39	17	,	,	PUNCT
ajlm-1434	39	18	nigeria	nigeria	PROPN
ajlm-1434	39	19	,	,	PUNCT
ajlm-1434	39	20	an	an	DET
ajlm-1434	39	21	850	850	NUM
ajlm-1434	39	22	-	-	PUNCT
ajlm-1434	39	23	bed	bed	NOUN
ajlm-1434	39	24	hospital	hospital	NOUN
ajlm-1434	39	25	with	with	ADP
ajlm-1434	39	26	163	163	NUM
ajlm-1434	39	27	examination	examination	NOUN
ajlm-1434	39	28	couches	couch	NOUN
ajlm-1434	39	29	,	,	PUNCT
ajlm-1434	39	30	excluding	exclude	VERB
ajlm-1434	39	31	private	private	ADJ
ajlm-1434	39	32	suites	suite	NOUN
ajlm-1434	39	33	.	.	PUNCT
ajlm-1434	40	1	this	this	DET
ajlm-1434	40	2	blood	blood	NOUN
ajlm-1434	40	3	bank	bank	NOUN
ajlm-1434	40	4	collects	collect	VERB
ajlm-1434	40	5	,	,	PUNCT
ajlm-1434	40	6	stores	store	NOUN
ajlm-1434	40	7	,	,	PUNCT
ajlm-1434	40	8	and	and	CCONJ
ajlm-1434	40	9	processes	process	VERB
ajlm-1434	40	10	blood	blood	NOUN
ajlm-1434	40	11	.	.	PUNCT
ajlm-1434	41	1	the	the	DET
ajlm-1434	41	2	target	target	NOUN
ajlm-1434	41	3	population	population	NOUN
ajlm-1434	41	4	were	be	AUX
ajlm-1434	41	5	replacement	replacement	NOUN
ajlm-1434	41	6	blood	blood	NOUN
ajlm-1434	41	7	donors	donor	NOUN
ajlm-1434	41	8	whom	whom	PRON
ajlm-1434	41	9	the	the	DET
ajlm-1434	41	10	patient	patient	NOUN
ajlm-1434	41	11	or	or	CCONJ
ajlm-1434	41	12	patient	patient	NOUN
ajlm-1434	41	13	’s	’s	PART
ajlm-1434	41	14	relatives	relative	NOUN
ajlm-1434	41	15	recruited	recruit	VERB
ajlm-1434	41	16	to	to	PART
ajlm-1434	41	17	replace	replace	VERB
ajlm-1434	41	18	blood	blood	NOUN
ajlm-1434	41	19	used	use	VERB
ajlm-1434	41	20	.	.	PUNCT
ajlm-1434	42	1	only	only	ADV
ajlm-1434	42	2	donors	donor	NOUN
ajlm-1434	42	3	who	who	PRON
ajlm-1434	42	4	presented	present	VERB
ajlm-1434	42	5	blood	blood	NOUN
ajlm-1434	42	6	donation	donation	NOUN
ajlm-1434	42	7	forms	form	NOUN
ajlm-1434	42	8	indicating	indicate	VERB
ajlm-1434	42	9	the	the	DET
ajlm-1434	42	10	patient	patient	NOUN
ajlm-1434	42	11	on	on	ADP
ajlm-1434	42	12	whose	whose	DET
ajlm-1434	42	13	behalf	behalf	NOUN
ajlm-1434	42	14	blood	blood	NOUN
ajlm-1434	42	15	was	be	AUX
ajlm-1434	42	16	being	be	AUX
ajlm-1434	42	17	donated	donate	VERB
ajlm-1434	42	18	were	be	AUX
ajlm-1434	42	19	eligible	eligible	ADJ
ajlm-1434	42	20	.	.	PUNCT
ajlm-1434	43	1	all	all	DET
ajlm-1434	43	2	donors	donor	NOUN
ajlm-1434	43	3	were	be	AUX
ajlm-1434	43	4	recruited	recruit	VERB
ajlm-1434	43	5	from	from	ADP
ajlm-1434	43	6	april	april	PROPN
ajlm-1434	43	7	2019	2019	NUM
ajlm-1434	43	8	to	to	ADP
ajlm-1434	43	9	may	may	PROPN
ajlm-1434	43	10	2019	2019	NUM
ajlm-1434	43	11	.	.	PUNCT
ajlm-1434	44	1	in	in	ADP
ajlm-1434	44	2	our	our	PRON
ajlm-1434	44	3	blood	blood	NOUN
ajlm-1434	44	4	bank	bank	NOUN
ajlm-1434	44	5	,	,	PUNCT
ajlm-1434	44	6	donors	donor	NOUN
ajlm-1434	44	7	were	be	AUX
ajlm-1434	44	8	allowed	allow	VERB
ajlm-1434	44	9	to	to	PART
ajlm-1434	44	10	donate	donate	VERB
ajlm-1434	44	11	blood	blood	NOUN
ajlm-1434	44	12	if	if	SCONJ
ajlm-1434	44	13	:	:	PUNCT
ajlm-1434	44	14	donors	donor	NOUN
ajlm-1434	44	15	were	be	AUX
ajlm-1434	44	16	between	between	ADP
ajlm-1434	44	17	18	18	NUM
ajlm-1434	44	18	and	and	CCONJ
ajlm-1434	44	19	65	65	NUM
ajlm-1434	44	20	years	year	NOUN
ajlm-1434	44	21	,	,	PUNCT
ajlm-1434	44	22	weighed	weigh	VERB
ajlm-1434	44	23	50	50	NUM
ajlm-1434	44	24	kg	kg	NOUN
ajlm-1434	44	25	and	and	CCONJ
ajlm-1434	44	26	above	above	ADV
ajlm-1434	44	27	,	,	PUNCT
ajlm-1434	44	28	passed	pass	VERB
ajlm-1434	44	29	the	the	DET
ajlm-1434	44	30	copper	copper	NOUN
ajlm-1434	44	31	sulphate	sulphate	NOUN
ajlm-1434	44	32	test	test	NOUN
ajlm-1434	44	33	and	and	CCONJ
ajlm-1434	44	34	the	the	DET
ajlm-1434	44	35	verbal	verbal	ADJ
ajlm-1434	44	36	questioning	questioning	NOUN
ajlm-1434	44	37	stage	stage	NOUN
ajlm-1434	44	38	,	,	PUNCT
ajlm-1434	44	39	and	and	CCONJ
ajlm-1434	44	40	were	be	AUX
ajlm-1434	44	41	negative	negative	ADJ
ajlm-1434	44	42	for	for	ADP
ajlm-1434	44	43	transfusion	transfusion	NOUN
ajlm-1434	44	44	-	-	PUNCT
ajlm-1434	44	45	transmitted	transmit	VERB
ajlm-1434	44	46	infections	infection	NOUN
ajlm-1434	44	47	,	,	PUNCT
ajlm-1434	44	48	including	include	VERB
ajlm-1434	44	49	syphilis	syphilis	PROPN
ajlm-1434	44	50	,	,	PUNCT
ajlm-1434	44	51	hiv	hiv	PROPN
ajlm-1434	44	52	,	,	PUNCT
ajlm-1434	44	53	hbv	hbv	NOUN
ajlm-1434	44	54	and	and	CCONJ
ajlm-1434	44	55	hepatitis	hepatitis	PROPN
ajlm-1434	44	56	c	c	PROPN
ajlm-1434	44	57	virus	virus	NOUN
ajlm-1434	44	58	.	.	PUNCT
ajlm-1434	45	1	donors	donor	NOUN
ajlm-1434	45	2	were	be	AUX
ajlm-1434	45	3	excluded	exclude	VERB
ajlm-1434	45	4	from	from	ADP
ajlm-1434	45	5	this	this	DET
ajlm-1434	45	6	study	study	NOUN
ajlm-1434	45	7	if	if	SCONJ
ajlm-1434	45	8	they	they	PRON
ajlm-1434	45	9	:	:	PUNCT
ajlm-1434	45	10	voluntarily	voluntarily	ADV
ajlm-1434	45	11	came	come	VERB
ajlm-1434	45	12	to	to	PART
ajlm-1434	45	13	donate	donate	VERB
ajlm-1434	45	14	blood	blood	NOUN
ajlm-1434	45	15	,	,	PUNCT
ajlm-1434	45	16	had	have	VERB
ajlm-1434	45	17	a	a	DET
ajlm-1434	45	18	tattoo	tattoo	NOUN
ajlm-1434	45	19	(	(	PUNCT
ajlm-1434	45	20	exclusive	exclusive	NOUN
ajlm-1434	45	21	of	of	ADP
ajlm-1434	45	22	tribal	tribal	ADJ
ajlm-1434	45	23	marks	mark	NOUN
ajlm-1434	45	24	obtained	obtain	VERB
ajlm-1434	45	25	from	from	ADP
ajlm-1434	45	26	infancy	infancy	NOUN
ajlm-1434	45	27	)	)	PUNCT
ajlm-1434	45	28	,	,	PUNCT
ajlm-1434	45	29	failed	fail	VERB
ajlm-1434	45	30	the	the	DET
ajlm-1434	45	31	copper	copper	NOUN
ajlm-1434	45	32	sulphate	sulphate	NOUN
ajlm-1434	45	33	screening	screen	VERB
ajlm-1434	45	34	test	test	NOUN
ajlm-1434	45	35	or	or	CCONJ
ajlm-1434	45	36	failed	fail	VERB
ajlm-1434	45	37	routine	routine	ADJ
ajlm-1434	45	38	eligibility	eligibility	NOUN
ajlm-1434	45	39	questioning	question	VERB
ajlm-1434	45	40	by	by	ADP
ajlm-1434	45	41	blood	blood	NOUN
ajlm-1434	45	42	bank	bank	NOUN
ajlm-1434	45	43	staff	staff	NOUN
ajlm-1434	45	44	(	(	PUNCT
ajlm-1434	45	45	which	which	PRON
ajlm-1434	45	46	includes	include	VERB
ajlm-1434	45	47	questions	question	NOUN
ajlm-1434	45	48	about	about	ADP
ajlm-1434	45	49	previous	previous	ADJ
ajlm-1434	45	50	blood	blood	NOUN
ajlm-1434	45	51	donations	donation	NOUN
ajlm-1434	45	52	,	,	PUNCT
ajlm-1434	45	53	breastfeeding	breastfeeding	NOUN
ajlm-1434	45	54	and	and	CCONJ
ajlm-1434	45	55	menstruation	menstruation	NOUN
ajlm-1434	45	56	status	status	NOUN
ajlm-1434	45	57	for	for	ADP
ajlm-1434	45	58	female	female	ADJ
ajlm-1434	45	59	donors	donor	NOUN
ajlm-1434	45	60	,	,	PUNCT
ajlm-1434	45	61	presence	presence	NOUN
ajlm-1434	45	62	of	of	ADP
ajlm-1434	45	63	any	any	DET
ajlm-1434	45	64	health	health	NOUN
ajlm-1434	45	65	condition	condition	NOUN
ajlm-1434	45	66	such	such	ADJ
ajlm-1434	45	67	as	as	ADP
ajlm-1434	45	68	hypertension	hypertension	NOUN
ajlm-1434	45	69	or	or	CCONJ
ajlm-1434	45	70	diabetes	diabetes	NOUN
ajlm-1434	45	71	,	,	PUNCT
ajlm-1434	45	72	and	and	CCONJ
ajlm-1434	45	73	hiv	hiv	PROPN
ajlm-1434	45	74	and	and	CCONJ
ajlm-1434	45	75	hepatitis	hepatitis	PROPN
ajlm-1434	45	76	c	c	PROPN
ajlm-1434	45	77	virus	virus	NOUN
ajlm-1434	45	78	status	status	NOUN
ajlm-1434	45	79	)	)	PUNCT
ajlm-1434	45	80	.	.	PUNCT
ajlm-1434	46	1	in	in	ADP
ajlm-1434	46	2	this	this	DET
ajlm-1434	46	3	study	study	NOUN
ajlm-1434	46	4	,	,	PUNCT
ajlm-1434	46	5	a	a	DET
ajlm-1434	46	6	questionnaire	questionnaire	NOUN
ajlm-1434	46	7	was	be	AUX
ajlm-1434	46	8	administered	administer	VERB
ajlm-1434	46	9	to	to	PART
ajlm-1434	46	10	include	include	VERB
ajlm-1434	46	11	consecutive	consecutive	ADJ
ajlm-1434	46	12	potential	potential	ADJ
ajlm-1434	46	13	replacement	replacement	NOUN
ajlm-1434	46	14	blood	blood	NOUN
ajlm-1434	46	15	donors	donor	NOUN
ajlm-1434	46	16	who	who	PRON
ajlm-1434	46	17	had	have	AUX
ajlm-1434	46	18	passed	pass	VERB
ajlm-1434	46	19	the	the	DET
ajlm-1434	46	20	copper	copper	NOUN
ajlm-1434	46	21	sulphate	sulphate	NOUN
ajlm-1434	46	22	test	test	NOUN
ajlm-1434	46	23	and	and	CCONJ
ajlm-1434	46	24	blood	blood	NOUN
ajlm-1434	46	25	bank	bank	NOUN
ajlm-1434	46	26	staff	staff	NOUN
ajlm-1434	46	27	eligibility	eligibility	NOUN
ajlm-1434	46	28	oral	oral	ADJ
ajlm-1434	46	29	questioning	questioning	NOUN
ajlm-1434	46	30	stage	stage	NOUN
ajlm-1434	46	31	.	.	PUNCT
ajlm-1434	47	1	the	the	DET
ajlm-1434	47	2	questionnaire	questionnaire	NOUN
ajlm-1434	47	3	was	be	AUX
ajlm-1434	47	4	translated	translate	VERB
ajlm-1434	47	5	into	into	ADP
ajlm-1434	47	6	the	the	DET
ajlm-1434	47	7	native	native	ADJ
ajlm-1434	47	8	language	language	NOUN
ajlm-1434	47	9	(	(	PUNCT
ajlm-1434	47	10	yoruba	yoruba	PROPN
ajlm-1434	47	11	)	)	PUNCT
ajlm-1434	47	12	for	for	ADP
ajlm-1434	47	13	non	non	ADJ
ajlm-1434	47	14	-	-	ADJ
ajlm-1434	47	15	english	english	ADJ
ajlm-1434	47	16	-	-	PUNCT
ajlm-1434	47	17	speaking	speak	VERB
ajlm-1434	47	18	participants	participant	NOUN
ajlm-1434	47	19	and	and	CCONJ
ajlm-1434	47	20	collected	collect	VERB
ajlm-1434	47	21	the	the	DET
ajlm-1434	47	22	patient	patient	NOUN
ajlm-1434	47	23	’s	’s	PART
ajlm-1434	47	24	demographic	demographic	ADJ
ajlm-1434	47	25	characteristics	characteristic	NOUN
ajlm-1434	47	26	and	and	CCONJ
ajlm-1434	47	27	knowledge	knowledge	NOUN
ajlm-1434	47	28	of	of	ADP
ajlm-1434	47	29	and	and	CCONJ
ajlm-1434	47	30	risk	risk	NOUN
ajlm-1434	47	31	factors	factor	NOUN
ajlm-1434	47	32	of	of	ADP
ajlm-1434	47	33	hbv	hbv	NOUN
ajlm-1434	47	34	.	.	PUNCT
ajlm-1434	48	1	four	four	NUM
ajlm-1434	48	2	questions	question	NOUN
ajlm-1434	48	3	tested	test	VERB
ajlm-1434	48	4	hbv	hbv	NOUN
ajlm-1434	48	5	knowledge	knowledge	NOUN
ajlm-1434	48	6	with	with	ADP
ajlm-1434	48	7	‘	'	PUNCT
ajlm-1434	48	8	yes	yes	NOUN
ajlm-1434	48	9	’	'	PUNCT
ajlm-1434	48	10	or	or	CCONJ
ajlm-1434	48	11	‘	'	PUNCT
ajlm-1434	48	12	no	no	PRON
ajlm-1434	48	13	’	'	PUNCT
ajlm-1434	48	14	questions	question	NOUN
ajlm-1434	48	15	.	.	PUNCT
ajlm-1434	49	1	each	each	DET
ajlm-1434	49	2	‘	'	PUNCT
ajlm-1434	49	3	yes	yes	ADJ
ajlm-1434	49	4	’	'	PUNCT
ajlm-1434	49	5	response	response	NOUN
ajlm-1434	49	6	scored	score	VERB
ajlm-1434	49	7	1	1	NUM
ajlm-1434	49	8	,	,	PUNCT
ajlm-1434	49	9	while	while	SCONJ
ajlm-1434	49	10	each	each	DET
ajlm-1434	49	11	‘	'	PUNCT
ajlm-1434	49	12	no	no	DET
ajlm-1434	49	13	’	'	PUNCT
ajlm-1434	49	14	response	response	NOUN
ajlm-1434	49	15	scored	score	VERB
ajlm-1434	49	16	0	0	NUM
ajlm-1434	49	17	.	.	PUNCT
ajlm-1434	50	1	knowledge	knowledge	NOUN
ajlm-1434	50	2	was	be	AUX
ajlm-1434	50	3	graded	grade	VERB
ajlm-1434	50	4	from	from	ADP
ajlm-1434	50	5	0	0	NUM
ajlm-1434	50	6	to	to	ADP
ajlm-1434	50	7	4	4	NUM
ajlm-1434	50	8	based	base	VERB
ajlm-1434	50	9	on	on	ADP
ajlm-1434	50	10	increasing	increase	VERB
ajlm-1434	50	11	correct	correct	ADJ
ajlm-1434	50	12	responses	response	NOUN
ajlm-1434	50	13	,	,	PUNCT
ajlm-1434	50	14	that	that	ADV
ajlm-1434	50	15	is	is	ADV
ajlm-1434	50	16	,	,	PUNCT
ajlm-1434	50	17	1	1	X
ajlm-1434	50	18	=	=	PUNCT
ajlm-1434	51	1	only	only	ADV
ajlm-1434	51	2	one	one	NUM
ajlm-1434	51	3	yes	yes	INTJ
ajlm-1434	51	4	,	,	PUNCT
ajlm-1434	51	5	2	2	NUM
ajlm-1434	51	6	=	=	SYM
ajlm-1434	51	7	two	two	NUM
ajlm-1434	51	8	yeses	yes	NOUN
ajlm-1434	51	9	,	,	PUNCT
ajlm-1434	51	10	3	3	NUM
ajlm-1434	51	11	=	=	SYM
ajlm-1434	51	12	three	three	NUM
ajlm-1434	51	13	yeses	yes	NOUN
ajlm-1434	51	14	and	and	CCONJ
ajlm-1434	51	15	4	4	NUM
ajlm-1434	51	16	=	=	SYM
ajlm-1434	51	17	four	four	NUM
ajlm-1434	51	18	yeses	yes	NOUN
ajlm-1434	51	19	.	.	PUNCT
ajlm-1434	52	1	sample	sample	NOUN
ajlm-1434	52	2	collection	collection	NOUN
ajlm-1434	52	3	six	six	NUM
ajlm-1434	52	4	millilitres	millilitre	NOUN
ajlm-1434	52	5	of	of	ADP
ajlm-1434	52	6	venous	venous	ADJ
ajlm-1434	52	7	blood	blood	NOUN
ajlm-1434	52	8	were	be	AUX
ajlm-1434	52	9	collected	collect	VERB
ajlm-1434	52	10	from	from	ADP
ajlm-1434	52	11	each	each	DET
ajlm-1434	52	12	donor	donor	NOUN
ajlm-1434	52	13	into	into	ADP
ajlm-1434	52	14	sterile	sterile	ADJ
ajlm-1434	52	15	plain	plain	ADJ
ajlm-1434	52	16	bottles	bottle	NOUN
ajlm-1434	52	17	labelled	label	VERB
ajlm-1434	52	18	with	with	ADP
ajlm-1434	52	19	the	the	DET
ajlm-1434	52	20	donor	donor	NOUN
ajlm-1434	52	21	’s	’s	PART
ajlm-1434	52	22	identity	identity	NOUN
ajlm-1434	52	23	number	number	NOUN
ajlm-1434	52	24	.	.	PUNCT
ajlm-1434	53	1	the	the	DET
ajlm-1434	53	2	blood	blood	NOUN
ajlm-1434	53	3	was	be	AUX
ajlm-1434	53	4	allowed	allow	VERB
ajlm-1434	53	5	to	to	PART
ajlm-1434	53	6	stand	stand	VERB
ajlm-1434	53	7	for	for	ADP
ajlm-1434	53	8	45	45	NUM
ajlm-1434	53	9	min	min	NOUN
ajlm-1434	53	10	,	,	PUNCT
ajlm-1434	53	11	and	and	CCONJ
ajlm-1434	53	12	then	then	ADV
ajlm-1434	53	13	the	the	DET
ajlm-1434	53	14	serum	serum	NOUN
ajlm-1434	53	15	was	be	AUX
ajlm-1434	53	16	separated	separate	VERB
ajlm-1434	53	17	by	by	ADP
ajlm-1434	53	18	centrifugation	centrifugation	NOUN
ajlm-1434	53	19	daily	daily	ADV
ajlm-1434	53	20	.	.	PUNCT
ajlm-1434	54	1	the	the	DET
ajlm-1434	54	2	serum	serum	NOUN
ajlm-1434	54	3	was	be	AUX
ajlm-1434	54	4	then	then	ADV
ajlm-1434	54	5	stored	store	VERB
ajlm-1434	54	6	in	in	ADP
ajlm-1434	54	7	two	two	NUM
ajlm-1434	54	8	aliquots	aliquot	NOUN
ajlm-1434	54	9	at	at	ADP
ajlm-1434	54	10	–	–	PUNCT
ajlm-1434	54	11	80	80	NUM
ajlm-1434	54	12	°	°	NOUN
ajlm-1434	54	13	c	c	NOUN
ajlm-1434	54	14	.	.	PUNCT
ajlm-1434	55	1	the	the	DET
ajlm-1434	55	2	samples	sample	NOUN
ajlm-1434	55	3	were	be	AUX
ajlm-1434	55	4	thawed	thaw	VERB
ajlm-1434	55	5	to	to	ADP
ajlm-1434	55	6	room	room	NOUN
ajlm-1434	55	7	temperature	temperature	NOUN
ajlm-1434	55	8	for	for	ADP
ajlm-1434	55	9	each	each	DET
ajlm-1434	55	10	laboratory	laboratory	NOUN
ajlm-1434	55	11	analysis	analysis	NOUN
ajlm-1434	55	12	.	.	PUNCT
ajlm-1434	56	1	the	the	DET
ajlm-1434	56	2	serological	serological	ADJ
ajlm-1434	56	3	tests	test	NOUN
ajlm-1434	56	4	were	be	AUX
ajlm-1434	56	5	performed	perform	VERB
ajlm-1434	56	6	a	a	DET
ajlm-1434	56	7	week	week	NOUN
ajlm-1434	56	8	after	after	ADP
ajlm-1434	56	9	collecting	collect	VERB
ajlm-1434	56	10	samples	sample	NOUN
ajlm-1434	56	11	,	,	PUNCT
ajlm-1434	56	12	and	and	CCONJ
ajlm-1434	56	13	the	the	DET
ajlm-1434	56	14	polymerase	polymerase	NOUN
ajlm-1434	56	15	chain	chain	NOUN
ajlm-1434	56	16	reaction	reaction	NOUN
ajlm-1434	56	17	(	(	PUNCT
ajlm-1434	56	18	pcr	pcr	NOUN
ajlm-1434	56	19	)	)	PUNCT
ajlm-1434	56	20	test	test	NOUN
ajlm-1434	56	21	was	be	AUX
ajlm-1434	56	22	carried	carry	VERB
ajlm-1434	56	23	out	out	ADP
ajlm-1434	56	24	in	in	ADP
ajlm-1434	56	25	july	july	PROPN
ajlm-1434	56	26	2019	2019	NUM
ajlm-1434	56	27	,	,	PUNCT
ajlm-1434	56	28	two	two	NUM
ajlm-1434	56	29	months	month	NOUN
ajlm-1434	56	30	after	after	ADP
ajlm-1434	56	31	the	the	DET
ajlm-1434	56	32	collection	collection	NOUN
ajlm-1434	56	33	of	of	ADP
ajlm-1434	56	34	samples	sample	NOUN
ajlm-1434	56	35	.	.	PUNCT
ajlm-1434	57	1	serology	serology	NOUN
ajlm-1434	57	2	the	the	DET
ajlm-1434	57	3	blood	blood	NOUN
ajlm-1434	57	4	bank	bank	NOUN
ajlm-1434	57	5	’s	’s	PART
ajlm-1434	57	6	screening	screen	VERB
ajlm-1434	57	7	algorithm	algorithm	NOUN
ajlm-1434	57	8	identifies	identify	VERB
ajlm-1434	57	9	a	a	DET
ajlm-1434	57	10	blood	blood	NOUN
ajlm-1434	57	11	donor	donor	NOUN
ajlm-1434	57	12	as	as	ADP
ajlm-1434	57	13	hbv	hbv	NOUN
ajlm-1434	57	14	-	-	PUNCT
ajlm-1434	57	15	positive	positive	ADJ
ajlm-1434	57	16	using	use	VERB
ajlm-1434	57	17	hbsag	hbsag	ADJ
ajlm-1434	57	18	rapid	rapid	ADJ
ajlm-1434	57	19	diagnostic	diagnostic	ADJ
ajlm-1434	57	20	test	test	NOUN
ajlm-1434	57	21	(	(	PUNCT
ajlm-1434	57	22	rdt	rdt	NOUN
ajlm-1434	57	23	)	)	PUNCT
ajlm-1434	57	24	kit	kit	NOUN
ajlm-1434	57	25	and	and	CCONJ
ajlm-1434	57	26	a	a	DET
ajlm-1434	57	27	conventional	conventional	ADJ
ajlm-1434	57	28	semi	semi	ADJ
ajlm-1434	57	29	-	-	ADJ
ajlm-1434	57	30	automated	automated	ADJ
ajlm-1434	57	31	enzyme	enzyme	NOUN
ajlm-1434	57	32	-	-	PUNCT
ajlm-1434	57	33	linked	link	VERB
ajlm-1434	57	34	immunosorbent	immunosorbent	NOUN
ajlm-1434	57	35	assay	assay	PROPN
ajlm-1434	57	36	(	(	PUNCT
ajlm-1434	57	37	elisa	elisa	NOUN
ajlm-1434	57	38	)	)	PUNCT
ajlm-1434	57	39	.	.	PUNCT
ajlm-1434	58	1	the	the	DET
ajlm-1434	58	2	bio	bio	ADJ
ajlm-1434	58	3	-	-	ADJ
ajlm-1434	58	4	check	check	ADJ
ajlm-1434	58	5	rapid	rapid	ADJ
ajlm-1434	58	6	kit	kit	NOUN
ajlm-1434	58	7	test	test	NOUN
ajlm-1434	58	8	(	(	PUNCT
ajlm-1434	58	9	bio	bio	NOUN
ajlm-1434	58	10	-	-	NOUN
ajlm-1434	58	11	check	check	NOUN
ajlm-1434	58	12	,	,	PUNCT
ajlm-1434	58	13	san	san	PROPN
ajlm-1434	58	14	francisco	francisco	PROPN
ajlm-1434	58	15	,	,	PUNCT
ajlm-1434	58	16	california	california	PROPN
ajlm-1434	58	17	,	,	PUNCT
ajlm-1434	58	18	united	united	PROPN
ajlm-1434	58	19	states	states	PROPN
ajlm-1434	58	20	)	)	PUNCT
ajlm-1434	58	21	employs	employ	VERB
ajlm-1434	58	22	lateral	lateral	ADJ
ajlm-1434	58	23	chromatographic	chromatographic	ADJ
ajlm-1434	58	24	flow	flow	NOUN
ajlm-1434	58	25	,	,	PUNCT
ajlm-1434	58	26	while	while	SCONJ
ajlm-1434	58	27	the	the	DET
ajlm-1434	58	28	monolisa	monolisa	NOUN
ajlm-1434	58	29	™	™	SCONJ
ajlm-1434	58	30	hbs	hbs	PROPN
ajlm-1434	58	31	ag	ag	PROPN
ajlm-1434	58	32	ultra	ultra	ADJ
ajlm-1434	58	33	elisa	elisa	PROPN
ajlm-1434	58	34	kit	kit	NOUN
ajlm-1434	58	35	(	(	PUNCT
ajlm-1434	58	36	bio	bio	NOUN
ajlm-1434	58	37	-	-	PROPN
ajlm-1434	58	38	rad	rad	ADJ
ajlm-1434	58	39	,	,	PUNCT
ajlm-1434	58	40	marnes	marne	NOUN
ajlm-1434	58	41	-	-	PUNCT
ajlm-1434	58	42	la	la	NOUN
ajlm-1434	58	43	-	-	PUNCT
ajlm-1434	58	44	coquette	coquette	NOUN
ajlm-1434	58	45	,	,	PUNCT
ajlm-1434	58	46	france	france	PROPN
ajlm-1434	58	47	)	)	PUNCT
ajlm-1434	58	48	employs	employ	VERB
ajlm-1434	58	49	a	a	DET
ajlm-1434	58	50	qualitative	qualitative	ADJ
ajlm-1434	58	51	one	one	NUM
ajlm-1434	58	52	-	-	PUNCT
ajlm-1434	58	53	step	step	NOUN
ajlm-1434	58	54	solid	solid	ADJ
ajlm-1434	58	55	-	-	PUNCT
ajlm-1434	58	56	phase	phase	NOUN
ajlm-1434	58	57	enzyme	enzyme	NOUN
ajlm-1434	58	58	-	-	PUNCT
ajlm-1434	58	59	linked	link	VERB
ajlm-1434	58	60	immunoassay	immunoassay	ADJ
ajlm-1434	58	61	technique	technique	NOUN
ajlm-1434	58	62	of	of	ADP
ajlm-1434	58	63	the	the	DET
ajlm-1434	58	64	‘	'	PUNCT
ajlm-1434	58	65	sandwich	sandwich	NOUN
ajlm-1434	58	66	’	'	PUNCT
ajlm-1434	58	67	type	type	NOUN
ajlm-1434	58	68	.	.	PUNCT
ajlm-1434	59	1	each	each	DET
ajlm-1434	59	2	test	test	NOUN
ajlm-1434	59	3	kit	kit	NOUN
ajlm-1434	59	4	came	come	VERB
ajlm-1434	59	5	with	with	ADP
ajlm-1434	59	6	positive	positive	ADJ
ajlm-1434	59	7	and	and	CCONJ
ajlm-1434	59	8	negative	negative	ADJ
ajlm-1434	59	9	controls	control	NOUN
ajlm-1434	59	10	used	use	VERB
ajlm-1434	59	11	in	in	ADP
ajlm-1434	59	12	each	each	DET
ajlm-1434	59	13	assay	assay	NOUN
ajlm-1434	59	14	.	.	PUNCT
ajlm-1434	60	1	first	first	ADV
ajlm-1434	60	2	,	,	PUNCT
ajlm-1434	60	3	the	the	DET
ajlm-1434	60	4	rapid	rapid	ADJ
ajlm-1434	60	5	test	test	NOUN
ajlm-1434	60	6	was	be	AUX
ajlm-1434	60	7	administered	administer	VERB
ajlm-1434	60	8	to	to	ADP
ajlm-1434	60	9	all	all	DET
ajlm-1434	60	10	donors	donor	NOUN
ajlm-1434	60	11	pre	pre	VERB
ajlm-1434	60	12	-	-	NOUN
ajlm-1434	60	13	donation	donation	NOUN
ajlm-1434	60	14	.	.	PUNCT
ajlm-1434	61	1	donors	donor	NOUN
ajlm-1434	61	2	who	who	PRON
ajlm-1434	61	3	were	be	AUX
ajlm-1434	61	4	hbsag	hbsag	ADJ
ajlm-1434	61	5	-	-	PUNCT
ajlm-1434	61	6	negative	negative	ADJ
ajlm-1434	61	7	by	by	ADP
ajlm-1434	61	8	the	the	DET
ajlm-1434	61	9	rapid	rapid	ADJ
ajlm-1434	61	10	test	test	NOUN
ajlm-1434	61	11	were	be	AUX
ajlm-1434	61	12	further	far	ADV
ajlm-1434	61	13	tested	test	VERB
ajlm-1434	61	14	with	with	ADP
ajlm-1434	61	15	the	the	DET
ajlm-1434	61	16	semi	semi	ADJ
ajlm-1434	61	17	-	-	ADJ
ajlm-1434	61	18	automated	automated	ADJ
ajlm-1434	61	19	elisa	elisa	NOUN
ajlm-1434	61	20	test	test	NOUN
ajlm-1434	61	21	.	.	PUNCT
ajlm-1434	62	1	then	then	ADV
ajlm-1434	62	2	,	,	PUNCT
ajlm-1434	62	3	using	use	VERB
ajlm-1434	62	4	one	one	NUM
ajlm-1434	62	5	of	of	ADP
ajlm-1434	62	6	the	the	DET
ajlm-1434	62	7	two	two	NUM
ajlm-1434	62	8	aliquots	aliquot	NOUN
ajlm-1434	62	9	of	of	ADP
ajlm-1434	62	10	sera	sera	NOUN
ajlm-1434	62	11	stored	store	VERB
ajlm-1434	62	12	,	,	PUNCT
ajlm-1434	62	13	all	all	DET
ajlm-1434	62	14	samples	sample	NOUN
ajlm-1434	62	15	were	be	AUX
ajlm-1434	62	16	tested	test	VERB
ajlm-1434	62	17	further	far	ADV
ajlm-1434	62	18	for	for	ADP
ajlm-1434	62	19	anti	anti	ADJ
ajlm-1434	62	20	-	-	NOUN
ajlm-1434	62	21	hbc	hbc	ADJ
ajlm-1434	62	22	using	use	VERB
ajlm-1434	62	23	the	the	DET
ajlm-1434	62	24	hbcab	hbcab	PROPN
ajlm-1434	62	25	elisa	elisa	PROPN
ajlm-1434	62	26	kit	kit	PROPN
ajlm-1434	62	27	(	(	PUNCT
ajlm-1434	62	28	melsin	melsin	PROPN
ajlm-1434	62	29	medical	medical	PROPN
ajlm-1434	62	30	co.	co.	PROPN
ajlm-1434	62	31	,	,	PUNCT
ajlm-1434	62	32	ltd	ltd	PROPN
ajlm-1434	62	33	,	,	PUNCT
ajlm-1434	62	34	changchun	changchun	PROPN
ajlm-1434	62	35	,	,	PUNCT
ajlm-1434	62	36	china	china	PROPN
ajlm-1434	62	37	)	)	PUNCT
ajlm-1434	62	38	.	.	PUNCT
ajlm-1434	63	1	the	the	DET
ajlm-1434	63	2	anti	anti	ADJ
ajlm-1434	63	3	-	-	ADJ
ajlm-1434	63	4	hbc	hbc	ADJ
ajlm-1434	63	5	assay	assay	NOUN
ajlm-1434	63	6	measures	measure	NOUN
ajlm-1434	63	7	the	the	DET
ajlm-1434	63	8	total	total	ADJ
ajlm-1434	63	9	anti	anti	ADJ
ajlm-1434	63	10	-	-	NOUN
ajlm-1434	63	11	hbc	hbc	NOUN
ajlm-1434	63	12	,	,	PUNCT
ajlm-1434	63	13	including	include	VERB
ajlm-1434	63	14	the	the	DET
ajlm-1434	63	15	igg	igg	PROPN
ajlm-1434	63	16	and	and	CCONJ
ajlm-1434	63	17	igm	igm	PROPN
ajlm-1434	63	18	hbc	hbc	PROPN
ajlm-1434	63	19	antibodies	antibodie	VERB
ajlm-1434	63	20	.	.	PUNCT
ajlm-1434	64	1	hepatitis	hepatitis	PROPN
ajlm-1434	64	2	b	b	PROPN
ajlm-1434	64	3	virus	virus	PROPN
ajlm-1434	64	4	dna	dna	PROPN
ajlm-1434	64	5	detection	detection	NOUN
ajlm-1434	64	6	sera	sera	NOUN
ajlm-1434	64	7	from	from	ADP
ajlm-1434	64	8	blood	blood	NOUN
ajlm-1434	64	9	donors	donor	NOUN
ajlm-1434	64	10	that	that	PRON
ajlm-1434	64	11	were	be	AUX
ajlm-1434	64	12	anti	anti	ADJ
ajlm-1434	64	13	-	-	ADJ
ajlm-1434	64	14	hbc	hbc	ADJ
ajlm-1434	64	15	positive	positive	ADJ
ajlm-1434	64	16	were	be	AUX
ajlm-1434	64	17	tested	test	VERB
ajlm-1434	64	18	for	for	ADP
ajlm-1434	64	19	hbv	hbv	NOUN
ajlm-1434	64	20	dna	dna	PROPN
ajlm-1434	64	21	with	with	ADP
ajlm-1434	64	22	primers	primer	NOUN
ajlm-1434	64	23	targeting	target	VERB
ajlm-1434	64	24	the	the	DET
ajlm-1434	64	25	hbv	hbv	NOUN
ajlm-1434	64	26	pre	pre	ADJ
ajlm-1434	64	27	-	-	PROPN
ajlm-1434	64	28	s	s	PART
ajlm-1434	64	29	gene	gene	NOUN
ajlm-1434	64	30	in	in	ADP
ajlm-1434	64	31	a	a	DET
ajlm-1434	64	32	semi	semi	ADJ
ajlm-1434	64	33	-	-	ADJ
ajlm-1434	64	34	nested	nested	ADJ
ajlm-1434	64	35	pcr	pcr	NOUN
ajlm-1434	64	36	protocol	protocol	NOUN
ajlm-1434	64	37	as	as	SCONJ
ajlm-1434	64	38	described	describe	VERB
ajlm-1434	64	39	below	below	ADV
ajlm-1434	64	40	.	.	PUNCT
ajlm-1434	65	1	briefly	briefly	ADV
ajlm-1434	65	2	,	,	PUNCT
ajlm-1434	65	3	the	the	DET
ajlm-1434	65	4	total	total	ADJ
ajlm-1434	65	5	hbv	hbv	NOUN
ajlm-1434	65	6	dna	dna	PROPN
ajlm-1434	65	7	was	be	AUX
ajlm-1434	65	8	extracted	extract	VERB
ajlm-1434	65	9	from	from	ADP
ajlm-1434	65	10	the	the	DET
ajlm-1434	65	11	samples	sample	NOUN
ajlm-1434	65	12	using	use	VERB
ajlm-1434	65	13	a	a	DET
ajlm-1434	65	14	dna	dna	PROPN
ajlm-1434	65	15	extraction	extraction	NOUN
ajlm-1434	65	16	method	method	NOUN
ajlm-1434	65	17	previously	previously	ADV
ajlm-1434	65	18	described	describe	VERB
ajlm-1434	65	19	by	by	ADP
ajlm-1434	65	20	wang	wang	PROPN
ajlm-1434	65	21	et	et	PROPN
ajlm-1434	65	22	al.12	al.12	VERB
ajlm-1434	65	23	the	the	DET
ajlm-1434	65	24	hbv	hbv	NOUN
ajlm-1434	65	25	pre	pre	ADJ
ajlm-1434	65	26	-	-	ADJ
ajlm-1434	65	27	s	s	PART
ajlm-1434	65	28	gene	gene	NOUN
ajlm-1434	65	29	was	be	AUX
ajlm-1434	65	30	amplified	amplify	VERB
ajlm-1434	65	31	in	in	ADP
ajlm-1434	65	32	a	a	DET
ajlm-1434	65	33	semi	semi	ADJ
ajlm-1434	65	34	-	-	ADJ
ajlm-1434	65	35	nested	nested	ADJ
ajlm-1434	65	36	pcr	pcr	NOUN
ajlm-1434	65	37	using	use	VERB
ajlm-1434	65	38	three	three	NUM
ajlm-1434	65	39	primers	primer	NOUN
ajlm-1434	65	40	.	.	PUNCT
ajlm-1434	66	1	the	the	DET
ajlm-1434	66	2	979	979	NUM
ajlm-1434	66	3	(	(	PUNCT
ajlm-1434	66	4	5ʹcaaaagacccacaattctttgacatactttccaa3ʹ	5ʹcaaaagacccacaattctttgacatactttccaa3ʹ	NUM
ajlm-1434	66	5	)	)	PUNCT
ajlm-1434	66	6	and	and	CCONJ
ajlm-1434	66	7	sf	sf	PROPN
ajlm-1434	66	8	(	(	PUNCT
ajlm-1434	66	9	5ʹgtgtcttggccaaaattcgcagt3ʹ	5ʹgtgtcttggccaaaattcgcagt3ʹ	NUM
ajlm-1434	66	10	)	)	PUNCT
ajlm-1434	66	11	primers	primer	NOUN
ajlm-1434	66	12	were	be	AUX
ajlm-1434	66	13	used	use	VERB
ajlm-1434	66	14	in	in	ADP
ajlm-1434	66	15	the	the	DET
ajlm-1434	66	16	first	first	ADJ
ajlm-1434	66	17	pcr	pcr	ADJ
ajlm-1434	66	18	run	run	NOUN
ajlm-1434	66	19	,	,	PUNCT
ajlm-1434	66	20	while	while	SCONJ
ajlm-1434	66	21	the	the	DET
ajlm-1434	66	22	primers	primer	NOUN
ajlm-1434	66	23	979	979	NUM
ajlm-1434	66	24	and	and	CCONJ
ajlm-1434	66	25	mc	mc	PROPN
ajlm-1434	66	26	-	-	PUNCT
ajlm-1434	66	27	f	f	PROPN
ajlm-1434	66	28	(	(	PUNCT
ajlm-1434	66	29	5ʹtcggatccggtatgttgcccgtttgtc3ʹ	5ʹtcggatccggtatgttgcccgtttgtc3ʹ	NUM
ajlm-1434	66	30	)	)	PUNCT
ajlm-1434	66	31	were	be	AUX
ajlm-1434	66	32	used	use	VERB
ajlm-1434	66	33	in	in	ADP
ajlm-1434	66	34	the	the	DET
ajlm-1434	66	35	second	second	ADJ
ajlm-1434	66	36	pcr	pcr	ADJ
ajlm-1434	66	37	round	round	NOUN
ajlm-1434	66	38	.	.	PUNCT
ajlm-1434	67	1	the	the	DET
ajlm-1434	67	2	cycling	cycling	NOUN
ajlm-1434	67	3	conditions	condition	NOUN
ajlm-1434	67	4	used	use	VERB
ajlm-1434	67	5	are	be	AUX
ajlm-1434	67	6	as	as	SCONJ
ajlm-1434	67	7	follows	follow	VERB
ajlm-1434	67	8	:	:	PUNCT
ajlm-1434	67	9	95	95	NUM
ajlm-1434	67	10	°	°	NUM
ajlm-1434	67	11	c	c	NOUN
ajlm-1434	67	12	for	for	ADP
ajlm-1434	67	13	5	5	NUM
ajlm-1434	67	14	min	min	NOUN
ajlm-1434	67	15	;	;	PUNCT
ajlm-1434	67	16	40	40	NUM
ajlm-1434	67	17	cycles	cycle	NOUN
ajlm-1434	67	18	of	of	ADP
ajlm-1434	67	19	95	95	NUM
ajlm-1434	67	20	°	°	ADP
ajlm-1434	67	21	c	c	NOUN
ajlm-1434	67	22	for	for	ADP
ajlm-1434	67	23	30	30	NUM
ajlm-1434	67	24	s	s	NOUN
ajlm-1434	67	25	,	,	PUNCT
ajlm-1434	67	26	60	60	NUM
ajlm-1434	67	27	°	°	NUM
ajlm-1434	67	28	c	c	NOUN
ajlm-1434	67	29	for	for	ADP
ajlm-1434	67	30	45	45	NUM
ajlm-1434	67	31	s	s	NOUN
ajlm-1434	67	32	,	,	PUNCT
ajlm-1434	67	33	and	and	CCONJ
ajlm-1434	67	34	72	72	NUM
ajlm-1434	67	35	°	°	NUM
ajlm-1434	67	36	c	c	NOUN
ajlm-1434	67	37	for	for	ADP
ajlm-1434	67	38	45	45	NUM
ajlm-1434	67	39	s	s	NOUN
ajlm-1434	67	40	;	;	PUNCT
ajlm-1434	67	41	and	and	CCONJ
ajlm-1434	67	42	a	a	DET
ajlm-1434	67	43	final	final	ADJ
ajlm-1434	67	44	extension	extension	NOUN
ajlm-1434	67	45	of	of	ADP
ajlm-1434	67	46	72	72	NUM
ajlm-1434	67	47	°	°	NOUN
ajlm-1434	67	48	c	c	NOUN
ajlm-1434	67	49	for	for	ADP
ajlm-1434	67	50	7	7	NUM
ajlm-1434	67	51	min	min	NOUN
ajlm-1434	67	52	.	.	PUNCT
ajlm-1434	68	1	the	the	DET
ajlm-1434	68	2	amplicon	amplicon	NOUN
ajlm-1434	68	3	of	of	ADP
ajlm-1434	68	4	~550	~550	PROPN
ajlm-1434	68	5	base	base	NOUN
ajlm-1434	68	6	pairs	pair	NOUN
ajlm-1434	68	7	was	be	AUX
ajlm-1434	68	8	analysed	analyse	VERB
ajlm-1434	68	9	by	by	ADP
ajlm-1434	68	10	gel	gel	NOUN
ajlm-1434	68	11	electrophoresis	electrophoresis	NOUN
ajlm-1434	68	12	using	use	VERB
ajlm-1434	68	13	2	2	NUM
ajlm-1434	68	14	%	%	NOUN
ajlm-1434	68	15	(	(	PUNCT
ajlm-1434	68	16	weight	weight	NOUN
ajlm-1434	68	17	/	/	SYM
ajlm-1434	68	18	volume	volume	NOUN
ajlm-1434	68	19	)	)	PUNCT
ajlm-1434	68	20	agarose	agarose	NOUN
ajlm-1434	68	21	gel	gel	NOUN
ajlm-1434	68	22	and	and	CCONJ
ajlm-1434	68	23	stained	stain	VERB
ajlm-1434	68	24	with	with	ADP
ajlm-1434	68	25	sybr	sybr	NOUN
ajlm-1434	68	26	stain	stain	NOUN
ajlm-1434	68	27	(	(	PUNCT
ajlm-1434	68	28	jena	jena	PROPN
ajlm-1434	68	29	biosciences	biosciences	PROPN
ajlm-1434	68	30	,	,	PUNCT
ajlm-1434	68	31	jena	jena	PROPN
ajlm-1434	68	32	,	,	PUNCT
ajlm-1434	68	33	germany	germany	PROPN
ajlm-1434	68	34	)	)	PUNCT
ajlm-1434	68	35	.	.	PUNCT
ajlm-1434	69	1	amplicons	amplicon	NOUN
ajlm-1434	69	2	were	be	AUX
ajlm-1434	69	3	visualised	visualise	VERB
ajlm-1434	69	4	in	in	ADP
ajlm-1434	69	5	an	an	DET
ajlm-1434	69	6	ultraviolet	ultraviolet	NOUN
ajlm-1434	69	7	illuminator	illuminator	NOUN
ajlm-1434	69	8	.	.	PUNCT
ajlm-1434	70	1	the	the	DET
ajlm-1434	70	2	negative	negative	ADJ
ajlm-1434	70	3	control	control	NOUN
ajlm-1434	70	4	was	be	AUX
ajlm-1434	70	5	a	a	DET
ajlm-1434	70	6	previously	previously	ADV
ajlm-1434	70	7	known	know	VERB
ajlm-1434	70	8	hbv	hbv	NOUN
ajlm-1434	70	9	-	-	PUNCT
ajlm-1434	70	10	negative	negative	ADJ
ajlm-1434	70	11	sample	sample	NOUN
ajlm-1434	70	12	,	,	PUNCT
ajlm-1434	70	13	while	while	SCONJ
ajlm-1434	70	14	the	the	DET
ajlm-1434	70	15	positive	positive	ADJ
ajlm-1434	70	16	control	control	NOUN
ajlm-1434	70	17	was	be	AUX
ajlm-1434	70	18	a	a	DET
ajlm-1434	70	19	previously	previously	ADV
ajlm-1434	70	20	confirmed	confirm	VERB
ajlm-1434	70	21	hbv	hbv	PROPN
ajlm-1434	70	22	dna	dna	PROPN
ajlm-1434	70	23	-	-	PUNCT
ajlm-1434	70	24	positive	positive	ADJ
ajlm-1434	70	25	sample	sample	NOUN
ajlm-1434	70	26	.	.	PUNCT
ajlm-1434	71	1	occult	occult	NOUN
ajlm-1434	71	2	hbv	hbv	NOUN
ajlm-1434	71	3	infection	infection	NOUN
ajlm-1434	71	4	was	be	AUX
ajlm-1434	71	5	defined	define	VERB
ajlm-1434	71	6	as	as	ADP
ajlm-1434	71	7	hbv	hbv	NOUN
ajlm-1434	71	8	dna	dna	NOUN
ajlm-1434	71	9	-	-	PUNCT
ajlm-1434	71	10	positive	positive	ADJ
ajlm-1434	71	11	,	,	PUNCT
ajlm-1434	71	12	and	and	CCONJ
ajlm-1434	71	13	serology	serology	NOUN
ajlm-1434	71	14	hbsag	hbsag	NOUN
ajlm-1434	71	15	-	-	PUNCT
ajlm-1434	71	16	negative	negative	ADJ
ajlm-1434	71	17	and	and	CCONJ
ajlm-1434	71	18	anti	anti	ADJ
ajlm-1434	71	19	-	-	ADJ
ajlm-1434	71	20	hbc	hbc	ADJ
ajlm-1434	71	21	positive	positive	NOUN
ajlm-1434	71	22	.	.	PUNCT
ajlm-1434	72	1	data	datum	NOUN
ajlm-1434	72	2	analysis	analysis	NOUN
ajlm-1434	72	3	statistical	statistical	ADJ
ajlm-1434	72	4	package	package	NOUN
ajlm-1434	72	5	for	for	ADP
ajlm-1434	72	6	social	social	ADJ
ajlm-1434	72	7	sciences	science	NOUN
ajlm-1434	72	8	version	version	NOUN
ajlm-1434	72	9	20	20	NUM
ajlm-1434	72	10	(	(	PUNCT
ajlm-1434	72	11	ibm	ibm	PROPN
ajlm-1434	72	12	corp	corp	PROPN
ajlm-1434	72	13	.	.	PROPN
ajlm-1434	72	14	,	,	PUNCT
ajlm-1434	72	15	chicago	chicago	PROPN
ajlm-1434	72	16	,	,	PUNCT
ajlm-1434	72	17	illinois	illinois	PROPN
ajlm-1434	72	18	,	,	PUNCT
ajlm-1434	72	19	united	united	PROPN
ajlm-1434	72	20	states	states	PROPN
ajlm-1434	72	21	)	)	PUNCT
ajlm-1434	72	22	was	be	AUX
ajlm-1434	72	23	used	use	VERB
ajlm-1434	72	24	.	.	PUNCT
ajlm-1434	73	1	frequencies	frequency	NOUN
ajlm-1434	73	2	and	and	CCONJ
ajlm-1434	73	3	percentages	percentage	NOUN
ajlm-1434	73	4	in	in	ADP
ajlm-1434	73	5	tables	table	NOUN
ajlm-1434	73	6	or	or	CCONJ
ajlm-1434	73	7	charts	chart	NOUN
ajlm-1434	73	8	were	be	AUX
ajlm-1434	73	9	used	use	VERB
ajlm-1434	73	10	to	to	PART
ajlm-1434	73	11	present	present	VERB
ajlm-1434	73	12	the	the	DET
ajlm-1434	73	13	demographic	demographic	ADJ
ajlm-1434	73	14	characteristics	characteristic	NOUN
ajlm-1434	73	15	,	,	PUNCT
ajlm-1434	73	16	risk	risk	NOUN
ajlm-1434	73	17	factors	factor	NOUN
ajlm-1434	73	18	for	for	ADP
ajlm-1434	73	19	hbv	hbv	NOUN
ajlm-1434	73	20	infection	infection	NOUN
ajlm-1434	73	21	among	among	ADP
ajlm-1434	73	22	donors	donor	NOUN
ajlm-1434	73	23	,	,	PUNCT
ajlm-1434	73	24	and	and	CCONJ
ajlm-1434	73	25	hepatitis	hepatitis	NOUN
ajlm-1434	73	26	b	b	PROPN
ajlm-1434	73	27	screening	screening	NOUN
ajlm-1434	73	28	results	result	NOUN
ajlm-1434	73	29	for	for	ADP
ajlm-1434	73	30	participants	participant	NOUN
ajlm-1434	73	31	.	.	PUNCT
ajlm-1434	74	1	means	mean	NOUN
ajlm-1434	74	2	and	and	CCONJ
ajlm-1434	74	3	standard	standard	ADJ
ajlm-1434	74	4	deviations	deviation	NOUN
ajlm-1434	74	5	were	be	AUX
ajlm-1434	74	6	used	use	VERB
ajlm-1434	74	7	to	to	PART
ajlm-1434	74	8	summarise	summarise	VERB
ajlm-1434	74	9	continuous	continuous	ADJ
ajlm-1434	74	10	variables	variable	NOUN
ajlm-1434	74	11	such	such	ADJ
ajlm-1434	74	12	as	as	ADP
ajlm-1434	74	13	the	the	DET
ajlm-1434	74	14	age	age	NOUN
ajlm-1434	74	15	of	of	ADP
ajlm-1434	74	16	participants	participant	NOUN
ajlm-1434	74	17	.	.	PUNCT
ajlm-1434	75	1	odds	odd	NOUN
ajlm-1434	75	2	ratios	ratio	NOUN
ajlm-1434	75	3	(	(	PUNCT
ajlm-1434	75	4	ors	or	NOUN
ajlm-1434	75	5	)	)	PUNCT
ajlm-1434	75	6	and	and	CCONJ
ajlm-1434	75	7	95	95	NUM
ajlm-1434	75	8	%	%	NOUN
ajlm-1434	75	9	confidence	confidence	NOUN
ajlm-1434	75	10	intervals	interval	NOUN
ajlm-1434	75	11	(	(	PUNCT
ajlm-1434	75	12	cis	cis	NOUN
ajlm-1434	75	13	)	)	PUNCT
ajlm-1434	75	14	were	be	AUX
ajlm-1434	75	15	calculated	calculate	VERB
ajlm-1434	75	16	to	to	PART
ajlm-1434	75	17	test	test	VERB
ajlm-1434	75	18	for	for	ADP
ajlm-1434	75	19	the	the	DET
ajlm-1434	75	20	association	association	NOUN
ajlm-1434	75	21	between	between	ADP
ajlm-1434	75	22	risk	risk	NOUN
ajlm-1434	75	23	factors	factor	NOUN
ajlm-1434	75	24	and	and	CCONJ
ajlm-1434	75	25	anti	anti	ADJ
ajlm-1434	75	26	-	-	ADJ
ajlm-1434	75	27	hbc	hbc	ADJ
ajlm-1434	75	28	positivity	positivity	NOUN
ajlm-1434	75	29	.	.	PUNCT
ajlm-1434	76	1	the	the	DET
ajlm-1434	76	2	chi	chi	NOUN
ajlm-1434	76	3	-	-	PUNCT
ajlm-1434	76	4	square	square	PROPN
ajlm-1434	76	5	was	be	AUX
ajlm-1434	76	6	also	also	ADV
ajlm-1434	76	7	used	use	VERB
ajlm-1434	76	8	to	to	PART
ajlm-1434	76	9	test	test	VERB
ajlm-1434	76	10	the	the	DET
ajlm-1434	76	11	association	association	NOUN
ajlm-1434	76	12	between	between	ADP
ajlm-1434	76	13	anti	anti	ADJ
ajlm-1434	76	14	-	-	ADJ
ajlm-1434	76	15	hbc	hbc	ADJ
ajlm-1434	76	16	,	,	PUNCT
ajlm-1434	76	17	socio	socio	NOUN
ajlm-1434	76	18	-	-	ADJ
ajlm-1434	76	19	demographic	demographic	ADJ
ajlm-1434	76	20	features	feature	NOUN
ajlm-1434	76	21	and	and	CCONJ
ajlm-1434	76	22	risk	risk	NOUN
ajlm-1434	76	23	factors	factor	NOUN
ajlm-1434	76	24	of	of	ADP
ajlm-1434	76	25	the	the	DET
ajlm-1434	76	26	participants	participant	NOUN
ajlm-1434	76	27	.	.	PUNCT
ajlm-1434	77	1	the	the	DET
ajlm-1434	77	2	statistical	statistical	ADJ
ajlm-1434	77	3	significance	significance	NOUN
ajlm-1434	77	4	was	be	AUX
ajlm-1434	77	5	set	set	VERB
ajlm-1434	77	6	at	at	ADP
ajlm-1434	77	7	p	p	NOUN
ajlm-1434	77	8	<	<	X
ajlm-1434	77	9	0.05	0.05	NUM
ajlm-1434	77	10	.	.	PUNCT
ajlm-1434	78	1	results	result	NOUN
ajlm-1434	78	2	socio	socio	VERB
ajlm-1434	78	3	-	-	ADJ
ajlm-1434	78	4	demographic	demographic	ADJ
ajlm-1434	78	5	and	and	CCONJ
ajlm-1434	78	6	risk	risk	NOUN
ajlm-1434	78	7	factors	factor	NOUN
ajlm-1434	78	8	for	for	ADP
ajlm-1434	78	9	acquisition	acquisition	NOUN
ajlm-1434	78	10	of	of	ADP
ajlm-1434	78	11	hepatitis	hepatitis	PROPN
ajlm-1434	78	12	b	b	PROPN
ajlm-1434	78	13	virus	virus	NOUN
ajlm-1434	78	14	infection	infection	NOUN
ajlm-1434	78	15	from	from	ADP
ajlm-1434	78	16	blood	blood	NOUN
ajlm-1434	78	17	donors	donor	NOUN
ajlm-1434	78	18	the	the	DET
ajlm-1434	78	19	274	274	NUM
ajlm-1434	78	20	participants	participant	NOUN
ajlm-1434	78	21	included	include	VERB
ajlm-1434	78	22	in	in	ADP
ajlm-1434	78	23	the	the	DET
ajlm-1434	78	24	study	study	NOUN
ajlm-1434	78	25	ranged	range	VERB
ajlm-1434	78	26	from	from	ADP
ajlm-1434	78	27	18	18	NUM
ajlm-1434	78	28	to	to	PART
ajlm-1434	78	29	62	62	NUM
ajlm-1434	78	30	years	year	NOUN
ajlm-1434	78	31	(	(	PUNCT
ajlm-1434	78	32	mean	mean	INTJ
ajlm-1434	78	33	age	age	NOUN
ajlm-1434	78	34	of	of	ADP
ajlm-1434	78	35	32.0	32.0	NUM
ajlm-1434	78	36	±	±	NUM
ajlm-1434	78	37	8.86	8.86	NUM
ajlm-1434	78	38	years	year	NOUN
ajlm-1434	78	39	)	)	PUNCT
ajlm-1434	78	40	.	.	PUNCT
ajlm-1434	79	1	approximately	approximately	ADV
ajlm-1434	79	2	half	half	NOUN
ajlm-1434	79	3	of	of	ADP
ajlm-1434	79	4	the	the	DET
ajlm-1434	79	5	participants	participant	NOUN
ajlm-1434	79	6	,	,	PUNCT
ajlm-1434	79	7	157	157	NUM
ajlm-1434	79	8	(	(	PUNCT
ajlm-1434	79	9	57.3	57.3	NUM
ajlm-1434	79	10	%	%	NOUN
ajlm-1434	79	11	)	)	PUNCT
ajlm-1434	79	12	,	,	PUNCT
ajlm-1434	79	13	were	be	AUX
ajlm-1434	79	14	married	marry	VERB
ajlm-1434	79	15	,	,	PUNCT
ajlm-1434	79	16	and	and	CCONJ
ajlm-1434	79	17	25	25	NUM
ajlm-1434	79	18	(	(	PUNCT
ajlm-1434	79	19	9.1	9.1	NUM
ajlm-1434	79	20	%	%	NOUN
ajlm-1434	79	21	)	)	PUNCT
ajlm-1434	79	22	had	have	VERB
ajlm-1434	79	23	multiple	multiple	ADJ
ajlm-1434	79	24	sexual	sexual	ADJ
ajlm-1434	79	25	partners	partner	NOUN
ajlm-1434	79	26	,	,	PUNCT
ajlm-1434	79	27	while	while	SCONJ
ajlm-1434	79	28	14	14	NUM
ajlm-1434	79	29	(	(	PUNCT
ajlm-1434	79	30	5.1	5.1	NUM
ajlm-1434	79	31	%	%	NOUN
ajlm-1434	79	32	)	)	PUNCT
ajlm-1434	79	33	had	have	AUX
ajlm-1434	79	34	been	be	AUX
ajlm-1434	79	35	previously	previously	ADV
ajlm-1434	79	36	treated	treat	VERB
ajlm-1434	79	37	for	for	ADP
ajlm-1434	79	38	a	a	DET
ajlm-1434	79	39	sexually	sexually	ADV
ajlm-1434	79	40	transmitted	transmit	VERB
ajlm-1434	79	41	disease	disease	NOUN
ajlm-1434	79	42	(	(	PUNCT
ajlm-1434	79	43	table	table	NOUN
ajlm-1434	79	44	1	1	NUM
ajlm-1434	79	45	)	)	PUNCT
ajlm-1434	79	46	.	.	PUNCT
ajlm-1434	80	1	twenty	twenty	NUM
ajlm-1434	80	2	-	-	PUNCT
ajlm-1434	80	3	eight	eight	NUM
ajlm-1434	80	4	(	(	PUNCT
ajlm-1434	80	5	10.2	10.2	NUM
ajlm-1434	80	6	%	%	NOUN
ajlm-1434	80	7	)	)	PUNCT
ajlm-1434	80	8	participants	participant	NOUN
ajlm-1434	80	9	had	have	VERB
ajlm-1434	80	10	scarification	scarification	NOUN
ajlm-1434	80	11	or	or	CCONJ
ajlm-1434	80	12	tribal	tribal	ADJ
ajlm-1434	80	13	marks	mark	NOUN
ajlm-1434	80	14	,	,	PUNCT
ajlm-1434	80	15	87	87	NUM
ajlm-1434	80	16	(	(	PUNCT
ajlm-1434	80	17	31.8	31.8	NUM
ajlm-1434	80	18	%	%	NOUN
ajlm-1434	80	19	)	)	PUNCT
ajlm-1434	80	20	shared	share	VERB
ajlm-1434	80	21	sharp	sharp	ADJ
ajlm-1434	80	22	objects	object	NOUN
ajlm-1434	80	23	(	(	PUNCT
ajlm-1434	80	24	pedicure	pedicure	NOUN
ajlm-1434	80	25	,	,	PUNCT
ajlm-1434	80	26	manicure	manicure	NOUN
ajlm-1434	80	27	and	and	CCONJ
ajlm-1434	80	28	use	use	NOUN
ajlm-1434	80	29	of	of	ADP
ajlm-1434	80	30	razor	razor	NOUN
ajlm-1434	80	31	blade	blade	NOUN
ajlm-1434	80	32	)	)	PUNCT
ajlm-1434	80	33	,	,	PUNCT
ajlm-1434	80	34	and	and	CCONJ
ajlm-1434	80	35	9	9	NUM
ajlm-1434	80	36	(	(	PUNCT
ajlm-1434	80	37	3.3	3.3	NUM
ajlm-1434	80	38	%	%	NOUN
ajlm-1434	80	39	)	)	PUNCT
ajlm-1434	80	40	had	have	AUX
ajlm-1434	80	41	previously	previously	ADV
ajlm-1434	80	42	used	use	VERB
ajlm-1434	80	43	sex	sex	NOUN
ajlm-1434	80	44	performance	performance	NOUN
ajlm-1434	80	45	enhancement	enhancement	NOUN
ajlm-1434	80	46	recreational	recreational	ADJ
ajlm-1434	80	47	drugs	drug	NOUN
ajlm-1434	80	48	.	.	PUNCT
ajlm-1434	81	1	furthermore	furthermore	ADV
ajlm-1434	81	2	,	,	PUNCT
ajlm-1434	81	3	18	18	NUM
ajlm-1434	81	4	(	(	PUNCT
ajlm-1434	81	5	6.6	6.6	NUM
ajlm-1434	81	6	%	%	NOUN
ajlm-1434	81	7	)	)	PUNCT
ajlm-1434	81	8	participants	participant	NOUN
ajlm-1434	81	9	had	have	AUX
ajlm-1434	81	10	been	be	AUX
ajlm-1434	81	11	previously	previously	ADV
ajlm-1434	81	12	transfused	transfuse	VERB
ajlm-1434	81	13	with	with	ADP
ajlm-1434	81	14	blood	blood	NOUN
ajlm-1434	81	15	,	,	PUNCT
ajlm-1434	81	16	7	7	NUM
ajlm-1434	81	17	(	(	PUNCT
ajlm-1434	81	18	2.2	2.2	NUM
ajlm-1434	81	19	%	%	NOUN
ajlm-1434	81	20	)	)	PUNCT
ajlm-1434	81	21	had	have	VERB
ajlm-1434	81	22	jaundice	jaundice	NOUN
ajlm-1434	81	23	in	in	ADP
ajlm-1434	81	24	the	the	DET
ajlm-1434	81	25	last	last	ADJ
ajlm-1434	81	26	year	year	NOUN
ajlm-1434	81	27	,	,	PUNCT
ajlm-1434	81	28	and	and	CCONJ
ajlm-1434	81	29	57	57	NUM
ajlm-1434	81	30	(	(	PUNCT
ajlm-1434	81	31	20.8	20.8	NUM
ajlm-1434	81	32	%	%	NOUN
ajlm-1434	81	33	)	)	PUNCT
ajlm-1434	81	34	had	have	AUX
ajlm-1434	81	35	been	be	AUX
ajlm-1434	81	36	asked	ask	VERB
ajlm-1434	81	37	to	to	PART
ajlm-1434	81	38	do	do	VERB
ajlm-1434	81	39	a	a	DET
ajlm-1434	81	40	test	test	NOUN
ajlm-1434	81	41	for	for	ADP
ajlm-1434	81	42	hepatitis	hepatitis	PROPN
ajlm-1434	81	43	b	b	PROPN
ajlm-1434	81	44	before	before	ADP
ajlm-1434	81	45	coming	come	VERB
ajlm-1434	81	46	to	to	PART
ajlm-1434	81	47	donate	donate	VERB
ajlm-1434	81	48	blood	blood	NOUN
ajlm-1434	81	49	.	.	PUNCT
ajlm-1434	82	1	participants	participant	NOUN
ajlm-1434	82	2	’	'	PUNCT
ajlm-1434	82	3	hbv	hbv	PROPN
ajlm-1434	82	4	knowledge	knowledge	NOUN
ajlm-1434	82	5	scores	score	NOUN
ajlm-1434	82	6	were	be	AUX
ajlm-1434	82	7	:	:	PUNCT
ajlm-1434	82	8	zero	zero	NUM
ajlm-1434	82	9	,	,	PUNCT
ajlm-1434	82	10	120	120	NUM
ajlm-1434	82	11	(	(	PUNCT
ajlm-1434	82	12	46.9	46.9	NUM
ajlm-1434	82	13	%	%	NOUN
ajlm-1434	82	14	)	)	PUNCT
ajlm-1434	82	15	;	;	PUNCT
ajlm-1434	82	16	one	one	NUM
ajlm-1434	82	17	,	,	PUNCT
ajlm-1434	82	18	29	29	NUM
ajlm-1434	82	19	(	(	PUNCT
ajlm-1434	82	20	11.3	11.3	NUM
ajlm-1434	82	21	%	%	NOUN
ajlm-1434	82	22	)	)	PUNCT
ajlm-1434	82	23	;	;	PUNCT
ajlm-1434	82	24	two	two	NUM
ajlm-1434	82	25	,	,	PUNCT
ajlm-1434	82	26	21	21	NUM
ajlm-1434	82	27	(	(	PUNCT
ajlm-1434	82	28	8.1	8.1	NUM
ajlm-1434	82	29	%	%	NOUN
ajlm-1434	82	30	)	)	PUNCT
ajlm-1434	82	31	;	;	PUNCT
ajlm-1434	82	32	three	three	NUM
ajlm-1434	82	33	,	,	PUNCT
ajlm-1434	82	34	57	57	NUM
ajlm-1434	82	35	(	(	PUNCT
ajlm-1434	82	36	22.3	22.3	NUM
ajlm-1434	82	37	%	%	NOUN
ajlm-1434	82	38	)	)	PUNCT
ajlm-1434	82	39	;	;	PUNCT
ajlm-1434	82	40	and	and	CCONJ
ajlm-1434	82	41	four	four	NUM
ajlm-1434	82	42	,	,	PUNCT
ajlm-1434	82	43	29	29	NUM
ajlm-1434	82	44	(	(	PUNCT
ajlm-1434	82	45	11.3	11.3	NUM
ajlm-1434	82	46	%	%	NOUN
ajlm-1434	82	47	)	)	PUNCT
ajlm-1434	82	48	.	.	PUNCT
ajlm-1434	83	1	table	table	NOUN
ajlm-1434	83	2	1	1	NUM
ajlm-1434	83	3	:	:	PUNCT
ajlm-1434	83	4	 	 	SPACE
ajlm-1434	83	5	demographic	demographic	ADJ
ajlm-1434	83	6	characteristics	characteristic	NOUN
ajlm-1434	83	7	of	of	ADP
ajlm-1434	83	8	274	274	NUM
ajlm-1434	83	9	blood	blood	NOUN
ajlm-1434	83	10	donors	donor	NOUN
ajlm-1434	83	11	in	in	ADP
ajlm-1434	83	12	ibadan	ibadan	PROPN
ajlm-1434	83	13	,	,	PUNCT
ajlm-1434	83	14	nigeria	nigeria	PROPN
ajlm-1434	83	15	,	,	PUNCT
ajlm-1434	83	16	between	between	ADP
ajlm-1434	83	17	april	april	PROPN
ajlm-1434	83	18	2019	2019	NUM
ajlm-1434	83	19	and	and	CCONJ
ajlm-1434	83	20	may	may	PROPN
ajlm-1434	83	21	2019	2019	NUM
ajlm-1434	83	22	.	.	PUNCT
ajlm-1434	84	1	risk	risk	NOUN
ajlm-1434	84	2	factors	factor	NOUN
ajlm-1434	84	3	for	for	ADP
ajlm-1434	84	4	hepatitis	hepatitis	PROPN
ajlm-1434	84	5	b	b	PROPN
ajlm-1434	84	6	virus	virus	NOUN
ajlm-1434	84	7	and	and	CCONJ
ajlm-1434	84	8	anti	anti	ADJ
ajlm-1434	84	9	-	-	ADJ
ajlm-1434	84	10	hepatitis	hepatitis	ADJ
ajlm-1434	84	11	b	b	NOUN
ajlm-1434	84	12	core	core	NOUN
ajlm-1434	84	13	protein	protein	NOUN
ajlm-1434	84	14	or	or	CCONJ
ajlm-1434	84	15	antigen	antigen	ADJ
ajlm-1434	84	16	positivity	positivity	NOUN
ajlm-1434	84	17	a	a	DET
ajlm-1434	84	18	total	total	NOUN
ajlm-1434	84	19	of	of	ADP
ajlm-1434	84	20	133	133	NUM
ajlm-1434	84	21	blood	blood	NOUN
ajlm-1434	84	22	donors	donor	NOUN
ajlm-1434	84	23	were	be	AUX
ajlm-1434	84	24	anti	anti	ADJ
ajlm-1434	84	25	-	-	ADJ
ajlm-1434	84	26	hbc	hbc	ADJ
ajlm-1434	84	27	positive	positive	NOUN
ajlm-1434	84	28	.	.	PUNCT
ajlm-1434	85	1	the	the	DET
ajlm-1434	85	2	proportion	proportion	NOUN
ajlm-1434	85	3	of	of	ADP
ajlm-1434	85	4	participants	participant	NOUN
ajlm-1434	85	5	aged	age	VERB
ajlm-1434	85	6	18–35	18–35	NUM
ajlm-1434	85	7	years	year	NOUN
ajlm-1434	85	8	with	with	ADP
ajlm-1434	85	9	a	a	DET
ajlm-1434	85	10	positive	positive	ADJ
ajlm-1434	85	11	anti	anti	ADJ
ajlm-1434	85	12	-	-	NOUN
ajlm-1434	85	13	hbc	hbc	ADJ
ajlm-1434	85	14	(	(	PUNCT
ajlm-1434	85	15	42.2	42.2	NUM
ajlm-1434	85	16	%	%	NOUN
ajlm-1434	85	17	)	)	PUNCT
ajlm-1434	85	18	was	be	AUX
ajlm-1434	85	19	lower	low	ADJ
ajlm-1434	85	20	than	than	ADP
ajlm-1434	85	21	the	the	DET
ajlm-1434	85	22	proportion	proportion	NOUN
ajlm-1434	85	23	of	of	ADP
ajlm-1434	85	24	participants	participant	NOUN
ajlm-1434	85	25	above	above	ADP
ajlm-1434	85	26	36	36	NUM
ajlm-1434	85	27	years	year	NOUN
ajlm-1434	85	28	with	with	ADP
ajlm-1434	85	29	a	a	DET
ajlm-1434	85	30	positive	positive	ADJ
ajlm-1434	85	31	anti	anti	ADJ
ajlm-1434	85	32	-	-	NOUN
ajlm-1434	85	33	hbc	hbc	ADJ
ajlm-1434	85	34	(	(	PUNCT
ajlm-1434	85	35	61.8	61.8	NUM
ajlm-1434	85	36	%	%	NOUN
ajlm-1434	85	37	)	)	PUNCT
ajlm-1434	85	38	.	.	PUNCT
ajlm-1434	86	1	donors	donor	NOUN
ajlm-1434	86	2	showed	show	VERB
ajlm-1434	86	3	a	a	DET
ajlm-1434	86	4	declining	decline	VERB
ajlm-1434	86	5	prevalence	prevalence	NOUN
ajlm-1434	86	6	of	of	ADP
ajlm-1434	86	7	anti	anti	NOUN
ajlm-1434	86	8	-	-	NOUN
ajlm-1434	86	9	hbc	hbc	NOUN
ajlm-1434	86	10	with	with	ADP
ajlm-1434	86	11	an	an	DET
ajlm-1434	86	12	increasing	increase	VERB
ajlm-1434	86	13	hbv	hbv	NOUN
ajlm-1434	86	14	knowledge	knowledge	NOUN
ajlm-1434	86	15	score	score	NOUN
ajlm-1434	86	16	(	(	PUNCT
ajlm-1434	86	17	p	p	X
ajlm-1434	86	18	=	=	NOUN
ajlm-1434	86	19	0.046	0.046	NUM
ajlm-1434	86	20	)	)	PUNCT
ajlm-1434	86	21	.	.	PUNCT
ajlm-1434	87	1	the	the	DET
ajlm-1434	87	2	odds	odd	NOUN
ajlm-1434	87	3	of	of	ADP
ajlm-1434	87	4	being	be	AUX
ajlm-1434	87	5	hbcab	hbcab	NOUN
ajlm-1434	87	6	positive	positive	ADJ
ajlm-1434	87	7	were	be	AUX
ajlm-1434	87	8	0.35	0.35	NUM
ajlm-1434	87	9	times	time	NOUN
ajlm-1434	87	10	less	less	ADV
ajlm-1434	87	11	likely	likely	ADJ
ajlm-1434	87	12	among	among	ADP
ajlm-1434	87	13	blood	blood	NOUN
ajlm-1434	87	14	donors	donor	NOUN
ajlm-1434	87	15	who	who	PRON
ajlm-1434	87	16	had	have	VERB
ajlm-1434	87	17	a	a	DET
ajlm-1434	87	18	knowledge	knowledge	NOUN
ajlm-1434	87	19	score	score	NOUN
ajlm-1434	87	20	of	of	ADP
ajlm-1434	87	21	4	4	NUM
ajlm-1434	87	22	than	than	ADP
ajlm-1434	87	23	blood	blood	NOUN
ajlm-1434	87	24	donors	donor	NOUN
ajlm-1434	87	25	who	who	PRON
ajlm-1434	87	26	had	have	VERB
ajlm-1434	87	27	a	a	DET
ajlm-1434	87	28	knowledge	knowledge	NOUN
ajlm-1434	87	29	score	score	NOUN
ajlm-1434	87	30	of	of	ADP
ajlm-1434	87	31	0	0	NUM
ajlm-1434	87	32	(	(	PUNCT
ajlm-1434	87	33	95	95	NUM
ajlm-1434	87	34	%	%	NOUN
ajlm-1434	87	35	ci	ci	NOUN
ajlm-1434	87	36	:	:	PUNCT
ajlm-1434	87	37	0.14	0.14	NUM
ajlm-1434	87	38	;	;	PUNCT
ajlm-1434	87	39	0.84	0.84	NUM
ajlm-1434	87	40	)	)	PUNCT
ajlm-1434	87	41	.	.	PUNCT
ajlm-1434	88	1	all	all	DET
ajlm-1434	88	2	9	9	NUM
ajlm-1434	88	3	participants	participant	NOUN
ajlm-1434	88	4	who	who	PRON
ajlm-1434	88	5	used	use	VERB
ajlm-1434	88	6	recreational	recreational	ADJ
ajlm-1434	88	7	drugs	drug	NOUN
ajlm-1434	88	8	had	have	VERB
ajlm-1434	88	9	a	a	DET
ajlm-1434	88	10	positive	positive	ADJ
ajlm-1434	88	11	anti	anti	ADJ
ajlm-1434	88	12	-	-	NOUN
ajlm-1434	88	13	hbc	hbc	NOUN
ajlm-1434	88	14	compared	compare	VERB
ajlm-1434	88	15	to	to	ADP
ajlm-1434	88	16	117/252	117/252	NUM
ajlm-1434	88	17	(	(	PUNCT
ajlm-1434	88	18	46.8	46.8	NUM
ajlm-1434	88	19	%	%	NOUN
ajlm-1434	88	20	)	)	PUNCT
ajlm-1434	88	21	of	of	ADP
ajlm-1434	88	22	participants	participant	NOUN
ajlm-1434	88	23	who	who	PRON
ajlm-1434	88	24	did	do	AUX
ajlm-1434	88	25	not	not	PART
ajlm-1434	88	26	use	use	VERB
ajlm-1434	88	27	(	(	PUNCT
ajlm-1434	88	28	p	p	X
ajlm-1434	88	29	=	=	NOUN
ajlm-1434	88	30	0.001	0.001	NUM
ajlm-1434	88	31	)	)	PUNCT
ajlm-1434	88	32	.	.	PUNCT
ajlm-1434	89	1	in	in	ADP
ajlm-1434	89	2	contrast	contrast	NOUN
ajlm-1434	89	3	,	,	PUNCT
ajlm-1434	89	4	there	there	PRON
ajlm-1434	89	5	was	be	VERB
ajlm-1434	89	6	a	a	DET
ajlm-1434	89	7	lower	low	ADJ
ajlm-1434	89	8	proportion	proportion	NOUN
ajlm-1434	89	9	of	of	ADP
ajlm-1434	89	10	participants	participant	NOUN
ajlm-1434	89	11	who	who	PRON
ajlm-1434	89	12	shared	share	VERB
ajlm-1434	89	13	sharp	sharp	ADJ
ajlm-1434	89	14	objects	object	NOUN
ajlm-1434	89	15	with	with	ADP
ajlm-1434	89	16	positive	positive	ADJ
ajlm-1434	89	17	anti	anti	ADJ
ajlm-1434	89	18	-	-	NOUN
ajlm-1434	89	19	hbc	hbc	ADJ
ajlm-1434	89	20	,	,	PUNCT
ajlm-1434	89	21	34	34	NUM
ajlm-1434	89	22	(	(	PUNCT
ajlm-1434	89	23	39.1	39.1	NUM
ajlm-1434	89	24	%	%	NOUN
ajlm-1434	89	25	)	)	PUNCT
ajlm-1434	89	26	,	,	PUNCT
ajlm-1434	89	27	compared	compare	VERB
ajlm-1434	89	28	to	to	ADP
ajlm-1434	89	29	96	96	NUM
ajlm-1434	89	30	(	(	PUNCT
ajlm-1434	89	31	52.9	52.9	NUM
ajlm-1434	89	32	%	%	NOUN
ajlm-1434	89	33	)	)	PUNCT
ajlm-1434	89	34	for	for	ADP
ajlm-1434	89	35	those	those	PRON
ajlm-1434	89	36	who	who	PRON
ajlm-1434	89	37	did	do	AUX
ajlm-1434	89	38	not	not	PART
ajlm-1434	89	39	share	share	VERB
ajlm-1434	89	40	(	(	PUNCT
ajlm-1434	89	41	table	table	NOUN
ajlm-1434	89	42	2	2	NUM
ajlm-1434	89	43	)	)	PUNCT
ajlm-1434	89	44	.	.	PUNCT
ajlm-1434	90	1	the	the	DET
ajlm-1434	90	2	sharp	sharp	ADJ
ajlm-1434	90	3	objects	object	NOUN
ajlm-1434	90	4	shared	share	VERB
ajlm-1434	90	5	included	include	VERB
ajlm-1434	90	6	blades	blade	NOUN
ajlm-1434	90	7	and	and	CCONJ
ajlm-1434	90	8	sharps	sharps	NOUN
ajlm-1434	90	9	used	use	VERB
ajlm-1434	90	10	for	for	ADP
ajlm-1434	90	11	a	a	DET
ajlm-1434	90	12	pedicure	pedicure	NOUN
ajlm-1434	90	13	,	,	PUNCT
ajlm-1434	90	14	manicure	manicure	NOUN
ajlm-1434	90	15	,	,	PUNCT
ajlm-1434	90	16	beauty	beauty	NOUN
ajlm-1434	90	17	treatment	treatment	NOUN
ajlm-1434	90	18	,	,	PUNCT
ajlm-1434	90	19	and	and	CCONJ
ajlm-1434	90	20	shaving	shaving	NOUN
ajlm-1434	90	21	hair	hair	NOUN
ajlm-1434	90	22	.	.	PUNCT
ajlm-1434	91	1	the	the	DET
ajlm-1434	91	2	age	age	NOUN
ajlm-1434	91	3	,	,	PUNCT
ajlm-1434	91	4	gender	gender	NOUN
ajlm-1434	91	5	,	,	PUNCT
ajlm-1434	91	6	educational	educational	ADJ
ajlm-1434	91	7	level	level	NOUN
ajlm-1434	91	8	,	,	PUNCT
ajlm-1434	91	9	number	number	NOUN
ajlm-1434	91	10	of	of	ADP
ajlm-1434	91	11	sexual	sexual	ADJ
ajlm-1434	91	12	partners	partner	NOUN
ajlm-1434	91	13	,	,	PUNCT
ajlm-1434	91	14	history	history	NOUN
ajlm-1434	91	15	of	of	ADP
ajlm-1434	91	16	sexually	sexually	ADV
ajlm-1434	91	17	transmitted	transmit	VERB
ajlm-1434	91	18	disease	disease	NOUN
ajlm-1434	91	19	transfusion	transfusion	NOUN
ajlm-1434	91	20	and	and	CCONJ
ajlm-1434	91	21	jaundice	jaundice	NOUN
ajlm-1434	91	22	did	do	AUX
ajlm-1434	91	23	not	not	PART
ajlm-1434	91	24	show	show	VERB
ajlm-1434	91	25	any	any	DET
ajlm-1434	91	26	significant	significant	ADJ
ajlm-1434	91	27	statistical	statistical	ADJ
ajlm-1434	91	28	relationship	relationship	NOUN
ajlm-1434	91	29	to	to	ADP
ajlm-1434	91	30	anti	anti	ADJ
ajlm-1434	91	31	-	-	ADJ
ajlm-1434	91	32	hbc	hbc	ADJ
ajlm-1434	91	33	positivity	positivity	NOUN
ajlm-1434	91	34	.	.	PUNCT
ajlm-1434	92	1	thirteen	thirteen	NUM
ajlm-1434	92	2	donors	donor	NOUN
ajlm-1434	92	3	had	have	VERB
ajlm-1434	92	4	prior	prior	ADJ
ajlm-1434	92	5	hbv	hbv	NOUN
ajlm-1434	92	6	vaccination	vaccination	NOUN
ajlm-1434	92	7	.	.	PUNCT
ajlm-1434	93	1	five	five	NUM
ajlm-1434	93	2	(	(	PUNCT
ajlm-1434	93	3	33.3	33.3	NUM
ajlm-1434	93	4	%	%	NOUN
ajlm-1434	93	5	)	)	PUNCT
ajlm-1434	93	6	of	of	ADP
ajlm-1434	93	7	the	the	DET
ajlm-1434	93	8	hbv	hbv	NOUN
ajlm-1434	93	9	vaccinated	vaccinate	VERB
ajlm-1434	93	10	donors	donor	NOUN
ajlm-1434	93	11	were	be	AUX
ajlm-1434	93	12	positive	positive	ADJ
ajlm-1434	93	13	for	for	ADP
ajlm-1434	93	14	anti	anti	ADJ
ajlm-1434	93	15	-	-	NOUN
ajlm-1434	93	16	hbc	hbc	ADJ
ajlm-1434	93	17	,	,	PUNCT
ajlm-1434	93	18	while	while	SCONJ
ajlm-1434	93	19	10	10	NUM
ajlm-1434	93	20	(	(	PUNCT
ajlm-1434	93	21	66.7	66.7	NUM
ajlm-1434	93	22	%	%	NOUN
ajlm-1434	93	23	)	)	PUNCT
ajlm-1434	93	24	were	be	AUX
ajlm-1434	93	25	negative	negative	ADJ
ajlm-1434	93	26	.	.	PUNCT
ajlm-1434	94	1	however	however	ADV
ajlm-1434	94	2	,	,	PUNCT
ajlm-1434	94	3	the	the	DET
ajlm-1434	94	4	difference	difference	NOUN
ajlm-1434	94	5	was	be	AUX
ajlm-1434	94	6	not	not	PART
ajlm-1434	94	7	statistically	statistically	ADV
ajlm-1434	94	8	significant	significant	ADJ
ajlm-1434	94	9	.	.	PUNCT
ajlm-1434	95	1	the	the	DET
ajlm-1434	95	2	odds	odd	NOUN
ajlm-1434	95	3	of	of	ADP
ajlm-1434	95	4	being	be	AUX
ajlm-1434	95	5	hbcab	hbcab	NOUN
ajlm-1434	95	6	positive	positive	ADJ
ajlm-1434	95	7	were	be	AUX
ajlm-1434	95	8	2.22	2.22	NUM
ajlm-1434	95	9	times	time	NOUN
ajlm-1434	95	10	more	more	ADV
ajlm-1434	95	11	likely	likely	ADJ
ajlm-1434	95	12	among	among	ADP
ajlm-1434	95	13	blood	blood	NOUN
ajlm-1434	95	14	donors	donor	NOUN
ajlm-1434	95	15	over	over	ADP
ajlm-1434	95	16	35	35	NUM
ajlm-1434	95	17	years	year	NOUN
ajlm-1434	95	18	old	old	ADJ
ajlm-1434	95	19	than	than	ADP
ajlm-1434	95	20	those	those	DET
ajlm-1434	95	21	aged	age	VERB
ajlm-1434	95	22	18–35	18–35	NUM
ajlm-1434	95	23	years	year	NOUN
ajlm-1434	95	24	(	(	PUNCT
ajlm-1434	95	25	95	95	NUM
ajlm-1434	95	26	%	%	NOUN
ajlm-1434	95	27	ci	ci	NOUN
ajlm-1434	95	28	:	:	PUNCT
ajlm-1434	95	29	1.32	1.32	NUM
ajlm-1434	95	30	;	;	PUNCT
ajlm-1434	95	31	3.72	3.72	NUM
ajlm-1434	95	32	)	)	PUNCT
ajlm-1434	95	33	.	.	PUNCT
ajlm-1434	96	1	the	the	DET
ajlm-1434	96	2	odds	odd	NOUN
ajlm-1434	96	3	of	of	ADP
ajlm-1434	96	4	being	be	AUX
ajlm-1434	96	5	hbcab	hbcab	NOUN
ajlm-1434	96	6	positive	positive	ADJ
ajlm-1434	96	7	were	be	AUX
ajlm-1434	96	8	0.35	0.35	NUM
ajlm-1434	96	9	times	time	NOUN
ajlm-1434	96	10	less	less	ADV
ajlm-1434	96	11	likely	likely	ADJ
ajlm-1434	96	12	among	among	ADP
ajlm-1434	96	13	blood	blood	NOUN
ajlm-1434	96	14	donors	donor	NOUN
ajlm-1434	96	15	who	who	PRON
ajlm-1434	96	16	had	have	VERB
ajlm-1434	96	17	a	a	DET
ajlm-1434	96	18	knowledge	knowledge	NOUN
ajlm-1434	96	19	score	score	NOUN
ajlm-1434	96	20	of	of	ADP
ajlm-1434	96	21	4	4	NUM
ajlm-1434	96	22	than	than	ADP
ajlm-1434	96	23	blood	blood	NOUN
ajlm-1434	96	24	donors	donor	NOUN
ajlm-1434	96	25	who	who	PRON
ajlm-1434	96	26	had	have	VERB
ajlm-1434	96	27	a	a	DET
ajlm-1434	96	28	knowledge	knowledge	NOUN
ajlm-1434	96	29	score	score	NOUN
ajlm-1434	96	30	of	of	ADP
ajlm-1434	96	31	0	0	NUM
ajlm-1434	96	32	(	(	PUNCT
ajlm-1434	96	33	95	95	NUM
ajlm-1434	96	34	%	%	NOUN
ajlm-1434	96	35	ci	ci	NOUN
ajlm-1434	96	36	:	:	PUNCT
ajlm-1434	96	37	0.14	0.14	NUM
ajlm-1434	96	38	;	;	PUNCT
ajlm-1434	96	39	0.84	0.84	NUM
ajlm-1434	96	40	)	)	PUNCT
ajlm-1434	96	41	.	.	PUNCT
ajlm-1434	97	1	the	the	DET
ajlm-1434	97	2	relative	relative	ADJ
ajlm-1434	97	3	risk	risk	NOUN
ajlm-1434	97	4	(	(	PUNCT
ajlm-1434	97	5	rr	rr	NOUN
ajlm-1434	97	6	)	)	PUNCT
ajlm-1434	97	7	of	of	ADP
ajlm-1434	97	8	blood	blood	NOUN
ajlm-1434	97	9	donors	donor	NOUN
ajlm-1434	97	10	being	be	AUX
ajlm-1434	97	11	hbcab	hbcab	NOUN
ajlm-1434	97	12	positive	positive	ADJ
ajlm-1434	97	13	was	be	AUX
ajlm-1434	97	14	2.14	2.14	NUM
ajlm-1434	97	15	times	time	NOUN
ajlm-1434	97	16	higher	high	ADJ
ajlm-1434	97	17	among	among	ADP
ajlm-1434	97	18	blood	blood	NOUN
ajlm-1434	97	19	donors	donor	NOUN
ajlm-1434	97	20	who	who	PRON
ajlm-1434	97	21	had	have	AUX
ajlm-1434	97	22	ever	ever	ADV
ajlm-1434	97	23	used	use	VERB
ajlm-1434	97	24	recreational	recreational	ADJ
ajlm-1434	97	25	drugs	drug	NOUN
ajlm-1434	97	26	before	before	ADP
ajlm-1434	97	27	or	or	CCONJ
ajlm-1434	97	28	during	during	ADP
ajlm-1434	97	29	sex	sex	NOUN
ajlm-1434	97	30	than	than	ADP
ajlm-1434	97	31	in	in	ADP
ajlm-1434	97	32	blood	blood	NOUN
ajlm-1434	97	33	donors	donor	NOUN
ajlm-1434	97	34	who	who	PRON
ajlm-1434	97	35	never	never	ADV
ajlm-1434	97	36	used	use	VERB
ajlm-1434	97	37	recreational	recreational	ADJ
ajlm-1434	97	38	drugs	drug	NOUN
ajlm-1434	97	39	before	before	ADP
ajlm-1434	97	40	or	or	CCONJ
ajlm-1434	97	41	during	during	ADP
ajlm-1434	97	42	sex	sex	NOUN
ajlm-1434	97	43	(	(	PUNCT
ajlm-1434	97	44	95	95	NUM
ajlm-1434	97	45	%	%	NOUN
ajlm-1434	97	46	ci	ci	NOUN
ajlm-1434	97	47	:	:	PUNCT
ajlm-1434	97	48	1.88	1.88	NUM
ajlm-1434	97	49	;	;	PUNCT
ajlm-1434	97	50	2.43	2.43	NUM
ajlm-1434	97	51	)	)	PUNCT
ajlm-1434	97	52	.	.	PUNCT
ajlm-1434	98	1	there	there	PRON
ajlm-1434	98	2	is	be	VERB
ajlm-1434	98	3	a	a	DET
ajlm-1434	98	4	2.23	2.23	NUM
ajlm-1434	98	5	times	time	NOUN
ajlm-1434	98	6	higher	high	ADJ
ajlm-1434	98	7	likelihood	likelihood	NOUN
ajlm-1434	98	8	of	of	ADP
ajlm-1434	98	9	anti	anti	ADJ
ajlm-1434	98	10	-	-	ADJ
ajlm-1434	98	11	hbc	hbc	ADJ
ajlm-1434	98	12	positivity	positivity	NOUN
ajlm-1434	98	13	for	for	ADP
ajlm-1434	98	14	blood	blood	NOUN
ajlm-1434	98	15	donors	donor	NOUN
ajlm-1434	98	16	who	who	PRON
ajlm-1434	98	17	had	have	AUX
ajlm-1434	98	18	ever	ever	ADV
ajlm-1434	98	19	been	be	AUX
ajlm-1434	98	20	transfused	transfuse	VERB
ajlm-1434	98	21	with	with	ADP
ajlm-1434	98	22	blood	blood	NOUN
ajlm-1434	98	23	.	.	PUNCT
ajlm-1434	99	1	blood	blood	NOUN
ajlm-1434	99	2	donors	donor	NOUN
ajlm-1434	99	3	who	who	PRON
ajlm-1434	99	4	shared	share	VERB
ajlm-1434	99	5	sharp	sharp	ADJ
ajlm-1434	99	6	objects	object	NOUN
ajlm-1434	99	7	were	be	AUX
ajlm-1434	99	8	0.57	0.57	NUM
ajlm-1434	99	9	times	time	NOUN
ajlm-1434	99	10	less	less	ADV
ajlm-1434	99	11	likely	likely	ADJ
ajlm-1434	99	12	to	to	PART
ajlm-1434	99	13	be	be	AUX
ajlm-1434	99	14	hbcab	hbcab	NOUN
ajlm-1434	99	15	positive	positive	ADJ
ajlm-1434	99	16	compared	compare	VERB
ajlm-1434	99	17	to	to	ADP
ajlm-1434	99	18	donors	donor	NOUN
ajlm-1434	99	19	who	who	PRON
ajlm-1434	99	20	do	do	AUX
ajlm-1434	99	21	not	not	PART
ajlm-1434	99	22	share	share	VERB
ajlm-1434	99	23	sharp	sharp	ADJ
ajlm-1434	99	24	objects	object	NOUN
ajlm-1434	99	25	(	(	PUNCT
ajlm-1434	99	26	95	95	NUM
ajlm-1434	99	27	%	%	NOUN
ajlm-1434	99	28	ci	ci	NOUN
ajlm-1434	99	29	of	of	ADP
ajlm-1434	99	30	or	or	CCONJ
ajlm-1434	99	31	:	:	PUNCT
ajlm-1434	99	32	0.34	0.34	NUM
ajlm-1434	99	33	;	;	PUNCT
ajlm-1434	99	34	0.96	0.96	NUM
ajlm-1434	99	35	)	)	PUNCT
ajlm-1434	99	36	.	.	PUNCT
ajlm-1434	100	1	the	the	DET
ajlm-1434	100	2	comparison	comparison	NOUN
ajlm-1434	100	3	of	of	ADP
ajlm-1434	100	4	the	the	DET
ajlm-1434	100	5	different	different	ADJ
ajlm-1434	100	6	risk	risk	NOUN
ajlm-1434	100	7	factors	factor	NOUN
ajlm-1434	100	8	with	with	ADP
ajlm-1434	100	9	hbcab	hbcab	NOUN
ajlm-1434	100	10	is	be	AUX
ajlm-1434	100	11	shown	show	VERB
ajlm-1434	100	12	in	in	ADP
ajlm-1434	100	13	figure	figure	NOUN
ajlm-1434	100	14	1	1	NUM
ajlm-1434	100	15	.	.	PUNCT
ajlm-1434	100	16	figure	figure	NOUN
ajlm-1434	100	17	1	1	NUM
ajlm-1434	100	18	:	:	PUNCT
ajlm-1434	100	19	risk	risk	NOUN
ajlm-1434	100	20	factors	factor	NOUN
ajlm-1434	100	21	for	for	ADP
ajlm-1434	100	22	hepatitis	hepatitis	PROPN
ajlm-1434	100	23	b	b	PROPN
ajlm-1434	100	24	virus	virus	NOUN
ajlm-1434	100	25	infection	infection	NOUN
ajlm-1434	100	26	among	among	ADP
ajlm-1434	100	27	133	133	NUM
ajlm-1434	100	28	donors	donor	NOUN
ajlm-1434	100	29	with	with	ADP
ajlm-1434	100	30	positive	positive	ADJ
ajlm-1434	100	31	anti	anti	ADJ
ajlm-1434	100	32	-	-	ADJ
ajlm-1434	100	33	hepatitis	hepatitis	ADJ
ajlm-1434	100	34	b	b	NOUN
ajlm-1434	100	35	core	core	NOUN
ajlm-1434	100	36	protein	protein	NOUN
ajlm-1434	100	37	or	or	CCONJ
ajlm-1434	100	38	antigen	antigen	NOUN
ajlm-1434	100	39	in	in	ADP
ajlm-1434	100	40	ibadan	ibadan	PROPN
ajlm-1434	100	41	,	,	PUNCT
ajlm-1434	100	42	nigeria	nigeria	PROPN
ajlm-1434	100	43	,	,	PUNCT
ajlm-1434	100	44	between	between	ADP
ajlm-1434	100	45	april	april	PROPN
ajlm-1434	100	46	2019	2019	NUM
ajlm-1434	100	47	and	and	CCONJ
ajlm-1434	100	48	may	may	PROPN
ajlm-1434	100	49	2019	2019	NUM
ajlm-1434	100	50	.	.	PUNCT
ajlm-1434	101	1	table	table	NOUN
ajlm-1434	101	2	2	2	NUM
ajlm-1434	101	3	:	:	PUNCT
ajlm-1434	101	4	 	 	SPACE
ajlm-1434	101	5	comparison	comparison	NOUN
ajlm-1434	101	6	of	of	ADP
ajlm-1434	101	7	hepatitis	hepatitis	PROPN
ajlm-1434	101	8	b	b	PROPN
ajlm-1434	101	9	virus	virus	NOUN
ajlm-1434	101	10	risk	risk	NOUN
ajlm-1434	101	11	factors	factor	NOUN
ajlm-1434	101	12	among	among	ADP
ajlm-1434	101	13	anti	anti	ADJ
ajlm-1434	101	14	-	-	ADJ
ajlm-1434	101	15	hepatitis	hepatitis	ADJ
ajlm-1434	101	16	b	b	NOUN
ajlm-1434	101	17	core	core	NOUN
ajlm-1434	101	18	-	-	PUNCT
ajlm-1434	101	19	positive	positive	ADJ
ajlm-1434	101	20	and	and	CCONJ
ajlm-1434	101	21	-negative	-negative	ADJ
ajlm-1434	101	22	blood	blood	NOUN
ajlm-1434	101	23	donors	donor	NOUN
ajlm-1434	101	24	in	in	ADP
ajlm-1434	101	25	ibadan	ibadan	PROPN
ajlm-1434	101	26	,	,	PUNCT
ajlm-1434	101	27	nigeria	nigeria	PROPN
ajlm-1434	101	28	,	,	PUNCT
ajlm-1434	101	29	between	between	ADP
ajlm-1434	101	30	april	april	PROPN
ajlm-1434	101	31	and	and	CCONJ
ajlm-1434	101	32	may	may	PROPN
ajlm-1434	101	33	2019	2019	NUM
ajlm-1434	101	34	.	.	PUNCT
ajlm-1434	102	1	occult	occult	VERB
ajlm-1434	102	2	hepatitis	hepatitis	PROPN
ajlm-1434	102	3	b	b	PROPN
ajlm-1434	102	4	virus	virus	NOUN
ajlm-1434	102	5	infection	infection	NOUN
ajlm-1434	102	6	of	of	ADP
ajlm-1434	102	7	the	the	DET
ajlm-1434	102	8	274	274	NUM
ajlm-1434	102	9	blood	blood	NOUN
ajlm-1434	102	10	donors	donor	NOUN
ajlm-1434	102	11	,	,	PUNCT
ajlm-1434	102	12	42	42	NUM
ajlm-1434	102	13	(	(	PUNCT
ajlm-1434	102	14	15.3	15.3	NUM
ajlm-1434	102	15	%	%	NOUN
ajlm-1434	102	16	)	)	PUNCT
ajlm-1434	102	17	cases	case	NOUN
ajlm-1434	102	18	were	be	AUX
ajlm-1434	102	19	hbsag	hbsag	ADJ
ajlm-1434	102	20	-	-	PUNCT
ajlm-1434	102	21	positive	positive	ADJ
ajlm-1434	102	22	by	by	ADP
ajlm-1434	102	23	both	both	PRON
ajlm-1434	102	24	or	or	CCONJ
ajlm-1434	102	25	either	either	CCONJ
ajlm-1434	102	26	rdt	rdt	PROPN
ajlm-1434	102	27	or	or	CCONJ
ajlm-1434	102	28	elisa	elisa	PROPN
ajlm-1434	102	29	:	:	PUNCT
ajlm-1434	102	30	9	9	NUM
ajlm-1434	102	31	(	(	PUNCT
ajlm-1434	102	32	3.28	3.28	NUM
ajlm-1434	102	33	%	%	NOUN
ajlm-1434	102	34	)	)	PUNCT
ajlm-1434	102	35	by	by	ADP
ajlm-1434	102	36	both	both	CCONJ
ajlm-1434	102	37	rdt	rdt	PROPN
ajlm-1434	102	38	and	and	CCONJ
ajlm-1434	102	39	elisa	elisa	PROPN
ajlm-1434	102	40	,	,	PUNCT
ajlm-1434	102	41	6	6	NUM
ajlm-1434	102	42	(	(	PUNCT
ajlm-1434	102	43	2.19	2.19	NUM
ajlm-1434	102	44	%	%	NOUN
ajlm-1434	102	45	)	)	PUNCT
ajlm-1434	102	46	by	by	ADP
ajlm-1434	102	47	rdt	rdt	PROPN
ajlm-1434	102	48	only	only	ADV
ajlm-1434	102	49	,	,	PUNCT
ajlm-1434	102	50	and	and	CCONJ
ajlm-1434	102	51	27	27	NUM
ajlm-1434	102	52	(	(	PUNCT
ajlm-1434	102	53	9.85	9.85	NUM
ajlm-1434	102	54	%	%	NOUN
ajlm-1434	102	55	)	)	PUNCT
ajlm-1434	102	56	by	by	ADP
ajlm-1434	102	57	elisa	elisa	NOUN
ajlm-1434	102	58	only	only	ADV
ajlm-1434	102	59	;	;	PUNCT
ajlm-1434	102	60	232	232	NUM
ajlm-1434	102	61	(	(	PUNCT
ajlm-1434	102	62	84.7	84.7	NUM
ajlm-1434	102	63	%	%	NOUN
ajlm-1434	102	64	)	)	PUNCT
ajlm-1434	102	65	were	be	AUX
ajlm-1434	102	66	hbsag	hbsag	ADJ
ajlm-1434	102	67	-	-	PUNCT
ajlm-1434	102	68	negative	negative	ADJ
ajlm-1434	102	69	(	(	PUNCT
ajlm-1434	102	70	rdt	rdt	PROPN
ajlm-1434	102	71	and	and	CCONJ
ajlm-1434	102	72	elisa	elisa	NOUN
ajlm-1434	102	73	negative	negative	ADJ
ajlm-1434	102	74	)	)	PUNCT
ajlm-1434	102	75	.	.	PUNCT
ajlm-1434	103	1	almost	almost	ADV
ajlm-1434	103	2	half	half	NOUN
ajlm-1434	103	3	(	(	PUNCT
ajlm-1434	103	4	133/274	133/274	NUM
ajlm-1434	103	5	;	;	PUNCT
ajlm-1434	103	6	48.5	48.5	NUM
ajlm-1434	103	7	%	%	NOUN
ajlm-1434	103	8	)	)	PUNCT
ajlm-1434	103	9	of	of	ADP
ajlm-1434	103	10	the	the	DET
ajlm-1434	103	11	donors	donor	NOUN
ajlm-1434	103	12	were	be	AUX
ajlm-1434	103	13	anti	anti	ADJ
ajlm-1434	103	14	-	-	ADJ
ajlm-1434	103	15	hbc	hbc	ADJ
ajlm-1434	103	16	positive	positive	NOUN
ajlm-1434	103	17	,	,	PUNCT
ajlm-1434	103	18	while	while	SCONJ
ajlm-1434	103	19	26/274	26/274	NUM
ajlm-1434	103	20	(	(	PUNCT
ajlm-1434	103	21	9.5	9.5	NUM
ajlm-1434	103	22	%	%	NOUN
ajlm-1434	103	23	)	)	PUNCT
ajlm-1434	103	24	donors	donor	NOUN
ajlm-1434	103	25	were	be	AUX
ajlm-1434	103	26	hbsag	hbsag	ADJ
ajlm-1434	103	27	-	-	PUNCT
ajlm-1434	103	28	positive	positive	ADJ
ajlm-1434	103	29	and	and	CCONJ
ajlm-1434	103	30	anti	anti	ADJ
ajlm-1434	103	31	-	-	ADJ
ajlm-1434	103	32	hbc	hbc	ADJ
ajlm-1434	103	33	positive	positive	NOUN
ajlm-1434	103	34	.	.	PUNCT
ajlm-1434	104	1	among	among	ADP
ajlm-1434	104	2	the	the	DET
ajlm-1434	104	3	259	259	NUM
ajlm-1434	104	4	participants	participant	NOUN
ajlm-1434	104	5	who	who	PRON
ajlm-1434	104	6	tested	test	VERB
ajlm-1434	104	7	negative	negative	ADJ
ajlm-1434	104	8	for	for	ADP
ajlm-1434	104	9	hepatitis	hepatitis	PROPN
ajlm-1434	104	10	b	b	PROPN
ajlm-1434	104	11	by	by	ADP
ajlm-1434	104	12	rdt	rdt	PROPN
ajlm-1434	104	13	,	,	PUNCT
ajlm-1434	104	14	121	121	NUM
ajlm-1434	104	15	(	(	PUNCT
ajlm-1434	104	16	46.7	46.7	NUM
ajlm-1434	104	17	%	%	NOUN
ajlm-1434	104	18	)	)	PUNCT
ajlm-1434	104	19	had	have	VERB
ajlm-1434	104	20	a	a	DET
ajlm-1434	104	21	positive	positive	ADJ
ajlm-1434	104	22	anti	anti	ADJ
ajlm-1434	104	23	-	-	ADJ
ajlm-1434	104	24	hbc	hbc	ADJ
ajlm-1434	104	25	result	result	NOUN
ajlm-1434	104	26	,	,	PUNCT
ajlm-1434	104	27	while	while	SCONJ
ajlm-1434	104	28	110	110	NUM
ajlm-1434	104	29	(	(	PUNCT
ajlm-1434	104	30	46.2	46.2	NUM
ajlm-1434	104	31	%	%	NOUN
ajlm-1434	104	32	)	)	PUNCT
ajlm-1434	104	33	of	of	ADP
ajlm-1434	104	34	the	the	DET
ajlm-1434	104	35	238	238	NUM
ajlm-1434	104	36	participants	participant	NOUN
ajlm-1434	104	37	who	who	PRON
ajlm-1434	104	38	tested	test	VERB
ajlm-1434	104	39	negative	negative	ADJ
ajlm-1434	104	40	for	for	ADP
ajlm-1434	104	41	hbsag	hbsag	NOUN
ajlm-1434	104	42	by	by	ADP
ajlm-1434	104	43	elisa	elisa	PROPN
ajlm-1434	104	44	test	test	NOUN
ajlm-1434	104	45	had	have	VERB
ajlm-1434	104	46	a	a	DET
ajlm-1434	104	47	positive	positive	ADJ
ajlm-1434	104	48	anti	anti	ADJ
ajlm-1434	104	49	-	-	NOUN
ajlm-1434	104	50	hbc	hbc	ADJ
ajlm-1434	104	51	(	(	PUNCT
ajlm-1434	104	52	table	table	NOUN
ajlm-1434	104	53	3	3	NUM
ajlm-1434	104	54	)	)	PUNCT
ajlm-1434	104	55	.	.	PUNCT
ajlm-1434	105	1	table	table	NOUN
ajlm-1434	105	2	3	3	NUM
ajlm-1434	105	3	:	:	PUNCT
ajlm-1434	105	4	 	 	SPACE
ajlm-1434	105	5	patterns	pattern	NOUN
ajlm-1434	105	6	of	of	ADP
ajlm-1434	105	7	anti	anti	ADJ
ajlm-1434	105	8	-	-	ADJ
ajlm-1434	105	9	hepatitis	hepatitis	ADJ
ajlm-1434	105	10	b	b	NOUN
ajlm-1434	105	11	core	core	NOUN
ajlm-1434	105	12	results	result	NOUN
ajlm-1434	105	13	for	for	ADP
ajlm-1434	105	14	rapid	rapid	ADJ
ajlm-1434	105	15	and	and	CCONJ
ajlm-1434	105	16	enzyme	enzyme	NOUN
ajlm-1434	105	17	-	-	PUNCT
ajlm-1434	105	18	linked	link	VERB
ajlm-1434	105	19	immunosorbent	immunosorbent	NOUN
ajlm-1434	105	20	assay	assay	NOUN
ajlm-1434	105	21	tests	test	NOUN
ajlm-1434	105	22	for	for	ADP
ajlm-1434	105	23	hepatitis	hepatitis	PROPN
ajlm-1434	105	24	b	b	PROPN
ajlm-1434	105	25	surface	surface	NOUN
ajlm-1434	105	26	antigen	antigen	NOUN
ajlm-1434	105	27	and	and	CCONJ
ajlm-1434	105	28	relationship	relationship	NOUN
ajlm-1434	105	29	of	of	ADP
ajlm-1434	105	30	the	the	DET
ajlm-1434	105	31	two	two	NUM
ajlm-1434	105	32	hepatitis	hepatitis	PROPN
ajlm-1434	105	33	b	b	PROPN
ajlm-1434	105	34	surface	surface	NOUN
ajlm-1434	105	35	antigen	antigen	NOUN
ajlm-1434	105	36	detection	detection	NOUN
ajlm-1434	105	37	assays	assay	NOUN
ajlm-1434	105	38	in	in	ADP
ajlm-1434	105	39	ibadan	ibadan	PROPN
ajlm-1434	105	40	,	,	PUNCT
ajlm-1434	105	41	nigeria	nigeria	PROPN
ajlm-1434	105	42	,	,	PUNCT
ajlm-1434	105	43	between	between	ADP
ajlm-1434	105	44	april	april	PROPN
ajlm-1434	105	45	2019	2019	NUM
ajlm-1434	105	46	and	and	CCONJ
ajlm-1434	105	47	may	may	PROPN
ajlm-1434	105	48	2019	2019	NUM
ajlm-1434	105	49	.	.	PUNCT
ajlm-1434	106	1	of	of	ADP
ajlm-1434	106	2	the	the	DET
ajlm-1434	106	3	232	232	NUM
ajlm-1434	106	4	blood	blood	NOUN
ajlm-1434	106	5	donors	donor	NOUN
ajlm-1434	106	6	that	that	PRON
ajlm-1434	106	7	were	be	AUX
ajlm-1434	106	8	hbsag	hbsag	ADJ
ajlm-1434	106	9	-	-	PUNCT
ajlm-1434	106	10	negative	negative	ADJ
ajlm-1434	106	11	by	by	ADP
ajlm-1434	106	12	any	any	DET
ajlm-1434	106	13	method	method	NOUN
ajlm-1434	106	14	,	,	PUNCT
ajlm-1434	106	15	107	107	NUM
ajlm-1434	106	16	(	(	PUNCT
ajlm-1434	106	17	46.1	46.1	NUM
ajlm-1434	106	18	%	%	NOUN
ajlm-1434	106	19	)	)	PUNCT
ajlm-1434	106	20	were	be	AUX
ajlm-1434	106	21	positive	positive	ADJ
ajlm-1434	106	22	for	for	ADP
ajlm-1434	106	23	anti	anti	ADJ
ajlm-1434	106	24	-	-	NOUN
ajlm-1434	106	25	hbc	hbc	NOUN
ajlm-1434	106	26	.	.	PUNCT
ajlm-1434	107	1	however	however	ADV
ajlm-1434	107	2	,	,	PUNCT
ajlm-1434	107	3	only	only	ADV
ajlm-1434	107	4	one	one	NUM
ajlm-1434	107	5	case	case	NOUN
ajlm-1434	107	6	was	be	AUX
ajlm-1434	107	7	anti	anti	ADJ
ajlm-1434	107	8	-	-	ADJ
ajlm-1434	107	9	hbc	hbc	ADJ
ajlm-1434	107	10	positive	positive	ADJ
ajlm-1434	107	11	,	,	PUNCT
ajlm-1434	107	12	hbsag	hbsag	NOUN
ajlm-1434	107	13	-	-	PUNCT
ajlm-1434	107	14	negative	negative	ADJ
ajlm-1434	107	15	and	and	CCONJ
ajlm-1434	107	16	hbv	hbv	NOUN
ajlm-1434	107	17	dna	dna	PROPN
ajlm-1434	107	18	-	-	PUNCT
ajlm-1434	107	19	positive	positive	ADJ
ajlm-1434	107	20	(	(	PUNCT
ajlm-1434	107	21	0.93	0.93	NUM
ajlm-1434	107	22	%	%	NOUN
ajlm-1434	107	23	)	)	PUNCT
ajlm-1434	107	24	.	.	PUNCT
ajlm-1434	108	1	discussion	discussion	NOUN
ajlm-1434	108	2	this	this	DET
ajlm-1434	108	3	study	study	NOUN
ajlm-1434	108	4	on	on	ADP
ajlm-1434	108	5	hbc	hbc	PROPN
ajlm-1434	108	6	antibodies	antibody	NOUN
ajlm-1434	108	7	among	among	ADP
ajlm-1434	108	8	replacement	replacement	NOUN
ajlm-1434	108	9	blood	blood	NOUN
ajlm-1434	108	10	donors	donor	NOUN
ajlm-1434	108	11	,	,	PUNCT
ajlm-1434	108	12	who	who	PRON
ajlm-1434	108	13	form	form	VERB
ajlm-1434	108	14	a	a	DET
ajlm-1434	108	15	significant	significant	ADJ
ajlm-1434	108	16	proportion	proportion	NOUN
ajlm-1434	108	17	of	of	ADP
ajlm-1434	108	18	blood	blood	NOUN
ajlm-1434	108	19	donors	donor	NOUN
ajlm-1434	108	20	in	in	ADP
ajlm-1434	108	21	nigeria	nigeria	PROPN
ajlm-1434	108	22	,	,	PUNCT
ajlm-1434	108	23	showed	show	VERB
ajlm-1434	108	24	that	that	SCONJ
ajlm-1434	108	25	48.8	48.8	NUM
ajlm-1434	108	26	%	%	NOUN
ajlm-1434	108	27	were	be	AUX
ajlm-1434	108	28	positive	positive	ADJ
ajlm-1434	108	29	for	for	ADP
ajlm-1434	108	30	total	total	ADJ
ajlm-1434	108	31	anti	anti	ADJ
ajlm-1434	108	32	-	-	NOUN
ajlm-1434	108	33	hbc	hbc	ADJ
ajlm-1434	108	34	(	(	PUNCT
ajlm-1434	108	35	igg	igg	PROPN
ajlm-1434	108	36	and	and	CCONJ
ajlm-1434	108	37	igm	igm	PROPN
ajlm-1434	108	38	)	)	PUNCT
ajlm-1434	108	39	,	,	PUNCT
ajlm-1434	108	40	and	and	CCONJ
ajlm-1434	108	41	over	over	ADP
ajlm-1434	108	42	60.0	60.0	NUM
ajlm-1434	108	43	%	%	NOUN
ajlm-1434	108	44	of	of	ADP
ajlm-1434	108	45	the	the	DET
ajlm-1434	108	46	donors	donor	NOUN
ajlm-1434	108	47	had	have	VERB
ajlm-1434	108	48	a	a	DET
ajlm-1434	108	49	tertiary	tertiary	ADJ
ajlm-1434	108	50	education	education	NOUN
ajlm-1434	108	51	level	level	NOUN
ajlm-1434	108	52	,	,	PUNCT
ajlm-1434	108	53	with	with	ADP
ajlm-1434	108	54	47.0	47.0	NUM
ajlm-1434	108	55	%	%	NOUN
ajlm-1434	108	56	of	of	ADP
ajlm-1434	108	57	the	the	DET
ajlm-1434	108	58	donors	donor	NOUN
ajlm-1434	108	59	having	have	VERB
ajlm-1434	108	60	an	an	DET
ajlm-1434	108	61	hbv	hbv	NOUN
ajlm-1434	108	62	infection	infection	NOUN
ajlm-1434	108	63	knowledge	knowledge	NOUN
ajlm-1434	108	64	score	score	NOUN
ajlm-1434	108	65	of	of	ADP
ajlm-1434	108	66	0	0	NUM
ajlm-1434	108	67	.	.	PUNCT
ajlm-1434	109	1	in	in	ADP
ajlm-1434	109	2	addition	addition	NOUN
ajlm-1434	109	3	,	,	PUNCT
ajlm-1434	109	4	the	the	DET
ajlm-1434	109	5	risk	risk	NOUN
ajlm-1434	109	6	factors	factor	NOUN
ajlm-1434	109	7	for	for	ADP
ajlm-1434	109	8	hbv	hbv	NOUN
ajlm-1434	109	9	acquisition	acquisition	NOUN
ajlm-1434	109	10	among	among	ADP
ajlm-1434	109	11	anti	anti	ADJ
ajlm-1434	109	12	-	-	ADJ
ajlm-1434	109	13	hbc	hbc	ADJ
ajlm-1434	109	14	-	-	PUNCT
ajlm-1434	109	15	positive	positive	ADJ
ajlm-1434	109	16	donors	donor	NOUN
ajlm-1434	109	17	were	be	AUX
ajlm-1434	109	18	being	be	AUX
ajlm-1434	109	19	older	old	ADJ
ajlm-1434	109	20	than	than	ADP
ajlm-1434	109	21	35	35	NUM
ajlm-1434	109	22	years	year	NOUN
ajlm-1434	109	23	,	,	PUNCT
ajlm-1434	109	24	having	have	VERB
ajlm-1434	109	25	poor	poor	ADJ
ajlm-1434	109	26	knowledge	knowledge	NOUN
ajlm-1434	109	27	of	of	ADP
ajlm-1434	109	28	the	the	DET
ajlm-1434	109	29	hbv	hbv	NOUN
ajlm-1434	109	30	transmission	transmission	NOUN
ajlm-1434	109	31	route	route	NOUN
ajlm-1434	109	32	,	,	PUNCT
ajlm-1434	109	33	and	and	CCONJ
ajlm-1434	109	34	the	the	DET
ajlm-1434	109	35	use	use	NOUN
ajlm-1434	109	36	of	of	ADP
ajlm-1434	109	37	sex	sex	NOUN
ajlm-1434	109	38	enhancement	enhancement	NOUN
ajlm-1434	109	39	recreational	recreational	ADJ
ajlm-1434	109	40	drugs	drug	NOUN
ajlm-1434	109	41	.	.	PUNCT
ajlm-1434	110	1	an	an	DET
ajlm-1434	110	2	inconsistent	inconsistent	ADJ
ajlm-1434	110	3	positivity	positivity	NOUN
ajlm-1434	110	4	rate	rate	NOUN
ajlm-1434	110	5	was	be	AUX
ajlm-1434	110	6	observed	observe	VERB
ajlm-1434	110	7	when	when	SCONJ
ajlm-1434	110	8	rdt	rdt	PROPN
ajlm-1434	110	9	and	and	CCONJ
ajlm-1434	110	10	elisa	elisa	PROPN
ajlm-1434	110	11	were	be	AUX
ajlm-1434	110	12	used	use	VERB
ajlm-1434	110	13	to	to	PART
ajlm-1434	110	14	screen	screen	VERB
ajlm-1434	110	15	for	for	ADP
ajlm-1434	110	16	hbsag	hbsag	NOUN
ajlm-1434	110	17	among	among	ADP
ajlm-1434	110	18	blood	blood	NOUN
ajlm-1434	110	19	donors	donor	NOUN
ajlm-1434	110	20	.	.	PUNCT
ajlm-1434	111	1	this	this	DET
ajlm-1434	111	2	incongruity	incongruity	NOUN
ajlm-1434	111	3	in	in	ADP
ajlm-1434	111	4	the	the	DET
ajlm-1434	111	5	results	result	NOUN
ajlm-1434	111	6	suggests	suggest	VERB
ajlm-1434	111	7	that	that	SCONJ
ajlm-1434	111	8	it	it	PRON
ajlm-1434	111	9	is	be	AUX
ajlm-1434	111	10	better	well	ADJ
ajlm-1434	111	11	to	to	PART
ajlm-1434	111	12	use	use	VERB
ajlm-1434	111	13	both	both	DET
ajlm-1434	111	14	methods	method	NOUN
ajlm-1434	111	15	in	in	ADP
ajlm-1434	111	16	screening	screen	VERB
ajlm-1434	111	17	blood	blood	NOUN
ajlm-1434	111	18	for	for	ADP
ajlm-1434	111	19	transfusion	transfusion	NOUN
ajlm-1434	111	20	to	to	PART
ajlm-1434	111	21	reduce	reduce	VERB
ajlm-1434	111	22	the	the	DET
ajlm-1434	111	23	escape	escape	NOUN
ajlm-1434	111	24	of	of	ADP
ajlm-1434	111	25	hbv	hbv	NOUN
ajlm-1434	111	26	-	-	PUNCT
ajlm-1434	111	27	positive	positive	ADJ
ajlm-1434	111	28	blood	blood	NOUN
ajlm-1434	111	29	into	into	ADP
ajlm-1434	111	30	the	the	DET
ajlm-1434	111	31	transfusion	transfusion	NOUN
ajlm-1434	111	32	pool	pool	NOUN
ajlm-1434	111	33	,	,	PUNCT
ajlm-1434	111	34	especially	especially	ADV
ajlm-1434	111	35	when	when	SCONJ
ajlm-1434	111	36	hbv	hbv	PROPN
ajlm-1434	111	37	dna	dna	PROPN
ajlm-1434	111	38	screening	screen	VERB
ajlm-1434	111	39	is	be	AUX
ajlm-1434	111	40	not	not	PART
ajlm-1434	111	41	in	in	ADP
ajlm-1434	111	42	use	use	NOUN
ajlm-1434	111	43	.	.	PUNCT
ajlm-1434	112	1	testing	testing	NOUN
ajlm-1434	112	2	for	for	ADP
ajlm-1434	112	3	anti	anti	ADJ
ajlm-1434	112	4	-	-	ADJ
ajlm-1434	112	5	hbc	hbc	NOUN
ajlm-1434	112	6	has	have	AUX
ajlm-1434	112	7	been	be	AUX
ajlm-1434	112	8	used	use	VERB
ajlm-1434	112	9	in	in	ADP
ajlm-1434	112	10	blood	blood	NOUN
ajlm-1434	112	11	transfusion	transfusion	NOUN
ajlm-1434	112	12	in	in	ADP
ajlm-1434	112	13	low	low	ADJ
ajlm-1434	112	14	hbv	hbv	NOUN
ajlm-1434	112	15	-	-	PUNCT
ajlm-1434	112	16	endemic	endemic	ADJ
ajlm-1434	112	17	regions	region	NOUN
ajlm-1434	112	18	to	to	PART
ajlm-1434	112	19	minimise	minimise	VERB
ajlm-1434	112	20	the	the	DET
ajlm-1434	112	21	incidence	incidence	NOUN
ajlm-1434	112	22	of	of	ADP
ajlm-1434	112	23	post	post	ADJ
ajlm-1434	112	24	-	-	ADJ
ajlm-1434	112	25	transfusion	transfusion	ADJ
ajlm-1434	112	26	hepatitis	hepatitis	NOUN
ajlm-1434	112	27	following	follow	VERB
ajlm-1434	112	28	transfusion	transfusion	NOUN
ajlm-1434	112	29	of	of	ADP
ajlm-1434	112	30	hbsag	hbsag	ADJ
ajlm-1434	112	31	-	-	PUNCT
ajlm-1434	112	32	negative	negative	ADJ
ajlm-1434	112	33	blood	blood	NOUN
ajlm-1434	112	34	.	.	PUNCT
ajlm-1434	113	1	the	the	DET
ajlm-1434	113	2	assay	assay	NOUN
ajlm-1434	113	3	identifies	identify	VERB
ajlm-1434	113	4	chronically	chronically	ADV
ajlm-1434	113	5	infected	infect	VERB
ajlm-1434	113	6	low	low	ADJ
ajlm-1434	113	7	-	-	PUNCT
ajlm-1434	113	8	level	level	NOUN
ajlm-1434	113	9	hbv	hbv	NOUN
ajlm-1434	113	10	donors.13	donors.13	NOUN
ajlm-1434	113	11	the	the	DET
ajlm-1434	113	12	prevalence	prevalence	NOUN
ajlm-1434	113	13	of	of	ADP
ajlm-1434	113	14	anti	anti	ADJ
ajlm-1434	113	15	-	-	NOUN
ajlm-1434	113	16	hbc	hbc	ADJ
ajlm-1434	113	17	(	(	PUNCT
ajlm-1434	113	18	35.7	35.7	NUM
ajlm-1434	113	19	%	%	NOUN
ajlm-1434	113	20	)	)	PUNCT
ajlm-1434	113	21	among	among	ADP
ajlm-1434	113	22	our	our	PRON
ajlm-1434	113	23	hbsag	hbsag	ADJ
ajlm-1434	113	24	-	-	PUNCT
ajlm-1434	113	25	negative	negative	ADJ
ajlm-1434	113	26	blood	blood	NOUN
ajlm-1434	113	27	donors	donor	NOUN
ajlm-1434	113	28	is	be	AUX
ajlm-1434	113	29	high	high	ADJ
ajlm-1434	113	30	.	.	PUNCT
ajlm-1434	114	1	other	other	ADJ
ajlm-1434	114	2	studies	study	NOUN
ajlm-1434	114	3	have	have	AUX
ajlm-1434	114	4	reported	report	VERB
ajlm-1434	114	5	lower	low	ADJ
ajlm-1434	114	6	anti	anti	ADJ
ajlm-1434	114	7	-	-	ADJ
ajlm-1434	114	8	hbc	hbc	ADJ
ajlm-1434	114	9	prevalence	prevalence	NOUN
ajlm-1434	114	10	in	in	ADP
ajlm-1434	114	11	low	low	ADJ
ajlm-1434	114	12	and	and	CCONJ
ajlm-1434	114	13	intermediate	intermediate	ADJ
ajlm-1434	114	14	hbv	hbv	NOUN
ajlm-1434	114	15	-	-	PUNCT
ajlm-1434	114	16	endemic	endemic	ADJ
ajlm-1434	114	17	regions	region	NOUN
ajlm-1434	114	18	and	and	CCONJ
ajlm-1434	114	19	in	in	ADP
ajlm-1434	114	20	some	some	DET
ajlm-1434	114	21	high	high	ADJ
ajlm-1434	114	22	hbv	hbv	NOUN
ajlm-1434	114	23	-	-	PUNCT
ajlm-1434	114	24	endemic	endemic	ADJ
ajlm-1434	114	25	regions	region	NOUN
ajlm-1434	114	26	like	like	ADP
ajlm-1434	114	27	india14	india14	NOUN
ajlm-1434	114	28	and	and	CCONJ
ajlm-1434	114	29	north	north	NOUN
ajlm-1434	114	30	africa.15	africa.15	PROPN
ajlm-1434	114	31	the	the	DET
ajlm-1434	114	32	higher	high	ADJ
ajlm-1434	114	33	prevalence	prevalence	NOUN
ajlm-1434	114	34	of	of	ADP
ajlm-1434	114	35	anti	anti	ADJ
ajlm-1434	114	36	-	-	NOUN
ajlm-1434	114	37	hbc	hbc	ADJ
ajlm-1434	114	38	(	(	PUNCT
ajlm-1434	114	39	35.7	35.7	NUM
ajlm-1434	114	40	%	%	NOUN
ajlm-1434	114	41	)	)	PUNCT
ajlm-1434	114	42	among	among	ADP
ajlm-1434	114	43	the	the	DET
ajlm-1434	114	44	blood	blood	NOUN
ajlm-1434	114	45	donors	donor	NOUN
ajlm-1434	114	46	may	may	AUX
ajlm-1434	114	47	be	be	AUX
ajlm-1434	114	48	attributed	attribute	VERB
ajlm-1434	114	49	to	to	ADP
ajlm-1434	114	50	a	a	DET
ajlm-1434	114	51	higher	high	ADJ
ajlm-1434	114	52	number	number	NOUN
ajlm-1434	114	53	of	of	ADP
ajlm-1434	114	54	blood	blood	NOUN
ajlm-1434	114	55	donors	donor	NOUN
ajlm-1434	114	56	who	who	PRON
ajlm-1434	114	57	had	have	VERB
ajlm-1434	114	58	current	current	ADJ
ajlm-1434	114	59	or	or	CCONJ
ajlm-1434	114	60	past	past	ADJ
ajlm-1434	114	61	exposure	exposure	NOUN
ajlm-1434	114	62	to	to	ADP
ajlm-1434	114	63	hbv	hbv	NOUN
ajlm-1434	114	64	since	since	SCONJ
ajlm-1434	114	65	anti	anti	ADJ
ajlm-1434	114	66	-	-	ADJ
ajlm-1434	114	67	hbc	hbc	ADJ
ajlm-1434	114	68	persists	persist	NOUN
ajlm-1434	114	69	for	for	ADP
ajlm-1434	114	70	life	life	NOUN
ajlm-1434	114	71	even	even	ADV
ajlm-1434	114	72	though	though	SCONJ
ajlm-1434	114	73	the	the	DET
ajlm-1434	114	74	hbv	hbv	NOUN
ajlm-1434	114	75	infection	infection	NOUN
ajlm-1434	114	76	is	be	AUX
ajlm-1434	114	77	resolved	resolve	VERB
ajlm-1434	114	78	.	.	PUNCT
ajlm-1434	115	1	the	the	DET
ajlm-1434	115	2	possibility	possibility	NOUN
ajlm-1434	115	3	of	of	ADP
ajlm-1434	115	4	obi	obi	PROPN
ajlm-1434	115	5	should	should	AUX
ajlm-1434	115	6	be	be	AUX
ajlm-1434	115	7	considered	consider	VERB
ajlm-1434	115	8	in	in	ADP
ajlm-1434	115	9	hbsag	hbsag	NOUN
ajlm-1434	115	10	-	-	PUNCT
ajlm-1434	115	11	negative	negative	ADJ
ajlm-1434	115	12	but	but	CCONJ
ajlm-1434	115	13	anti	anti	ADJ
ajlm-1434	115	14	-	-	ADJ
ajlm-1434	115	15	hbc	hbc	ADJ
ajlm-1434	115	16	-	-	PUNCT
ajlm-1434	115	17	positive	positive	ADJ
ajlm-1434	115	18	blood	blood	NOUN
ajlm-1434	115	19	donors	donor	NOUN
ajlm-1434	115	20	.	.	PUNCT
ajlm-1434	116	1	occult	occult	NOUN
ajlm-1434	116	2	hbv	hbv	NOUN
ajlm-1434	116	3	is	be	AUX
ajlm-1434	116	4	more	more	ADV
ajlm-1434	116	5	frequently	frequently	ADV
ajlm-1434	116	6	diagnosed	diagnose	VERB
ajlm-1434	116	7	in	in	ADP
ajlm-1434	116	8	anti	anti	ADJ
ajlm-1434	116	9	-	-	ADJ
ajlm-1434	116	10	hbc	hbc	ADJ
ajlm-1434	116	11	-	-	PUNCT
ajlm-1434	116	12	positive	positive	ADJ
ajlm-1434	116	13	individuals	individual	NOUN
ajlm-1434	116	14	than	than	ADP
ajlm-1434	116	15	in	in	ADP
ajlm-1434	116	16	anti	anti	ADJ
ajlm-1434	116	17	-	-	ADJ
ajlm-1434	116	18	hbc	hbc	ADJ
ajlm-1434	116	19	-	-	PUNCT
ajlm-1434	116	20	negative	negative	ADJ
ajlm-1434	116	21	individuals.16,17	individuals.16,17	ADJ
ajlm-1434	116	22	occult	occult	NOUN
ajlm-1434	116	23	hbv	hbv	NOUN
ajlm-1434	116	24	has	have	AUX
ajlm-1434	116	25	been	be	AUX
ajlm-1434	116	26	reported	report	VERB
ajlm-1434	116	27	to	to	PART
ajlm-1434	116	28	range	range	VERB
ajlm-1434	116	29	from	from	ADP
ajlm-1434	116	30	3.0	3.0	NUM
ajlm-1434	116	31	%	%	NOUN
ajlm-1434	116	32	to	to	ADP
ajlm-1434	116	33	17.0	17.0	NUM
ajlm-1434	116	34	%	%	NOUN
ajlm-1434	116	35	in	in	ADP
ajlm-1434	116	36	nigeria.18,19	nigeria.18,19	NOUN
ajlm-1434	116	37	the	the	DET
ajlm-1434	116	38	prevalence	prevalence	NOUN
ajlm-1434	116	39	of	of	ADP
ajlm-1434	116	40	anti	anti	ADJ
ajlm-1434	116	41	-	-	ADJ
ajlm-1434	116	42	hbc	hbc	ADJ
ajlm-1434	116	43	antibody	antibody	NOUN
ajlm-1434	116	44	positivity	positivity	NOUN
ajlm-1434	116	45	among	among	ADP
ajlm-1434	116	46	blood	blood	NOUN
ajlm-1434	116	47	donors	donor	NOUN
ajlm-1434	116	48	varies	vary	VERB
ajlm-1434	116	49	between	between	ADP
ajlm-1434	116	50	and	and	CCONJ
ajlm-1434	116	51	within	within	ADP
ajlm-1434	116	52	countries	country	NOUN
ajlm-1434	116	53	,	,	PUNCT
ajlm-1434	116	54	depending	depend	VERB
ajlm-1434	116	55	on	on	ADP
ajlm-1434	116	56	the	the	DET
ajlm-1434	116	57	assay	assay	NOUN
ajlm-1434	116	58	method	method	NOUN
ajlm-1434	116	59	.	.	PUNCT
ajlm-1434	117	1	the	the	DET
ajlm-1434	117	2	anti	anti	ADJ
ajlm-1434	117	3	-	-	ADJ
ajlm-1434	117	4	hbc	hbc	ADJ
ajlm-1434	117	5	test	test	NOUN
ajlm-1434	117	6	lacks	lack	VERB
ajlm-1434	117	7	specificity	specificity	NOUN
ajlm-1434	117	8	as	as	ADP
ajlm-1434	117	9	test	test	NOUN
ajlm-1434	117	10	reagents	reagent	NOUN
ajlm-1434	117	11	reactivity	reactivity	NOUN
ajlm-1434	117	12	varies	varie	NOUN
ajlm-1434	117	13	between	between	ADP
ajlm-1434	117	14	manufacturers	manufacturer	NOUN
ajlm-1434	117	15	,	,	PUNCT
ajlm-1434	117	16	which	which	PRON
ajlm-1434	117	17	may	may	AUX
ajlm-1434	117	18	affect	affect	VERB
ajlm-1434	117	19	between	between	ADP
ajlm-1434	117	20	-	-	PUNCT
ajlm-1434	117	21	study	study	NOUN
ajlm-1434	117	22	comparisons.20	comparisons.20	NOUN
ajlm-1434	117	23	depending	depend	VERB
ajlm-1434	117	24	on	on	ADP
ajlm-1434	117	25	the	the	DET
ajlm-1434	117	26	assay	assay	NOUN
ajlm-1434	117	27	type	type	NOUN
ajlm-1434	117	28	and	and	CCONJ
ajlm-1434	117	29	screening	screen	VERB
ajlm-1434	117	30	algorithms	algorithm	NOUN
ajlm-1434	117	31	,	,	PUNCT
ajlm-1434	117	32	false	false	ADJ
ajlm-1434	117	33	-	-	PUNCT
ajlm-1434	117	34	reactivity	reactivity	NOUN
ajlm-1434	117	35	rates	rate	NOUN
ajlm-1434	117	36	ranged	range	VERB
ajlm-1434	117	37	between	between	ADP
ajlm-1434	117	38	16.0	16.0	NUM
ajlm-1434	117	39	%	%	NOUN
ajlm-1434	117	40	and	and	CCONJ
ajlm-1434	117	41	75.0%.21	75.0%.21	ADJ
ajlm-1434	117	42	the	the	DET
ajlm-1434	117	43	confirmatory	confirmatory	NOUN
ajlm-1434	117	44	algorithm	algorithm	NOUN
ajlm-1434	117	45	is	be	AUX
ajlm-1434	117	46	complex	complex	ADJ
ajlm-1434	117	47	.	.	PUNCT
ajlm-1434	118	1	however	however	ADV
ajlm-1434	118	2	,	,	PUNCT
ajlm-1434	118	3	a	a	DET
ajlm-1434	118	4	positive	positive	ADJ
ajlm-1434	118	5	anti	anti	NOUN
ajlm-1434	118	6	-	-	NOUN
ajlm-1434	118	7	hbc	hbc	NOUN
ajlm-1434	118	8	in	in	ADP
ajlm-1434	118	9	a	a	DET
ajlm-1434	118	10	high	high	ADJ
ajlm-1434	118	11	hbv	hbv	NOUN
ajlm-1434	118	12	-	-	PUNCT
ajlm-1434	118	13	endemic	endemic	ADJ
ajlm-1434	118	14	region	region	NOUN
ajlm-1434	118	15	establishes	establish	VERB
ajlm-1434	118	16	a	a	DET
ajlm-1434	118	17	history	history	NOUN
ajlm-1434	118	18	of	of	ADP
ajlm-1434	118	19	hbv	hbv	NOUN
ajlm-1434	118	20	infection	infection	NOUN
ajlm-1434	118	21	and	and	CCONJ
ajlm-1434	118	22	portends	portend	VERB
ajlm-1434	118	23	a	a	DET
ajlm-1434	118	24	high	high	ADJ
ajlm-1434	118	25	risk	risk	NOUN
ajlm-1434	118	26	of	of	ADP
ajlm-1434	118	27	obi	obi	PROPN
ajlm-1434	118	28	with	with	ADP
ajlm-1434	118	29	the	the	DET
ajlm-1434	118	30	possibility	possibility	NOUN
ajlm-1434	118	31	of	of	ADP
ajlm-1434	118	32	deferring	defer	VERB
ajlm-1434	118	33	the	the	DET
ajlm-1434	118	34	blood	blood	NOUN
ajlm-1434	118	35	donor	donor	NOUN
ajlm-1434	118	36	.	.	PUNCT
ajlm-1434	119	1	japhet	japhet	PROPN
ajlm-1434	119	2	et	et	PROPN
ajlm-1434	119	3	al	al	PROPN
ajlm-1434	119	4	.	.	PROPN
ajlm-1434	120	1	from	from	ADP
ajlm-1434	120	2	nigeria	nigeria	PROPN
ajlm-1434	120	3	reported	report	VERB
ajlm-1434	120	4	a	a	DET
ajlm-1434	120	5	lower	low	ADJ
ajlm-1434	120	6	anti	anti	ADJ
ajlm-1434	120	7	-	-	ADJ
ajlm-1434	120	8	hbc	hbc	ADJ
ajlm-1434	120	9	prevalence	prevalence	NOUN
ajlm-1434	120	10	of	of	ADP
ajlm-1434	120	11	13.0	13.0	NUM
ajlm-1434	120	12	%	%	NOUN
ajlm-1434	120	13	and	and	CCONJ
ajlm-1434	120	14	a	a	DET
ajlm-1434	120	15	higher	high	ADJ
ajlm-1434	120	16	prevalence	prevalence	NOUN
ajlm-1434	120	17	of	of	ADP
ajlm-1434	120	18	19.6	19.6	NUM
ajlm-1434	120	19	%	%	NOUN
ajlm-1434	120	20	hbsag.22	hbsag.22	NOUN
ajlm-1434	120	21	the	the	DET
ajlm-1434	120	22	lower	low	ADJ
ajlm-1434	120	23	anti	anti	ADJ
ajlm-1434	120	24	-	-	ADJ
ajlm-1434	120	25	hbc	hbc	ADJ
ajlm-1434	120	26	prevalence	prevalence	NOUN
ajlm-1434	120	27	was	be	AUX
ajlm-1434	120	28	probably	probably	ADV
ajlm-1434	120	29	caused	cause	VERB
ajlm-1434	120	30	by	by	ADP
ajlm-1434	120	31	the	the	DET
ajlm-1434	120	32	igm	igm	PROPN
ajlm-1434	120	33	anti	anti	ADJ
ajlm-1434	120	34	-	-	ADJ
ajlm-1434	120	35	hbc	hbc	ADJ
ajlm-1434	120	36	test	test	NOUN
ajlm-1434	120	37	used	use	VERB
ajlm-1434	120	38	in	in	ADP
ajlm-1434	120	39	that	that	DET
ajlm-1434	120	40	study	study	NOUN
ajlm-1434	120	41	,	,	PUNCT
ajlm-1434	120	42	which	which	PRON
ajlm-1434	120	43	detects	detect	VERB
ajlm-1434	120	44	acute	acute	NOUN
ajlm-1434	120	45	infections	infection	NOUN
ajlm-1434	120	46	but	but	CCONJ
ajlm-1434	120	47	misses	miss	VERB
ajlm-1434	120	48	chronic	chronic	ADJ
ajlm-1434	120	49	hbv	hbv	NOUN
ajlm-1434	120	50	carriers	carrier	NOUN
ajlm-1434	120	51	,	,	PUNCT
ajlm-1434	120	52	whereas	whereas	SCONJ
ajlm-1434	120	53	the	the	DET
ajlm-1434	120	54	current	current	ADJ
ajlm-1434	120	55	study	study	NOUN
ajlm-1434	120	56	detected	detect	VERB
ajlm-1434	120	57	total	total	ADJ
ajlm-1434	120	58	anti	anti	ADJ
ajlm-1434	120	59	-	-	NOUN
ajlm-1434	120	60	hbc	hbc	ADJ
ajlm-1434	120	61	(	(	PUNCT
ajlm-1434	120	62	igm	igm	NOUN
ajlm-1434	120	63	and	and	CCONJ
ajlm-1434	120	64	igg	igg	PROPN
ajlm-1434	120	65	)	)	PUNCT
ajlm-1434	120	66	.	.	PUNCT
ajlm-1434	121	1	the	the	DET
ajlm-1434	121	2	shortcoming	shortcoming	NOUN
ajlm-1434	121	3	of	of	ADP
ajlm-1434	121	4	the	the	DET
ajlm-1434	121	5	total	total	ADJ
ajlm-1434	121	6	anti	anti	ADJ
ajlm-1434	121	7	-	-	ADJ
ajlm-1434	121	8	hbc	hbc	ADJ
ajlm-1434	121	9	study	study	NOUN
ajlm-1434	121	10	is	be	AUX
ajlm-1434	121	11	that	that	SCONJ
ajlm-1434	121	12	it	it	PRON
ajlm-1434	121	13	includes	include	VERB
ajlm-1434	121	14	all	all	DET
ajlm-1434	121	15	blood	blood	NOUN
ajlm-1434	121	16	donors	donor	NOUN
ajlm-1434	121	17	who	who	PRON
ajlm-1434	121	18	had	have	AUX
ajlm-1434	121	19	been	be	AUX
ajlm-1434	121	20	exposed	expose	VERB
ajlm-1434	121	21	to	to	ADP
ajlm-1434	121	22	hbv	hbv	NOUN
ajlm-1434	121	23	including	include	VERB
ajlm-1434	121	24	those	those	PRON
ajlm-1434	121	25	with	with	ADP
ajlm-1434	121	26	resolved	resolved	ADJ
ajlm-1434	121	27	infection	infection	NOUN
ajlm-1434	121	28	.	.	PUNCT
ajlm-1434	122	1	this	this	DET
ajlm-1434	122	2	shortcoming	shortcoming	NOUN
ajlm-1434	122	3	may	may	AUX
ajlm-1434	122	4	exaggerate	exaggerate	VERB
ajlm-1434	122	5	the	the	DET
ajlm-1434	122	6	prevalence	prevalence	NOUN
ajlm-1434	122	7	of	of	ADP
ajlm-1434	122	8	hbv	hbv	NOUN
ajlm-1434	122	9	infection	infection	NOUN
ajlm-1434	122	10	in	in	ADP
ajlm-1434	122	11	high	high	ADJ
ajlm-1434	122	12	-	-	PUNCT
ajlm-1434	122	13	prevalence	prevalence	NOUN
ajlm-1434	122	14	regions	region	NOUN
ajlm-1434	122	15	,	,	PUNCT
ajlm-1434	122	16	thereby	thereby	ADV
ajlm-1434	122	17	shrinking	shrink	VERB
ajlm-1434	122	18	the	the	DET
ajlm-1434	122	19	size	size	NOUN
ajlm-1434	122	20	of	of	ADP
ajlm-1434	122	21	the	the	DET
ajlm-1434	122	22	eligible	eligible	ADJ
ajlm-1434	122	23	blood	blood	NOUN
ajlm-1434	122	24	donor	donor	NOUN
ajlm-1434	122	25	pool	pool	NOUN
ajlm-1434	122	26	.	.	PUNCT
ajlm-1434	123	1	dhawan	dhawan	PROPN
ajlm-1434	123	2	et	et	PROPN
ajlm-1434	123	3	al	al	PROPN
ajlm-1434	123	4	.	.	PROPN
ajlm-1434	123	5	observed	observe	VERB
ajlm-1434	123	6	a	a	DET
ajlm-1434	123	7	significantly	significantly	ADV
ajlm-1434	123	8	higher	high	ADJ
ajlm-1434	123	9	anti	anti	ADJ
ajlm-1434	123	10	-	-	NOUN
ajlm-1434	123	11	hbc	hbc	ADJ
ajlm-1434	123	12	(	(	PUNCT
ajlm-1434	123	13	8.4	8.4	NUM
ajlm-1434	123	14	%	%	NOUN
ajlm-1434	123	15	vs	vs	ADP
ajlm-1434	123	16	6.9	6.9	NUM
ajlm-1434	123	17	%	%	NOUN
ajlm-1434	123	18	)	)	PUNCT
ajlm-1434	123	19	among	among	ADP
ajlm-1434	123	20	replacement	replacement	NOUN
ajlm-1434	123	21	donors	donor	NOUN
ajlm-1434	123	22	than	than	ADP
ajlm-1434	123	23	among	among	ADP
ajlm-1434	123	24	voluntary	voluntary	ADJ
ajlm-1434	123	25	donors	donor	NOUN
ajlm-1434	123	26	in	in	ADP
ajlm-1434	123	27	india	india	PROPN
ajlm-1434	123	28	.	.	PUNCT
ajlm-1434	124	1	however	however	ADV
ajlm-1434	124	2	,	,	PUNCT
ajlm-1434	124	3	a	a	DET
ajlm-1434	124	4	wide	wide	ADJ
ajlm-1434	124	5	range	range	NOUN
ajlm-1434	124	6	of	of	ADP
ajlm-1434	124	7	prevalence	prevalence	NOUN
ajlm-1434	124	8	of	of	ADP
ajlm-1434	124	9	anti	anti	ADJ
ajlm-1434	124	10	-	-	ADJ
ajlm-1434	124	11	hbc	hbc	ADJ
ajlm-1434	124	12	positivity	positivity	NOUN
ajlm-1434	124	13	has	have	AUX
ajlm-1434	124	14	been	be	AUX
ajlm-1434	124	15	reported	report	VERB
ajlm-1434	124	16	among	among	ADP
ajlm-1434	124	17	indian	indian	ADJ
ajlm-1434	124	18	donors	donor	NOUN
ajlm-1434	124	19	,	,	PUNCT
ajlm-1434	124	20	and	and	CCONJ
ajlm-1434	124	21	this	this	PRON
ajlm-1434	124	22	has	have	AUX
ajlm-1434	124	23	been	be	AUX
ajlm-1434	124	24	attributed	attribute	VERB
ajlm-1434	124	25	to	to	ADP
ajlm-1434	124	26	the	the	DET
ajlm-1434	124	27	use	use	NOUN
ajlm-1434	124	28	of	of	ADP
ajlm-1434	124	29	assays	assay	NOUN
ajlm-1434	124	30	with	with	ADP
ajlm-1434	124	31	varying	vary	VERB
ajlm-1434	124	32	sensitivities	sensitivity	NOUN
ajlm-1434	124	33	in	in	ADP
ajlm-1434	124	34	different	different	ADJ
ajlm-1434	124	35	studies	study	NOUN
ajlm-1434	124	36	for	for	ADP
ajlm-1434	124	37	screening	screen	VERB
ajlm-1434	124	38	the	the	DET
ajlm-1434	124	39	donors	donor	NOUN
ajlm-1434	124	40	and	and	CCONJ
ajlm-1434	124	41	the	the	DET
ajlm-1434	124	42	nature	nature	NOUN
ajlm-1434	124	43	of	of	ADP
ajlm-1434	124	44	the	the	DET
ajlm-1434	124	45	study	study	NOUN
ajlm-1434	124	46	population.23	population.23	NOUN
ajlm-1434	124	47	this	this	DET
ajlm-1434	124	48	study	study	NOUN
ajlm-1434	124	49	suggests	suggest	VERB
ajlm-1434	124	50	that	that	SCONJ
ajlm-1434	124	51	donors	donor	NOUN
ajlm-1434	124	52	who	who	PRON
ajlm-1434	124	53	had	have	AUX
ajlm-1434	124	54	ever	ever	ADV
ajlm-1434	124	55	used	use	VERB
ajlm-1434	124	56	recreational	recreational	ADJ
ajlm-1434	124	57	drugs	drug	NOUN
ajlm-1434	124	58	are	be	AUX
ajlm-1434	124	59	likely	likely	ADJ
ajlm-1434	124	60	to	to	PART
ajlm-1434	124	61	be	be	AUX
ajlm-1434	124	62	positive	positive	ADJ
ajlm-1434	124	63	for	for	ADP
ajlm-1434	124	64	anti	anti	ADJ
ajlm-1434	124	65	-	-	NOUN
ajlm-1434	124	66	hbc	hbc	NOUN
ajlm-1434	124	67	.	.	PUNCT
ajlm-1434	125	1	therefore	therefore	ADV
ajlm-1434	125	2	,	,	PUNCT
ajlm-1434	125	3	stringent	stringent	ADJ
ajlm-1434	125	4	blood	blood	NOUN
ajlm-1434	125	5	donor	donor	NOUN
ajlm-1434	125	6	screening	screen	VERB
ajlm-1434	125	7	criteria	criterion	NOUN
ajlm-1434	125	8	using	use	VERB
ajlm-1434	125	9	a	a	DET
ajlm-1434	125	10	standard	standard	ADJ
ajlm-1434	125	11	questionnaire	questionnaire	NOUN
ajlm-1434	125	12	that	that	PRON
ajlm-1434	125	13	provides	provide	VERB
ajlm-1434	125	14	confidentiality	confidentiality	NOUN
ajlm-1434	125	15	for	for	ADP
ajlm-1434	125	16	donors	donor	NOUN
ajlm-1434	125	17	in	in	ADP
ajlm-1434	125	18	addition	addition	NOUN
ajlm-1434	125	19	to	to	ADP
ajlm-1434	125	20	educational	educational	ADJ
ajlm-1434	125	21	materials	material	NOUN
ajlm-1434	125	22	to	to	PART
ajlm-1434	125	23	eliminate	eliminate	VERB
ajlm-1434	125	24	donors	donor	NOUN
ajlm-1434	125	25	who	who	PRON
ajlm-1434	125	26	had	have	AUX
ajlm-1434	125	27	ever	ever	ADV
ajlm-1434	125	28	used	use	VERB
ajlm-1434	125	29	recreational	recreational	ADJ
ajlm-1434	125	30	drugs	drug	NOUN
ajlm-1434	125	31	may	may	AUX
ajlm-1434	125	32	significantly	significantly	ADV
ajlm-1434	125	33	reduce	reduce	VERB
ajlm-1434	125	34	hbv	hbv	NOUN
ajlm-1434	125	35	-	-	PUNCT
ajlm-1434	125	36	positive	positive	ADJ
ajlm-1434	125	37	donors	donor	NOUN
ajlm-1434	125	38	irrespective	irrespective	ADV
ajlm-1434	125	39	of	of	ADP
ajlm-1434	125	40	whether	whether	SCONJ
ajlm-1434	125	41	they	they	PRON
ajlm-1434	125	42	are	be	AUX
ajlm-1434	125	43	voluntary	voluntary	ADJ
ajlm-1434	125	44	or	or	CCONJ
ajlm-1434	125	45	replacement	replacement	NOUN
ajlm-1434	125	46	blood	blood	NOUN
ajlm-1434	125	47	donors	donor	NOUN
ajlm-1434	125	48	.	.	PUNCT
ajlm-1434	126	1	comparing	compare	VERB
ajlm-1434	126	2	this	this	DET
ajlm-1434	126	3	study	study	NOUN
ajlm-1434	126	4	with	with	ADP
ajlm-1434	126	5	other	other	ADJ
ajlm-1434	126	6	studies	study	NOUN
ajlm-1434	126	7	that	that	PRON
ajlm-1434	126	8	investigated	investigate	VERB
ajlm-1434	126	9	total	total	ADJ
ajlm-1434	126	10	anti	anti	ADJ
ajlm-1434	126	11	-	-	NOUN
ajlm-1434	126	12	hbc	hbc	NOUN
ajlm-1434	126	13	in	in	ADP
ajlm-1434	126	14	nigeria	nigeria	PROPN
ajlm-1434	126	15	,	,	PUNCT
ajlm-1434	126	16	the	the	DET
ajlm-1434	126	17	prevalence	prevalence	NOUN
ajlm-1434	126	18	of	of	ADP
ajlm-1434	126	19	48.5	48.5	NUM
ajlm-1434	126	20	%	%	NOUN
ajlm-1434	126	21	is	be	AUX
ajlm-1434	126	22	higher	high	ADJ
ajlm-1434	126	23	than	than	ADP
ajlm-1434	126	24	32.5	32.5	NUM
ajlm-1434	126	25	%	%	NOUN
ajlm-1434	126	26	by	by	ADP
ajlm-1434	126	27	ogunfemi	ogunfemi	ADV
ajlm-1434	126	28	et	et	PROPN
ajlm-1434	126	29	al	al	PROPN
ajlm-1434	126	30	.	.	PROPN
ajlm-1434	127	1	in	in	ADP
ajlm-1434	127	2	ilorin,24	ilorin,24	NOUN
ajlm-1434	127	3	but	but	CCONJ
ajlm-1434	127	4	lower	low	ADJ
ajlm-1434	127	5	than	than	ADP
ajlm-1434	127	6	60.7	60.7	NUM
ajlm-1434	127	7	%	%	NOUN
ajlm-1434	127	8	and	and	CCONJ
ajlm-1434	127	9	90.0	90.0	NUM
ajlm-1434	127	10	%	%	NOUN
ajlm-1434	127	11	from	from	ADP
ajlm-1434	127	12	the	the	DET
ajlm-1434	127	13	studies	study	NOUN
ajlm-1434	127	14	by	by	ADP
ajlm-1434	127	15	akinbami	akinbami	NOUN
ajlm-1434	127	16	et	et	PROPN
ajlm-1434	127	17	al	al	PROPN
ajlm-1434	127	18	.	.	PROPN
ajlm-1434	128	1	in	in	ADP
ajlm-1434	128	2	lagos18	lagos18	NOUN
ajlm-1434	128	3	and	and	CCONJ
ajlm-1434	128	4	ojo	ojo	NOUN
ajlm-1434	128	5	et	et	PROPN
ajlm-1434	128	6	al	al	PROPN
ajlm-1434	128	7	.	.	PROPN
ajlm-1434	129	1	in	in	ADP
ajlm-1434	129	2	ife.25	ife.25	PROPN
ajlm-1434	129	3	the	the	DET
ajlm-1434	129	4	90.0	90.0	NUM
ajlm-1434	129	5	%	%	NOUN
ajlm-1434	129	6	prevalence	prevalence	NOUN
ajlm-1434	129	7	was	be	AUX
ajlm-1434	129	8	reported	report	VERB
ajlm-1434	129	9	pre	pre	ADJ
ajlm-1434	129	10	-	-	ADJ
ajlm-1434	129	11	hbv	hbv	ADJ
ajlm-1434	129	12	vaccination	vaccination	NOUN
ajlm-1434	129	13	.	.	PUNCT
ajlm-1434	130	1	levels	level	NOUN
ajlm-1434	130	2	of	of	ADP
ajlm-1434	130	3	anti	anti	ADJ
ajlm-1434	130	4	-	-	ADJ
ajlm-1434	130	5	hbc	hbc	NOUN
ajlm-1434	130	6	have	have	AUX
ajlm-1434	130	7	been	be	AUX
ajlm-1434	130	8	shown	show	VERB
ajlm-1434	130	9	to	to	PART
ajlm-1434	130	10	decrease	decrease	VERB
ajlm-1434	130	11	in	in	ADP
ajlm-1434	130	12	the	the	DET
ajlm-1434	130	13	donor	donor	NOUN
ajlm-1434	130	14	population	population	NOUN
ajlm-1434	130	15	;	;	PUNCT
ajlm-1434	130	16	this	this	PRON
ajlm-1434	130	17	could	could	AUX
ajlm-1434	130	18	be	be	AUX
ajlm-1434	130	19	attributed	attribute	VERB
ajlm-1434	130	20	to	to	ADP
ajlm-1434	130	21	acquired	acquire	VERB
ajlm-1434	130	22	immunity	immunity	NOUN
ajlm-1434	130	23	from	from	ADP
ajlm-1434	130	24	vaccination	vaccination	NOUN
ajlm-1434	130	25	and	and	CCONJ
ajlm-1434	130	26	increased	increase	VERB
ajlm-1434	130	27	awareness.26	awareness.26	NOUN
ajlm-1434	130	28	similarly	similarly	ADV
ajlm-1434	130	29	,	,	PUNCT
ajlm-1434	130	30	in	in	ADP
ajlm-1434	130	31	germany	germany	PROPN
ajlm-1434	130	32	,	,	PUNCT
ajlm-1434	130	33	the	the	DET
ajlm-1434	130	34	trend	trend	NOUN
ajlm-1434	130	35	for	for	ADP
ajlm-1434	130	36	anti	anti	ADJ
ajlm-1434	130	37	-	-	ADJ
ajlm-1434	130	38	hbc	hbc	ADJ
ajlm-1434	130	39	-	-	PUNCT
ajlm-1434	130	40	positive	positive	ADJ
ajlm-1434	130	41	status	status	NOUN
ajlm-1434	130	42	was	be	AUX
ajlm-1434	130	43	1.17	1.17	NUM
ajlm-1434	130	44	%	%	NOUN
ajlm-1434	130	45	in	in	ADP
ajlm-1434	130	46	2007	2007	NUM
ajlm-1434	130	47	but	but	CCONJ
ajlm-1434	130	48	decreased	decrease	VERB
ajlm-1434	130	49	to	to	ADP
ajlm-1434	130	50	0.72	0.72	NUM
ajlm-1434	130	51	%	%	NOUN
ajlm-1434	130	52	in	in	ADP
ajlm-1434	130	53	2015.27	2015.27	NUM
ajlm-1434	130	54	summarily	summarily	ADV
ajlm-1434	130	55	,	,	PUNCT
ajlm-1434	130	56	the	the	DET
ajlm-1434	130	57	variations	variation	NOUN
ajlm-1434	130	58	in	in	ADP
ajlm-1434	130	59	prevalence	prevalence	NOUN
ajlm-1434	130	60	have	have	AUX
ajlm-1434	130	61	been	be	AUX
ajlm-1434	130	62	associated	associate	VERB
ajlm-1434	130	63	with	with	ADP
ajlm-1434	130	64	the	the	DET
ajlm-1434	130	65	different	different	ADJ
ajlm-1434	130	66	assays	assay	NOUN
ajlm-1434	130	67	used	use	VERB
ajlm-1434	130	68	,	,	PUNCT
ajlm-1434	130	69	study	study	NOUN
ajlm-1434	130	70	design	design	NOUN
ajlm-1434	130	71	and	and	CCONJ
ajlm-1434	130	72	hbv	hbv	NOUN
ajlm-1434	130	73	endemicity	endemicity	NOUN
ajlm-1434	130	74	.	.	PUNCT
ajlm-1434	131	1	some	some	DET
ajlm-1434	131	2	studies	study	NOUN
ajlm-1434	131	3	investigated	investigate	VERB
ajlm-1434	131	4	anti	anti	ADJ
ajlm-1434	131	5	-	-	NOUN
ajlm-1434	131	6	hbc	hbc	NOUN
ajlm-1434	131	7	in	in	ADP
ajlm-1434	131	8	hbsag	hbsag	ADJ
ajlm-1434	131	9	-	-	PUNCT
ajlm-1434	131	10	negative	negative	ADJ
ajlm-1434	131	11	donors	donor	NOUN
ajlm-1434	131	12	,	,	PUNCT
ajlm-1434	131	13	while	while	SCONJ
ajlm-1434	131	14	some	some	DET
ajlm-1434	131	15	studies	study	NOUN
ajlm-1434	131	16	investigated	investigate	VERB
ajlm-1434	131	17	in	in	ADP
ajlm-1434	131	18	both	both	CCONJ
ajlm-1434	131	19	hbsag	hbsag	ADJ
ajlm-1434	131	20	-	-	PUNCT
ajlm-1434	131	21	negative	negative	ADJ
ajlm-1434	131	22	and	and	CCONJ
ajlm-1434	131	23	hbsag	hbsag	ADJ
ajlm-1434	131	24	-	-	PUNCT
ajlm-1434	131	25	positive	positive	ADJ
ajlm-1434	131	26	donors.23,25,26,27	donors.23,25,26,27	PROPN
ajlm-1434	131	27	total	total	NOUN
ajlm-1434	131	28	anti	anti	NOUN
ajlm-1434	131	29	-	-	ADJ
ajlm-1434	131	30	hbc+/hbsagdonors	hbc+/hbsagdonor	NOUN
ajlm-1434	131	31	of	of	ADP
ajlm-1434	131	32	107	107	NUM
ajlm-1434	131	33	(	(	PUNCT
ajlm-1434	131	34	46.1	46.1	NUM
ajlm-1434	131	35	%	%	NOUN
ajlm-1434	131	36	)	)	PUNCT
ajlm-1434	131	37	in	in	ADP
ajlm-1434	131	38	our	our	PRON
ajlm-1434	131	39	study	study	NOUN
ajlm-1434	131	40	is	be	AUX
ajlm-1434	131	41	higher	high	ADJ
ajlm-1434	131	42	than	than	ADP
ajlm-1434	131	43	igm	igm	PROPN
ajlm-1434	131	44	anti	anti	NOUN
ajlm-1434	131	45	-	-	NOUN
ajlm-1434	131	46	hbc+/hbsagdonors	hbc+/hbsagdonor	NOUN
ajlm-1434	131	47	of	of	ADP
ajlm-1434	131	48	49	49	NUM
ajlm-1434	131	49	(	(	PUNCT
ajlm-1434	131	50	18.1	18.1	NUM
ajlm-1434	131	51	%	%	NOUN
ajlm-1434	131	52	)	)	PUNCT
ajlm-1434	131	53	and	and	CCONJ
ajlm-1434	131	54	20	20	NUM
ajlm-1434	131	55	(	(	PUNCT
ajlm-1434	131	56	4.4	4.4	NUM
ajlm-1434	131	57	%	%	NOUN
ajlm-1434	131	58	)	)	PUNCT
ajlm-1434	131	59	for	for	ADP
ajlm-1434	131	60	maiduguri28	maiduguri28	NOUN
ajlm-1434	131	61	and	and	CCONJ
ajlm-1434	131	62	ile	ile	PROPN
ajlm-1434	131	63	-	-	PUNCT
ajlm-1434	131	64	ife,29	ife,29	NOUN
ajlm-1434	131	65	nigeria	nigeria	PROPN
ajlm-1434	131	66	.	.	PUNCT
ajlm-1434	132	1	the	the	DET
ajlm-1434	132	2	higher	high	ADJ
ajlm-1434	132	3	anti	anti	NOUN
ajlm-1434	132	4	-	-	ADJ
ajlm-1434	132	5	hbc+/hbsagdonors	hbc+/hbsagdonor	NOUN
ajlm-1434	132	6	in	in	ADP
ajlm-1434	132	7	our	our	PRON
ajlm-1434	132	8	study	study	NOUN
ajlm-1434	132	9	could	could	AUX
ajlm-1434	132	10	suggest	suggest	VERB
ajlm-1434	132	11	a	a	DET
ajlm-1434	132	12	higher	high	ADJ
ajlm-1434	132	13	potential	potential	NOUN
ajlm-1434	132	14	for	for	ADP
ajlm-1434	132	15	hbv	hbv	NOUN
ajlm-1434	132	16	blood	blood	NOUN
ajlm-1434	132	17	transmission	transmission	NOUN
ajlm-1434	132	18	from	from	ADP
ajlm-1434	132	19	donors	donor	NOUN
ajlm-1434	132	20	.	.	PUNCT
ajlm-1434	133	1	however	however	ADV
ajlm-1434	133	2	,	,	PUNCT
ajlm-1434	133	3	this	this	PRON
ajlm-1434	133	4	may	may	AUX
ajlm-1434	133	5	not	not	PART
ajlm-1434	133	6	be	be	AUX
ajlm-1434	133	7	the	the	DET
ajlm-1434	133	8	case	case	NOUN
ajlm-1434	133	9	because	because	SCONJ
ajlm-1434	133	10	high	high	ADJ
ajlm-1434	133	11	anti	anti	ADJ
ajlm-1434	133	12	-	-	ADJ
ajlm-1434	133	13	hbc	hbc	ADJ
ajlm-1434	133	14	prevalence	prevalence	NOUN
ajlm-1434	133	15	does	do	AUX
ajlm-1434	133	16	not	not	PART
ajlm-1434	133	17	always	always	ADV
ajlm-1434	133	18	imply	imply	VERB
ajlm-1434	133	19	high	high	ADJ
ajlm-1434	133	20	obi	obi	NOUN
ajlm-1434	133	21	frequency.27	frequency.27	NOUN
ajlm-1434	133	22	although	although	SCONJ
ajlm-1434	133	23	other	other	ADJ
ajlm-1434	133	24	studies	study	NOUN
ajlm-1434	133	25	reported	report	VERB
ajlm-1434	133	26	a	a	DET
ajlm-1434	133	27	lower	low	ADJ
ajlm-1434	133	28	prevalence	prevalence	NOUN
ajlm-1434	133	29	of	of	ADP
ajlm-1434	133	30	anti	anti	NOUN
ajlm-1434	133	31	-	-	NOUN
ajlm-1434	133	32	hbc	hbc	NOUN
ajlm-1434	133	33	in	in	ADP
ajlm-1434	133	34	some	some	DET
ajlm-1434	133	35	nigerian	nigerian	ADJ
ajlm-1434	133	36	blood	blood	NOUN
ajlm-1434	133	37	centres	centre	NOUN
ajlm-1434	133	38	,	,	PUNCT
ajlm-1434	133	39	the	the	DET
ajlm-1434	133	40	anti	anti	ADJ
ajlm-1434	133	41	-	-	ADJ
ajlm-1434	133	42	hbc	hbc	ADJ
ajlm-1434	133	43	prevalence	prevalence	NOUN
ajlm-1434	133	44	in	in	ADP
ajlm-1434	133	45	those	those	DET
ajlm-1434	133	46	blood	blood	NOUN
ajlm-1434	133	47	centres	centre	NOUN
ajlm-1434	133	48	is	be	AUX
ajlm-1434	133	49	still	still	ADV
ajlm-1434	133	50	significant	significant	ADJ
ajlm-1434	133	51	to	to	PART
ajlm-1434	133	52	cause	cause	VERB
ajlm-1434	133	53	an	an	DET
ajlm-1434	133	54	increase	increase	NOUN
ajlm-1434	133	55	in	in	ADP
ajlm-1434	133	56	donor	donor	NOUN
ajlm-1434	133	57	deferral	deferral	ADJ
ajlm-1434	133	58	rate	rate	NOUN
ajlm-1434	133	59	and	and	CCONJ
ajlm-1434	133	60	reduce	reduce	VERB
ajlm-1434	133	61	blood	blood	NOUN
ajlm-1434	133	62	supply	supply	NOUN
ajlm-1434	133	63	if	if	SCONJ
ajlm-1434	133	64	anti	anti	ADJ
ajlm-1434	133	65	-	-	ADJ
ajlm-1434	133	66	hbc	hbc	ADJ
ajlm-1434	133	67	testing	testing	NOUN
ajlm-1434	133	68	is	be	AUX
ajlm-1434	133	69	added	add	VERB
ajlm-1434	133	70	to	to	ADP
ajlm-1434	133	71	the	the	DET
ajlm-1434	133	72	blood	blood	NOUN
ajlm-1434	133	73	donor	donor	NOUN
ajlm-1434	133	74	screening	screen	VERB
ajlm-1434	133	75	algorithm	algorithm	NOUN
ajlm-1434	133	76	.	.	PUNCT
ajlm-1434	134	1	the	the	DET
ajlm-1434	134	2	anti	anti	ADJ
ajlm-1434	134	3	-	-	ADJ
ajlm-1434	134	4	hbc	hbc	ADJ
ajlm-1434	134	5	test	test	NOUN
ajlm-1434	134	6	included	include	VERB
ajlm-1434	134	7	in	in	ADP
ajlm-1434	134	8	screening	screen	VERB
ajlm-1434	134	9	blood	blood	NOUN
ajlm-1434	134	10	donors	donor	NOUN
ajlm-1434	134	11	in	in	ADP
ajlm-1434	134	12	hbv	hbv	NOUN
ajlm-1434	134	13	non	non	ADJ
ajlm-1434	134	14	-	-	ADJ
ajlm-1434	134	15	endemic	endemic	ADJ
ajlm-1434	134	16	countries	country	NOUN
ajlm-1434	134	17	is	be	AUX
ajlm-1434	134	18	not	not	PART
ajlm-1434	134	19	routinely	routinely	ADV
ajlm-1434	134	20	used	use	VERB
ajlm-1434	134	21	in	in	ADP
ajlm-1434	134	22	hbv	hbv	NOUN
ajlm-1434	134	23	-	-	PUNCT
ajlm-1434	134	24	endemic	endemic	ADJ
ajlm-1434	134	25	countries	country	NOUN
ajlm-1434	134	26	because	because	SCONJ
ajlm-1434	134	27	many	many	ADJ
ajlm-1434	134	28	blood	blood	NOUN
ajlm-1434	134	29	products	product	NOUN
ajlm-1434	134	30	would	would	AUX
ajlm-1434	134	31	be	be	AUX
ajlm-1434	134	32	discarded	discard	VERB
ajlm-1434	134	33	due	due	ADP
ajlm-1434	134	34	to	to	ADP
ajlm-1434	134	35	positive	positive	ADJ
ajlm-1434	134	36	result	result	NOUN
ajlm-1434	134	37	even	even	ADV
ajlm-1434	134	38	though	though	SCONJ
ajlm-1434	134	39	most	most	ADJ
ajlm-1434	134	40	of	of	ADP
ajlm-1434	134	41	the	the	DET
ajlm-1434	134	42	blood	blood	NOUN
ajlm-1434	134	43	would	would	AUX
ajlm-1434	134	44	be	be	AUX
ajlm-1434	134	45	safe	safe	ADJ
ajlm-1434	134	46	for	for	SCONJ
ajlm-1434	134	47	transfusion.20	transfusion.20	PROPN
ajlm-1434	134	48	total	total	ADJ
ajlm-1434	134	49	anti	anti	ADJ
ajlm-1434	134	50	-	-	ADJ
ajlm-1434	134	51	hbc	hbc	ADJ
ajlm-1434	134	52	-	-	PUNCT
ajlm-1434	134	53	positivity	positivity	NOUN
ajlm-1434	134	54	was	be	AUX
ajlm-1434	134	55	significantly	significantly	ADV
ajlm-1434	134	56	higher	high	ADJ
ajlm-1434	134	57	among	among	ADP
ajlm-1434	134	58	donors	donor	NOUN
ajlm-1434	134	59	older	old	ADJ
ajlm-1434	134	60	than	than	ADP
ajlm-1434	134	61	35	35	NUM
ajlm-1434	134	62	years	year	NOUN
ajlm-1434	134	63	compared	compare	VERB
ajlm-1434	134	64	to	to	ADP
ajlm-1434	134	65	younger	young	ADJ
ajlm-1434	134	66	donors	donor	NOUN
ajlm-1434	134	67	,	,	PUNCT
ajlm-1434	134	68	which	which	PRON
ajlm-1434	134	69	is	be	AUX
ajlm-1434	134	70	contrary	contrary	ADJ
ajlm-1434	134	71	to	to	ADP
ajlm-1434	134	72	the	the	DET
ajlm-1434	134	73	statistically	statistically	ADV
ajlm-1434	134	74	non	non	ADJ
ajlm-1434	134	75	-	-	ADJ
ajlm-1434	134	76	significant	significant	ADJ
ajlm-1434	134	77	difference	difference	NOUN
ajlm-1434	134	78	observed	observe	VERB
ajlm-1434	134	79	in	in	ADP
ajlm-1434	134	80	ilorin	ilorin	NOUN
ajlm-1434	134	81	,	,	PUNCT
ajlm-1434	134	82	nigeria.23,24	nigeria.23,24	VERB
ajlm-1434	134	83	studies	study	NOUN
ajlm-1434	134	84	from	from	ADP
ajlm-1434	134	85	bangladesh	bangladesh	PROPN
ajlm-1434	134	86	,	,	PUNCT
ajlm-1434	134	87	italy	italy	PROPN
ajlm-1434	134	88	,	,	PUNCT
ajlm-1434	134	89	and	and	CCONJ
ajlm-1434	134	90	korea	korea	PROPN
ajlm-1434	134	91	also	also	ADV
ajlm-1434	134	92	reported	report	VERB
ajlm-1434	134	93	high	high	ADJ
ajlm-1434	134	94	anti	anti	ADJ
ajlm-1434	134	95	-	-	ADJ
ajlm-1434	134	96	hbc	hbc	ADJ
ajlm-1434	134	97	-	-	PUNCT
ajlm-1434	134	98	positive	positive	ADJ
ajlm-1434	134	99	status	status	NOUN
ajlm-1434	134	100	in	in	ADP
ajlm-1434	134	101	older	old	ADJ
ajlm-1434	134	102	donors	donor	NOUN
ajlm-1434	134	103	,	,	PUNCT
ajlm-1434	134	104	which	which	PRON
ajlm-1434	134	105	was	be	AUX
ajlm-1434	134	106	attributed	attribute	VERB
ajlm-1434	134	107	to	to	ADP
ajlm-1434	134	108	the	the	DET
ajlm-1434	134	109	acquisition	acquisition	NOUN
ajlm-1434	134	110	of	of	ADP
ajlm-1434	134	111	hbv	hbv	NOUN
ajlm-1434	134	112	infections	infection	NOUN
ajlm-1434	134	113	in	in	ADP
ajlm-1434	134	114	earlier	early	ADJ
ajlm-1434	134	115	years	year	NOUN
ajlm-1434	134	116	when	when	SCONJ
ajlm-1434	134	117	hbv	hbv	NOUN
ajlm-1434	134	118	was	be	AUX
ajlm-1434	134	119	highly	highly	ADV
ajlm-1434	134	120	endemic.30,31,32	endemic.30,31,32	VERB
ajlm-1434	134	121	although	although	SCONJ
ajlm-1434	134	122	the	the	DET
ajlm-1434	134	123	prevalence	prevalence	NOUN
ajlm-1434	134	124	of	of	ADP
ajlm-1434	134	125	hbv	hbv	NOUN
ajlm-1434	134	126	infection	infection	NOUN
ajlm-1434	134	127	is	be	AUX
ajlm-1434	134	128	still	still	ADV
ajlm-1434	134	129	high	high	ADJ
ajlm-1434	134	130	in	in	ADP
ajlm-1434	134	131	nigeria	nigeria	PROPN
ajlm-1434	134	132	,	,	PUNCT
ajlm-1434	134	133	declining	decline	VERB
ajlm-1434	134	134	rates	rate	NOUN
ajlm-1434	134	135	have	have	AUX
ajlm-1434	134	136	been	be	AUX
ajlm-1434	134	137	reported.33	reported.33	NOUN
ajlm-1434	134	138	this	this	DET
ajlm-1434	134	139	study	study	NOUN
ajlm-1434	134	140	suggests	suggest	VERB
ajlm-1434	134	141	that	that	SCONJ
ajlm-1434	134	142	donors	donor	NOUN
ajlm-1434	134	143	younger	young	ADJ
ajlm-1434	134	144	than	than	ADP
ajlm-1434	134	145	35	35	NUM
ajlm-1434	134	146	years	year	NOUN
ajlm-1434	134	147	may	may	AUX
ajlm-1434	134	148	be	be	AUX
ajlm-1434	134	149	less	less	ADV
ajlm-1434	134	150	likely	likely	ADJ
ajlm-1434	134	151	to	to	PART
ajlm-1434	134	152	have	have	VERB
ajlm-1434	134	153	hbv	hbv	NOUN
ajlm-1434	134	154	infection	infection	NOUN
ajlm-1434	134	155	or	or	CCONJ
ajlm-1434	134	156	be	be	AUX
ajlm-1434	134	157	an	an	DET
ajlm-1434	134	158	occult	occult	NOUN
ajlm-1434	134	159	hbv	hbv	NOUN
ajlm-1434	134	160	carrier	carrier	NOUN
ajlm-1434	134	161	.	.	PUNCT
ajlm-1434	135	1	occupation	occupation	NOUN
ajlm-1434	135	2	and	and	CCONJ
ajlm-1434	135	3	educational	educational	ADJ
ajlm-1434	135	4	level	level	NOUN
ajlm-1434	135	5	did	do	AUX
ajlm-1434	135	6	not	not	PART
ajlm-1434	135	7	significantly	significantly	ADV
ajlm-1434	135	8	affect	affect	VERB
ajlm-1434	135	9	the	the	DET
ajlm-1434	135	10	anti	anti	ADJ
ajlm-1434	135	11	-	-	ADJ
ajlm-1434	135	12	hbc	hbc	ADJ
ajlm-1434	135	13	status	status	NOUN
ajlm-1434	135	14	of	of	ADP
ajlm-1434	135	15	the	the	DET
ajlm-1434	135	16	donors	donor	NOUN
ajlm-1434	135	17	.	.	PUNCT
ajlm-1434	136	1	however	however	ADV
ajlm-1434	136	2	,	,	PUNCT
ajlm-1434	136	3	a	a	DET
ajlm-1434	136	4	good	good	ADJ
ajlm-1434	136	5	knowledge	knowledge	NOUN
ajlm-1434	136	6	of	of	ADP
ajlm-1434	136	7	the	the	DET
ajlm-1434	136	8	virus	virus	NOUN
ajlm-1434	136	9	transmission	transmission	NOUN
ajlm-1434	136	10	was	be	AUX
ajlm-1434	136	11	associated	associate	VERB
ajlm-1434	136	12	with	with	ADP
ajlm-1434	136	13	a	a	DET
ajlm-1434	136	14	lower	low	ADJ
ajlm-1434	136	15	anti	anti	ADJ
ajlm-1434	136	16	-	-	ADJ
ajlm-1434	136	17	hbc	hbc	ADJ
ajlm-1434	136	18	-	-	PUNCT
ajlm-1434	136	19	positive	positive	ADJ
ajlm-1434	136	20	rate	rate	NOUN
ajlm-1434	136	21	,	,	PUNCT
ajlm-1434	136	22	which	which	PRON
ajlm-1434	136	23	suggests	suggest	VERB
ajlm-1434	136	24	that	that	SCONJ
ajlm-1434	136	25	ignorance	ignorance	NOUN
ajlm-1434	136	26	about	about	ADP
ajlm-1434	136	27	the	the	DET
ajlm-1434	136	28	virus	virus	NOUN
ajlm-1434	136	29	increases	increase	VERB
ajlm-1434	136	30	vulnerability	vulnerability	NOUN
ajlm-1434	136	31	to	to	ADP
ajlm-1434	136	32	infection	infection	NOUN
ajlm-1434	136	33	.	.	PUNCT
ajlm-1434	137	1	therefore	therefore	ADV
ajlm-1434	137	2	,	,	PUNCT
ajlm-1434	137	3	health	health	NOUN
ajlm-1434	137	4	education	education	NOUN
ajlm-1434	137	5	to	to	PART
ajlm-1434	137	6	increase	increase	VERB
ajlm-1434	137	7	awareness	awareness	NOUN
ajlm-1434	137	8	of	of	ADP
ajlm-1434	137	9	hbv	hbv	NOUN
ajlm-1434	137	10	transmission	transmission	NOUN
ajlm-1434	137	11	and	and	CCONJ
ajlm-1434	137	12	prevention	prevention	NOUN
ajlm-1434	137	13	could	could	AUX
ajlm-1434	137	14	reduce	reduce	VERB
ajlm-1434	137	15	infection	infection	NOUN
ajlm-1434	137	16	among	among	ADP
ajlm-1434	137	17	the	the	DET
ajlm-1434	137	18	future	future	ADJ
ajlm-1434	137	19	donor	donor	NOUN
ajlm-1434	137	20	population	population	NOUN
ajlm-1434	137	21	.	.	PUNCT
ajlm-1434	138	1	the	the	DET
ajlm-1434	138	2	finding	finding	NOUN
ajlm-1434	138	3	of	of	ADP
ajlm-1434	138	4	lower	low	ADJ
ajlm-1434	138	5	anti	anti	ADJ
ajlm-1434	138	6	-	-	ADJ
ajlm-1434	138	7	hbc	hbc	ADJ
ajlm-1434	138	8	antibodies	antibody	NOUN
ajlm-1434	138	9	among	among	ADP
ajlm-1434	138	10	those	those	PRON
ajlm-1434	138	11	who	who	PRON
ajlm-1434	138	12	share	share	VERB
ajlm-1434	138	13	sharp	sharp	ADJ
ajlm-1434	138	14	objects	object	NOUN
ajlm-1434	138	15	in	in	ADP
ajlm-1434	138	16	salons	salon	NOUN
ajlm-1434	138	17	may	may	AUX
ajlm-1434	138	18	not	not	PART
ajlm-1434	138	19	have	have	VERB
ajlm-1434	138	20	any	any	DET
ajlm-1434	138	21	obvious	obvious	ADJ
ajlm-1434	138	22	explanation	explanation	NOUN
ajlm-1434	138	23	,	,	PUNCT
ajlm-1434	138	24	but	but	CCONJ
ajlm-1434	138	25	olayinka	olayinka	PROPN
ajlm-1434	138	26	et	et	PROPN
ajlm-1434	138	27	al	al	PROPN
ajlm-1434	138	28	.	.	PROPN
ajlm-1434	138	29	reported	report	VERB
ajlm-1434	138	30	in	in	ADP
ajlm-1434	138	31	a	a	DET
ajlm-1434	138	32	study	study	NOUN
ajlm-1434	138	33	in	in	ADP
ajlm-1434	138	34	nigeria	nigeria	PROPN
ajlm-1434	138	35	that	that	SCONJ
ajlm-1434	138	36	public	public	ADJ
ajlm-1434	138	37	barbing	barb	VERB
ajlm-1434	138	38	salon	salon	NOUN
ajlm-1434	138	39	clipper	clipper	NOUN
ajlm-1434	138	40	cuts	cut	NOUN
ajlm-1434	138	41	,	,	PUNCT
ajlm-1434	138	42	manicure	manicure	NOUN
ajlm-1434	138	43	and	and	CCONJ
ajlm-1434	138	44	pedicure	pedicure	NOUN
ajlm-1434	138	45	cuts	cut	NOUN
ajlm-1434	138	46	,	,	PUNCT
ajlm-1434	138	47	and	and	CCONJ
ajlm-1434	138	48	scarification	scarification	NOUN
ajlm-1434	138	49	were	be	AUX
ajlm-1434	138	50	not	not	PART
ajlm-1434	138	51	significantly	significantly	ADV
ajlm-1434	138	52	associated	associate	VERB
ajlm-1434	138	53	with	with	ADP
ajlm-1434	138	54	the	the	DET
ajlm-1434	138	55	presence	presence	NOUN
ajlm-1434	138	56	of	of	ADP
ajlm-1434	138	57	hbsag.34	hbsag.34	NOUN
ajlm-1434	138	58	all	all	DET
ajlm-1434	138	59	blood	blood	NOUN
ajlm-1434	138	60	donors	donor	NOUN
ajlm-1434	138	61	who	who	PRON
ajlm-1434	138	62	used	use	VERB
ajlm-1434	138	63	recreational	recreational	ADJ
ajlm-1434	138	64	drugs	drug	NOUN
ajlm-1434	138	65	were	be	AUX
ajlm-1434	138	66	anti	anti	ADJ
ajlm-1434	138	67	-	-	ADJ
ajlm-1434	138	68	hbc	hbc	ADJ
ajlm-1434	138	69	positive	positive	NOUN
ajlm-1434	138	70	.	.	PUNCT
ajlm-1434	139	1	blood	blood	NOUN
ajlm-1434	139	2	donors	donor	NOUN
ajlm-1434	139	3	who	who	PRON
ajlm-1434	139	4	use	use	VERB
ajlm-1434	139	5	recreational	recreational	ADJ
ajlm-1434	139	6	drugs	drug	NOUN
ajlm-1434	139	7	and	and	CCONJ
ajlm-1434	139	8	are	be	AUX
ajlm-1434	139	9	positive	positive	ADJ
ajlm-1434	139	10	should	should	AUX
ajlm-1434	139	11	be	be	AUX
ajlm-1434	139	12	identified	identify	VERB
ajlm-1434	139	13	and	and	CCONJ
ajlm-1434	139	14	permanently	permanently	ADV
ajlm-1434	139	15	deferred	deferred	ADJ
ajlm-1434	139	16	from	from	ADP
ajlm-1434	139	17	donating	donate	VERB
ajlm-1434	139	18	blood	blood	NOUN
ajlm-1434	139	19	.	.	PUNCT
ajlm-1434	140	1	surprisingly	surprisingly	ADV
ajlm-1434	140	2	,	,	PUNCT
ajlm-1434	140	3	five	five	NUM
ajlm-1434	140	4	blood	blood	NOUN
ajlm-1434	140	5	donors	donor	NOUN
ajlm-1434	140	6	who	who	PRON
ajlm-1434	140	7	had	have	VERB
ajlm-1434	140	8	hbv	hbv	NOUN
ajlm-1434	140	9	vaccination	vaccination	NOUN
ajlm-1434	140	10	were	be	AUX
ajlm-1434	140	11	anti	anti	ADJ
ajlm-1434	140	12	-	-	ADJ
ajlm-1434	140	13	hbc	hbc	ADJ
ajlm-1434	140	14	positive	positive	NOUN
ajlm-1434	140	15	.	.	PUNCT
ajlm-1434	141	1	vaccine	vaccine	NOUN
ajlm-1434	141	2	recipients	recipient	NOUN
ajlm-1434	141	3	who	who	PRON
ajlm-1434	141	4	develop	develop	VERB
ajlm-1434	141	5	anti	anti	ADJ
ajlm-1434	141	6	-	-	ADJ
ajlm-1434	141	7	hbc	hbc	ADJ
ajlm-1434	141	8	might	might	AUX
ajlm-1434	141	9	not	not	PART
ajlm-1434	141	10	have	have	AUX
ajlm-1434	141	11	responded	respond	VERB
ajlm-1434	141	12	to	to	ADP
ajlm-1434	141	13	the	the	DET
ajlm-1434	141	14	vaccine	vaccine	NOUN
ajlm-1434	141	15	.	.	PUNCT
ajlm-1434	142	1	it	it	PRON
ajlm-1434	142	2	may	may	AUX
ajlm-1434	142	3	also	also	ADV
ajlm-1434	142	4	be	be	AUX
ajlm-1434	142	5	indicative	indicative	ADJ
ajlm-1434	142	6	of	of	ADP
ajlm-1434	142	7	hbv	hbv	NOUN
ajlm-1434	142	8	infection	infection	NOUN
ajlm-1434	142	9	with	with	ADP
ajlm-1434	142	10	escape	escape	NOUN
ajlm-1434	142	11	mutants.20,33	mutants.20,33	NOUN
ajlm-1434	142	12	the	the	DET
ajlm-1434	142	13	anti	anti	ADJ
ajlm-1434	142	14	-	-	ADJ
ajlm-1434	142	15	hbsag	hbsag	ADJ
ajlm-1434	142	16	(	(	PUNCT
ajlm-1434	142	17	anti	anti	ADJ
ajlm-1434	142	18	-	-	ADJ
ajlm-1434	142	19	hbs	hbs	ADJ
ajlm-1434	142	20	)	)	PUNCT
ajlm-1434	142	21	titre	titre	NOUN
ajlm-1434	142	22	of	of	ADP
ajlm-1434	142	23	the	the	DET
ajlm-1434	142	24	vaccinated	vaccinated	ADJ
ajlm-1434	142	25	donors	donor	NOUN
ajlm-1434	142	26	was	be	AUX
ajlm-1434	142	27	not	not	PART
ajlm-1434	142	28	determined	determine	VERB
ajlm-1434	142	29	,	,	PUNCT
ajlm-1434	142	30	so	so	ADV
ajlm-1434	142	31	we	we	PRON
ajlm-1434	142	32	could	could	AUX
ajlm-1434	142	33	not	not	PART
ajlm-1434	142	34	confirm	confirm	VERB
ajlm-1434	142	35	if	if	SCONJ
ajlm-1434	142	36	the	the	DET
ajlm-1434	142	37	vaccination	vaccination	NOUN
ajlm-1434	142	38	provoked	provoke	VERB
ajlm-1434	142	39	an	an	DET
ajlm-1434	142	40	immune	immune	ADJ
ajlm-1434	142	41	response	response	NOUN
ajlm-1434	142	42	in	in	ADP
ajlm-1434	142	43	them	they	PRON
ajlm-1434	142	44	.	.	PUNCT
ajlm-1434	143	1	sharing	share	VERB
ajlm-1434	143	2	of	of	ADP
ajlm-1434	143	3	sharp	sharp	ADJ
ajlm-1434	143	4	objects	object	NOUN
ajlm-1434	143	5	,	,	PUNCT
ajlm-1434	143	6	being	be	AUX
ajlm-1434	143	7	sexually	sexually	ADV
ajlm-1434	143	8	active	active	ADJ
ajlm-1434	143	9	,	,	PUNCT
ajlm-1434	143	10	the	the	DET
ajlm-1434	143	11	number	number	NOUN
ajlm-1434	143	12	of	of	ADP
ajlm-1434	143	13	sex	sex	NOUN
ajlm-1434	143	14	partners	partner	NOUN
ajlm-1434	143	15	and	and	CCONJ
ajlm-1434	143	16	unprotected	unprotected	ADJ
ajlm-1434	143	17	sex	sex	NOUN
ajlm-1434	143	18	evidenced	evidence	VERB
ajlm-1434	143	19	by	by	ADP
ajlm-1434	143	20	those	those	PRON
ajlm-1434	143	21	with	with	ADP
ajlm-1434	143	22	an	an	DET
ajlm-1434	143	23	sexually	sexually	ADV
ajlm-1434	143	24	transmitted	transmit	VERB
ajlm-1434	143	25	disease	disease	NOUN
ajlm-1434	143	26	are	be	AUX
ajlm-1434	143	27	risk	risk	NOUN
ajlm-1434	143	28	factors	factor	NOUN
ajlm-1434	143	29	for	for	ADP
ajlm-1434	143	30	hbv	hbv	NOUN
ajlm-1434	143	31	infection35,36	infection35,36	NOUN
ajlm-1434	143	32	but	but	CCONJ
ajlm-1434	143	33	were	be	AUX
ajlm-1434	143	34	not	not	PART
ajlm-1434	143	35	evident	evident	ADJ
ajlm-1434	143	36	in	in	ADP
ajlm-1434	143	37	our	our	PRON
ajlm-1434	143	38	study	study	NOUN
ajlm-1434	143	39	.	.	PUNCT
ajlm-1434	144	1	this	this	PRON
ajlm-1434	144	2	might	might	AUX
ajlm-1434	144	3	be	be	AUX
ajlm-1434	144	4	due	due	ADJ
ajlm-1434	144	5	to	to	ADP
ajlm-1434	144	6	the	the	DET
ajlm-1434	144	7	targeted	target	VERB
ajlm-1434	144	8	study	study	NOUN
ajlm-1434	144	9	population	population	NOUN
ajlm-1434	144	10	and	and	CCONJ
ajlm-1434	144	11	the	the	DET
ajlm-1434	144	12	study	study	NOUN
ajlm-1434	144	13	’s	’s	PART
ajlm-1434	144	14	small	small	ADJ
ajlm-1434	144	15	sample	sample	NOUN
ajlm-1434	144	16	size	size	NOUN
ajlm-1434	144	17	.	.	PUNCT
ajlm-1434	145	1	the	the	DET
ajlm-1434	145	2	finding	finding	NOUN
ajlm-1434	145	3	in	in	ADP
ajlm-1434	145	4	this	this	DET
ajlm-1434	145	5	study	study	NOUN
ajlm-1434	145	6	does	do	AUX
ajlm-1434	145	7	not	not	PART
ajlm-1434	145	8	rule	rule	VERB
ajlm-1434	145	9	out	out	ADP
ajlm-1434	145	10	the	the	DET
ajlm-1434	145	11	danger	danger	NOUN
ajlm-1434	145	12	associated	associate	VERB
ajlm-1434	145	13	with	with	ADP
ajlm-1434	145	14	collecting	collect	VERB
ajlm-1434	145	15	blood	blood	NOUN
ajlm-1434	145	16	from	from	ADP
ajlm-1434	145	17	donors	donor	NOUN
ajlm-1434	145	18	with	with	ADP
ajlm-1434	145	19	risk	risk	NOUN
ajlm-1434	145	20	factors	factor	NOUN
ajlm-1434	145	21	.	.	PUNCT
ajlm-1434	146	1	recruiting	recruit	VERB
ajlm-1434	146	2	donors	donor	NOUN
ajlm-1434	146	3	with	with	ADP
ajlm-1434	146	4	risk	risk	NOUN
ajlm-1434	146	5	factors	factor	NOUN
ajlm-1434	146	6	is	be	AUX
ajlm-1434	146	7	strongly	strongly	ADV
ajlm-1434	146	8	discouraged	discouraged	ADJ
ajlm-1434	146	9	,	,	PUNCT
ajlm-1434	146	10	especially	especially	ADV
ajlm-1434	146	11	where	where	SCONJ
ajlm-1434	146	12	exhaustive	exhaustive	ADJ
ajlm-1434	146	13	screening	screening	NOUN
ajlm-1434	146	14	tests	test	NOUN
ajlm-1434	146	15	are	be	AUX
ajlm-1434	146	16	not	not	PART
ajlm-1434	146	17	available	available	ADJ
ajlm-1434	146	18	.	.	PUNCT
ajlm-1434	147	1	the	the	DET
ajlm-1434	147	2	screening	screening	NOUN
ajlm-1434	147	3	of	of	ADP
ajlm-1434	147	4	the	the	DET
ajlm-1434	147	5	donors	donor	NOUN
ajlm-1434	147	6	with	with	ADP
ajlm-1434	147	7	anti	anti	ADJ
ajlm-1434	147	8	-	-	ADJ
ajlm-1434	147	9	hbc	hbc	ADJ
ajlm-1434	147	10	-	-	PUNCT
ajlm-1434	147	11	positive	positive	ADJ
ajlm-1434	147	12	and	and	CCONJ
ajlm-1434	147	13	hbsag	hbsag	ADJ
ajlm-1434	147	14	-	-	PUNCT
ajlm-1434	147	15	negative	negative	ADJ
ajlm-1434	147	16	sera	sera	NOUN
ajlm-1434	147	17	for	for	ADP
ajlm-1434	147	18	hbv	hbv	NOUN
ajlm-1434	147	19	dna	dna	PROPN
ajlm-1434	147	20	showed	show	VERB
ajlm-1434	147	21	that	that	SCONJ
ajlm-1434	147	22	occult	occult	NOUN
ajlm-1434	147	23	infection	infection	NOUN
ajlm-1434	147	24	was	be	AUX
ajlm-1434	147	25	present	present	ADJ
ajlm-1434	147	26	in	in	ADP
ajlm-1434	147	27	one	one	NUM
ajlm-1434	147	28	of	of	ADP
ajlm-1434	147	29	the	the	DET
ajlm-1434	147	30	107	107	NUM
ajlm-1434	147	31	donors	donor	NOUN
ajlm-1434	147	32	(	(	PUNCT
ajlm-1434	147	33	0.93	0.93	NUM
ajlm-1434	147	34	%	%	NOUN
ajlm-1434	147	35	)	)	PUNCT
ajlm-1434	147	36	.	.	PUNCT
ajlm-1434	148	1	the	the	DET
ajlm-1434	148	2	presence	presence	NOUN
ajlm-1434	148	3	of	of	ADP
ajlm-1434	148	4	hbv	hbv	PROPN
ajlm-1434	148	5	dna	dna	PROPN
ajlm-1434	148	6	in	in	ADP
ajlm-1434	148	7	0.93	0.93	NUM
ajlm-1434	148	8	%	%	NOUN
ajlm-1434	148	9	of	of	ADP
ajlm-1434	148	10	our	our	PRON
ajlm-1434	148	11	serologically	serologically	ADV
ajlm-1434	148	12	screened	screen	VERB
ajlm-1434	148	13	donors	donor	NOUN
ajlm-1434	148	14	suggests	suggest	VERB
ajlm-1434	148	15	that	that	SCONJ
ajlm-1434	148	16	there	there	PRON
ajlm-1434	148	17	is	be	VERB
ajlm-1434	148	18	a	a	DET
ajlm-1434	148	19	potential	potential	NOUN
ajlm-1434	148	20	for	for	ADP
ajlm-1434	148	21	transmission	transmission	NOUN
ajlm-1434	148	22	of	of	ADP
ajlm-1434	148	23	hepatitis	hepatitis	PROPN
ajlm-1434	148	24	b	b	PROPN
ajlm-1434	148	25	to	to	ADP
ajlm-1434	148	26	blood	blood	NOUN
ajlm-1434	148	27	recipients	recipient	NOUN
ajlm-1434	148	28	.	.	PUNCT
ajlm-1434	149	1	this	this	PRON
ajlm-1434	149	2	is	be	AUX
ajlm-1434	149	3	higher	high	ADJ
ajlm-1434	149	4	than	than	ADP
ajlm-1434	149	5	0.56	0.56	NUM
ajlm-1434	149	6	%	%	NOUN
ajlm-1434	149	7	of	of	ADP
ajlm-1434	149	8	blood	blood	NOUN
ajlm-1434	149	9	donors	donor	NOUN
ajlm-1434	149	10	in	in	ADP
ajlm-1434	149	11	cameroon35	cameroon35	NOUN
ajlm-1434	149	12	and	and	CCONJ
ajlm-1434	149	13	0.5	0.5	NUM
ajlm-1434	149	14	%	%	NOUN
ajlm-1434	149	15	in	in	ADP
ajlm-1434	149	16	ghana,36,37	ghana,36,37	PROPN
ajlm-1434	149	17	but	but	CCONJ
ajlm-1434	149	18	less	less	ADJ
ajlm-1434	149	19	than	than	ADP
ajlm-1434	149	20	11.54	11.54	NUM
ajlm-1434	149	21	%	%	NOUN
ajlm-1434	149	22	–	–	PUNCT
ajlm-1434	149	23	14.5	14.5	NUM
ajlm-1434	149	24	%	%	NOUN
ajlm-1434	149	25	reported	report	VERB
ajlm-1434	149	26	in	in	ADP
ajlm-1434	149	27	blood	blood	NOUN
ajlm-1434	149	28	donors	donor	NOUN
ajlm-1434	149	29	in	in	ADP
ajlm-1434	149	30	egypt.37,38	egypt.37,38	NOUN
ajlm-1434	149	31	this	this	DET
ajlm-1434	149	32	study	study	NOUN
ajlm-1434	149	33	establishes	establish	VERB
ajlm-1434	149	34	that	that	SCONJ
ajlm-1434	149	35	hbv	hbv	NOUN
ajlm-1434	149	36	infection	infection	NOUN
ajlm-1434	149	37	may	may	AUX
ajlm-1434	149	38	occur	occur	VERB
ajlm-1434	149	39	among	among	ADP
ajlm-1434	149	40	recipients	recipient	NOUN
ajlm-1434	149	41	of	of	ADP
ajlm-1434	149	42	blood	blood	NOUN
ajlm-1434	149	43	from	from	ADP
ajlm-1434	149	44	donors	donor	NOUN
ajlm-1434	149	45	that	that	PRON
ajlm-1434	149	46	are	be	AUX
ajlm-1434	149	47	isolated	isolate	VERB
ajlm-1434	149	48	anti	anti	ADJ
ajlm-1434	149	49	-	-	ADJ
ajlm-1434	149	50	hbc	hbc	ADJ
ajlm-1434	149	51	positive	positive	NOUN
ajlm-1434	149	52	.	.	PUNCT
ajlm-1434	150	1	it	it	PRON
ajlm-1434	150	2	might	might	AUX
ajlm-1434	150	3	be	be	AUX
ajlm-1434	150	4	difficult	difficult	ADJ
ajlm-1434	150	5	to	to	PART
ajlm-1434	150	6	sustain	sustain	VERB
ajlm-1434	150	7	the	the	DET
ajlm-1434	150	8	blood	blood	NOUN
ajlm-1434	150	9	supply	supply	NOUN
ajlm-1434	150	10	if	if	SCONJ
ajlm-1434	150	11	all	all	DET
ajlm-1434	150	12	the	the	DET
ajlm-1434	150	13	48.5	48.5	NUM
ajlm-1434	150	14	%	%	NOUN
ajlm-1434	150	15	of	of	ADP
ajlm-1434	150	16	the	the	DET
ajlm-1434	150	17	blood	blood	NOUN
ajlm-1434	150	18	donors	donor	NOUN
ajlm-1434	150	19	who	who	PRON
ajlm-1434	150	20	have	have	VERB
ajlm-1434	150	21	anti	anti	ADJ
ajlm-1434	150	22	-	-	NOUN
ajlm-1434	150	23	hbc	hbc	ADJ
ajlm-1434	150	24	in	in	ADP
ajlm-1434	150	25	their	their	PRON
ajlm-1434	150	26	blood	blood	NOUN
ajlm-1434	150	27	are	be	AUX
ajlm-1434	150	28	deferred	defer	VERB
ajlm-1434	150	29	or	or	CCONJ
ajlm-1434	150	30	rejected	reject	VERB
ajlm-1434	150	31	.	.	PUNCT
ajlm-1434	151	1	implementing	implement	VERB
ajlm-1434	151	2	anti	anti	ADJ
ajlm-1434	151	3	-	-	ADJ
ajlm-1434	151	4	hbc	hbc	ADJ
ajlm-1434	151	5	testing	testing	NOUN
ajlm-1434	151	6	could	could	AUX
ajlm-1434	151	7	make	make	VERB
ajlm-1434	151	8	blood	blood	NOUN
ajlm-1434	151	9	safer	safe	ADJ
ajlm-1434	151	10	.	.	PUNCT
ajlm-1434	152	1	since	since	SCONJ
ajlm-1434	152	2	exclusion	exclusion	NOUN
ajlm-1434	152	3	of	of	ADP
ajlm-1434	152	4	all	all	DET
ajlm-1434	152	5	anti	anti	ADJ
ajlm-1434	152	6	-	-	ADJ
ajlm-1434	152	7	hbc	hbc	ADJ
ajlm-1434	152	8	-	-	PUNCT
ajlm-1434	152	9	positive	positive	ADJ
ajlm-1434	152	10	donors	donor	NOUN
ajlm-1434	152	11	may	may	AUX
ajlm-1434	152	12	reduce	reduce	VERB
ajlm-1434	152	13	the	the	DET
ajlm-1434	152	14	availability	availability	NOUN
ajlm-1434	152	15	of	of	ADP
ajlm-1434	152	16	safe	safe	ADJ
ajlm-1434	152	17	blood	blood	NOUN
ajlm-1434	152	18	in	in	ADP
ajlm-1434	152	19	the	the	DET
ajlm-1434	152	20	blood	blood	NOUN
ajlm-1434	152	21	banks	bank	NOUN
ajlm-1434	152	22	of	of	ADP
ajlm-1434	152	23	countries	country	NOUN
ajlm-1434	152	24	with	with	ADP
ajlm-1434	152	25	high	high	ADJ
ajlm-1434	152	26	hbv	hbv	NOUN
ajlm-1434	152	27	prevalence	prevalence	NOUN
ajlm-1434	152	28	,	,	PUNCT
ajlm-1434	152	29	and	and	CCONJ
ajlm-1434	152	30	screening	screen	VERB
ajlm-1434	152	31	all	all	DET
ajlm-1434	152	32	blood	blood	NOUN
ajlm-1434	152	33	donors	donor	NOUN
ajlm-1434	152	34	with	with	ADP
ajlm-1434	152	35	nat	nat	PROPN
ajlm-1434	152	36	to	to	PART
ajlm-1434	152	37	determine	determine	VERB
ajlm-1434	152	38	the	the	DET
ajlm-1434	152	39	hbv	hbv	NOUN
ajlm-1434	152	40	dna	dna	PROPN
ajlm-1434	152	41	status	status	NOUN
ajlm-1434	152	42	may	may	AUX
ajlm-1434	152	43	be	be	AUX
ajlm-1434	152	44	too	too	ADV
ajlm-1434	152	45	expensive	expensive	ADJ
ajlm-1434	152	46	in	in	ADP
ajlm-1434	152	47	resource	resource	NOUN
ajlm-1434	152	48	-	-	PUNCT
ajlm-1434	152	49	limited	limit	VERB
ajlm-1434	152	50	regions	region	NOUN
ajlm-1434	152	51	,	,	PUNCT
ajlm-1434	152	52	an	an	DET
ajlm-1434	152	53	algorithm	algorithm	NOUN
ajlm-1434	152	54	that	that	PRON
ajlm-1434	152	55	attempts	attempt	VERB
ajlm-1434	152	56	to	to	PART
ajlm-1434	152	57	detect	detect	VERB
ajlm-1434	152	58	occult	occult	NOUN
ajlm-1434	152	59	hbv	hbv	NOUN
ajlm-1434	152	60	is	be	AUX
ajlm-1434	152	61	being	be	AUX
ajlm-1434	152	62	suggested	suggest	VERB
ajlm-1434	152	63	.	.	PUNCT
ajlm-1434	153	1	the	the	DET
ajlm-1434	153	2	complementary	complementary	ADJ
ajlm-1434	153	3	use	use	NOUN
ajlm-1434	153	4	of	of	ADP
ajlm-1434	153	5	both	both	CCONJ
ajlm-1434	153	6	rdt	rdt	PROPN
ajlm-1434	153	7	and	and	CCONJ
ajlm-1434	153	8	elisa	elisa	PROPN
ajlm-1434	153	9	for	for	ADP
ajlm-1434	153	10	hbsag	hbsag	NOUN
ajlm-1434	153	11	screening	screening	NOUN
ajlm-1434	153	12	of	of	ADP
ajlm-1434	153	13	blood	blood	NOUN
ajlm-1434	153	14	donors	donor	NOUN
ajlm-1434	153	15	should	should	AUX
ajlm-1434	153	16	continue	continue	VERB
ajlm-1434	153	17	for	for	ADP
ajlm-1434	153	18	maximum	maximum	ADJ
ajlm-1434	153	19	identification	identification	NOUN
ajlm-1434	153	20	of	of	ADP
ajlm-1434	153	21	hbsag	hbsag	ADJ
ajlm-1434	153	22	-	-	PUNCT
ajlm-1434	153	23	positive	positive	ADJ
ajlm-1434	153	24	donors	donor	NOUN
ajlm-1434	153	25	.	.	PUNCT
ajlm-1434	154	1	the	the	DET
ajlm-1434	154	2	recommended	recommend	VERB
ajlm-1434	154	3	algorithm	algorithm	NOUN
ajlm-1434	154	4	includes	include	VERB
ajlm-1434	154	5	testing	test	VERB
ajlm-1434	154	6	all	all	DET
ajlm-1434	154	7	hbsag	hbsag	ADJ
ajlm-1434	154	8	-	-	PUNCT
ajlm-1434	154	9	negative	negative	ADJ
ajlm-1434	154	10	blood	blood	NOUN
ajlm-1434	154	11	(	(	PUNCT
ajlm-1434	154	12	by	by	ADP
ajlm-1434	154	13	both	both	CCONJ
ajlm-1434	154	14	rdt	rdt	PROPN
ajlm-1434	154	15	and	and	CCONJ
ajlm-1434	154	16	elisa	elisa	NOUN
ajlm-1434	154	17	)	)	PUNCT
ajlm-1434	154	18	for	for	ADP
ajlm-1434	154	19	antibodies	antibody	NOUN
ajlm-1434	154	20	to	to	PART
ajlm-1434	154	21	hbc	hbc	VERB
ajlm-1434	154	22	and	and	CCONJ
ajlm-1434	154	23	subjecting	subject	VERB
ajlm-1434	154	24	anti	anti	ADJ
ajlm-1434	154	25	-	-	ADJ
ajlm-1434	154	26	hbc	hbc	ADJ
ajlm-1434	154	27	-	-	PUNCT
ajlm-1434	154	28	positive	positive	ADJ
ajlm-1434	154	29	blood	blood	NOUN
ajlm-1434	154	30	to	to	ADP
ajlm-1434	154	31	nat	nat	PROPN
ajlm-1434	154	32	to	to	PART
ajlm-1434	154	33	identify	identify	VERB
ajlm-1434	154	34	potential	potential	ADJ
ajlm-1434	154	35	infectious	infectious	ADJ
ajlm-1434	154	36	blood	blood	NOUN
ajlm-1434	154	37	units	unit	NOUN
ajlm-1434	154	38	.	.	PUNCT
ajlm-1434	155	1	this	this	PRON
ajlm-1434	155	2	will	will	AUX
ajlm-1434	155	3	improve	improve	VERB
ajlm-1434	155	4	the	the	DET
ajlm-1434	155	5	safety	safety	NOUN
ajlm-1434	155	6	of	of	ADP
ajlm-1434	155	7	the	the	DET
ajlm-1434	155	8	blood	blood	NOUN
ajlm-1434	155	9	supply	supply	NOUN
ajlm-1434	155	10	and	and	CCONJ
ajlm-1434	155	11	reduce	reduce	VERB
ajlm-1434	155	12	costs	cost	NOUN
ajlm-1434	155	13	while	while	SCONJ
ajlm-1434	155	14	capturing	capture	VERB
ajlm-1434	155	15	samples	sample	NOUN
ajlm-1434	155	16	that	that	PRON
ajlm-1434	155	17	are	be	AUX
ajlm-1434	155	18	likely	likely	ADJ
ajlm-1434	155	19	to	to	PART
ajlm-1434	155	20	have	have	VERB
ajlm-1434	155	21	undetected	undetecte	VERB
ajlm-1434	155	22	threats	threat	NOUN
ajlm-1434	155	23	.	.	PUNCT
ajlm-1434	156	1	limitations	limitation	NOUN
ajlm-1434	156	2	the	the	DET
ajlm-1434	156	3	confirmatory	confirmatory	NOUN
ajlm-1434	156	4	algorithms	algorithm	NOUN
ajlm-1434	156	5	for	for	ADP
ajlm-1434	156	6	true	true	ADJ
ajlm-1434	156	7	positivity	positivity	NOUN
ajlm-1434	156	8	of	of	ADP
ajlm-1434	156	9	anti	anti	ADJ
ajlm-1434	156	10	-	-	ADJ
ajlm-1434	156	11	hbc	hbc	NOUN
ajlm-1434	156	12	include	include	VERB
ajlm-1434	156	13	secondary	secondary	ADJ
ajlm-1434	156	14	testing	testing	NOUN
ajlm-1434	156	15	with	with	ADP
ajlm-1434	156	16	an	an	DET
ajlm-1434	156	17	alternative	alternative	ADJ
ajlm-1434	156	18	elisa	elisa	NOUN
ajlm-1434	156	19	,	,	PUNCT
ajlm-1434	156	20	testing	testing	NOUN
ajlm-1434	156	21	for	for	ADP
ajlm-1434	156	22	anti	anti	ADJ
ajlm-1434	156	23	-	-	ADJ
ajlm-1434	156	24	hbs	hbs	ADJ
ajlm-1434	156	25	,	,	PUNCT
ajlm-1434	156	26	anti	anti	ADJ
ajlm-1434	156	27	-	-	ADJ
ajlm-1434	156	28	hbe	hbe	NOUN
ajlm-1434	156	29	or	or	CCONJ
ajlm-1434	156	30	hbeag	hbeag	NOUN
ajlm-1434	156	31	.	.	PUNCT
ajlm-1434	157	1	the	the	DET
ajlm-1434	157	2	most	most	ADV
ajlm-1434	157	3	frequently	frequently	ADV
ajlm-1434	157	4	used	use	VERB
ajlm-1434	157	5	is	be	AUX
ajlm-1434	157	6	anti	anti	ADJ
ajlm-1434	157	7	-	-	ADJ
ajlm-1434	157	8	hbs	hbs	ADJ
ajlm-1434	157	9	.	.	PUNCT
ajlm-1434	158	1	however	however	ADV
ajlm-1434	158	2	,	,	PUNCT
ajlm-1434	158	3	this	this	DET
ajlm-1434	158	4	study	study	NOUN
ajlm-1434	158	5	did	do	AUX
ajlm-1434	158	6	not	not	PART
ajlm-1434	158	7	investigate	investigate	VERB
ajlm-1434	158	8	the	the	DET
ajlm-1434	158	9	anti	anti	ADJ
ajlm-1434	158	10	-	-	ADJ
ajlm-1434	158	11	hbs	hbs	ADJ
ajlm-1434	158	12	titre	titre	NOUN
ajlm-1434	158	13	of	of	ADP
ajlm-1434	158	14	the	the	DET
ajlm-1434	158	15	participants	participant	NOUN
ajlm-1434	158	16	.	.	PUNCT
ajlm-1434	159	1	this	this	PRON
ajlm-1434	159	2	might	might	AUX
ajlm-1434	159	3	affect	affect	VERB
ajlm-1434	159	4	the	the	DET
ajlm-1434	159	5	significance	significance	NOUN
ajlm-1434	159	6	of	of	ADP
ajlm-1434	159	7	the	the	DET
ajlm-1434	159	8	observed	observed	ADJ
ajlm-1434	159	9	anti	anti	NOUN
ajlm-1434	159	10	-	-	ADJ
ajlm-1434	159	11	hbc	hbc	ADJ
ajlm-1434	159	12	and	and	CCONJ
ajlm-1434	159	13	hbv	hbv	NOUN
ajlm-1434	159	14	dna	dna	PROPN
ajlm-1434	159	15	positivity	positivity	NOUN
ajlm-1434	159	16	in	in	ADP
ajlm-1434	159	17	the	the	DET
ajlm-1434	159	18	donor	donor	NOUN
ajlm-1434	159	19	population	population	NOUN
ajlm-1434	159	20	.	.	PUNCT
ajlm-1434	160	1	conclusion	conclusion	NOUN
ajlm-1434	160	2	almost	almost	ADV
ajlm-1434	160	3	half	half	NOUN
ajlm-1434	160	4	of	of	ADP
ajlm-1434	160	5	the	the	DET
ajlm-1434	160	6	donors	donor	NOUN
ajlm-1434	160	7	in	in	ADP
ajlm-1434	160	8	this	this	DET
ajlm-1434	160	9	study	study	NOUN
ajlm-1434	160	10	were	be	AUX
ajlm-1434	160	11	anti	anti	ADJ
ajlm-1434	160	12	-	-	ADJ
ajlm-1434	160	13	hbc	hbc	ADJ
ajlm-1434	160	14	positive	positive	NOUN
ajlm-1434	160	15	,	,	PUNCT
ajlm-1434	160	16	suggesting	suggest	VERB
ajlm-1434	160	17	that	that	SCONJ
ajlm-1434	160	18	a	a	DET
ajlm-1434	160	19	large	large	ADJ
ajlm-1434	160	20	proportion	proportion	NOUN
ajlm-1434	160	21	of	of	ADP
ajlm-1434	160	22	the	the	DET
ajlm-1434	160	23	donors	donor	NOUN
ajlm-1434	160	24	had	have	AUX
ajlm-1434	160	25	been	be	AUX
ajlm-1434	160	26	exposed	expose	VERB
ajlm-1434	160	27	to	to	ADP
ajlm-1434	160	28	hbv	hbv	NOUN
ajlm-1434	160	29	.	.	PUNCT
ajlm-1434	161	1	moreover	moreover	ADV
ajlm-1434	161	2	,	,	PUNCT
ajlm-1434	161	3	donors	donor	NOUN
ajlm-1434	161	4	who	who	PRON
ajlm-1434	161	5	were	be	AUX
ajlm-1434	161	6	anti	anti	ADJ
ajlm-1434	161	7	-	-	ADJ
ajlm-1434	161	8	hbc	hbc	ADJ
ajlm-1434	161	9	positive	positive	ADJ
ajlm-1434	161	10	and	and	CCONJ
ajlm-1434	161	11	hbsag	hbsag	ADJ
ajlm-1434	161	12	-	-	PUNCT
ajlm-1434	161	13	negative	negative	ADJ
ajlm-1434	161	14	could	could	AUX
ajlm-1434	161	15	have	have	VERB
ajlm-1434	161	16	hbv	hbv	NOUN
ajlm-1434	161	17	dna	dna	PROPN
ajlm-1434	161	18	.	.	PUNCT
ajlm-1434	162	1	we	we	PRON
ajlm-1434	162	2	propose	propose	VERB
ajlm-1434	162	3	a	a	DET
ajlm-1434	162	4	testing	testing	NOUN
ajlm-1434	162	5	algorithm	algorithm	NOUN
ajlm-1434	162	6	that	that	PRON
ajlm-1434	162	7	can	can	AUX
ajlm-1434	162	8	be	be	AUX
ajlm-1434	162	9	utilised	utilise	VERB
ajlm-1434	162	10	in	in	ADP
ajlm-1434	162	11	hbv	hbv	NOUN
ajlm-1434	162	12	-	-	PUNCT
ajlm-1434	162	13	endemic	endemic	ADJ
ajlm-1434	162	14	,	,	PUNCT
ajlm-1434	162	15	resource	resource	NOUN
ajlm-1434	162	16	-	-	PUNCT
ajlm-1434	162	17	limited	limit	VERB
ajlm-1434	162	18	settings	setting	NOUN
ajlm-1434	162	19	.	.	PUNCT
ajlm-1434	163	1	all	all	DET
ajlm-1434	163	2	donors	donor	NOUN
ajlm-1434	163	3	should	should	AUX
ajlm-1434	163	4	be	be	AUX
ajlm-1434	163	5	tested	test	VERB
ajlm-1434	163	6	for	for	ADP
ajlm-1434	163	7	hbsag	hbsag	NOUN
ajlm-1434	163	8	(	(	PUNCT
ajlm-1434	163	9	by	by	ADP
ajlm-1434	163	10	both	both	DET
ajlm-1434	163	11	elisa	elisa	NOUN
ajlm-1434	163	12	and	and	CCONJ
ajlm-1434	163	13	rdt	rdt	PROPN
ajlm-1434	163	14	)	)	PUNCT
ajlm-1434	163	15	;	;	PUNCT
ajlm-1434	163	16	those	those	PRON
ajlm-1434	163	17	who	who	PRON
ajlm-1434	163	18	are	be	AUX
ajlm-1434	163	19	hbsag	hbsag	ADJ
ajlm-1434	163	20	-	-	PUNCT
ajlm-1434	163	21	negative	negative	ADJ
ajlm-1434	163	22	should	should	AUX
ajlm-1434	163	23	be	be	AUX
ajlm-1434	163	24	further	far	ADV
ajlm-1434	163	25	tested	test	VERB
ajlm-1434	163	26	for	for	ADP
ajlm-1434	163	27	anti	anti	ADJ
ajlm-1434	163	28	-	-	NOUN
ajlm-1434	163	29	hbc	hbc	ADJ
ajlm-1434	163	30	,	,	PUNCT
ajlm-1434	163	31	while	while	SCONJ
ajlm-1434	163	32	only	only	ADV
ajlm-1434	163	33	those	those	PRON
ajlm-1434	163	34	who	who	PRON
ajlm-1434	163	35	are	be	AUX
ajlm-1434	163	36	both	both	CCONJ
ajlm-1434	163	37	hbsag	hbsag	ADJ
ajlm-1434	163	38	-	-	PUNCT
ajlm-1434	163	39	negative	negative	ADJ
ajlm-1434	163	40	and	and	CCONJ
ajlm-1434	163	41	anti	anti	ADJ
ajlm-1434	163	42	-	-	ADJ
ajlm-1434	163	43	hbc	hbc	ADJ
ajlm-1434	163	44	positive	positive	NOUN
ajlm-1434	163	45	should	should	AUX
ajlm-1434	163	46	undergo	undergo	VERB
ajlm-1434	163	47	mini	mini	ADJ
ajlm-1434	163	48	-	-	NOUN
ajlm-1434	163	49	pool	pool	ADJ
ajlm-1434	163	50	nat	nat	NOUN
ajlm-1434	163	51	.	.	PUNCT
ajlm-1434	164	1	this	this	DET
ajlm-1434	164	2	algorithm	algorithm	NOUN
ajlm-1434	164	3	optimises	optimise	VERB
ajlm-1434	164	4	blood	blood	NOUN
ajlm-1434	164	5	safety	safety	NOUN
ajlm-1434	164	6	and	and	CCONJ
ajlm-1434	164	7	prevents	prevent	VERB
ajlm-1434	164	8	hbv	hbv	NOUN
ajlm-1434	164	9	transmission	transmission	NOUN
ajlm-1434	164	10	from	from	ADP
ajlm-1434	164	11	infected	infected	ADJ
ajlm-1434	164	12	blood	blood	NOUN
ajlm-1434	164	13	units	unit	NOUN
ajlm-1434	164	14	.	.	PUNCT
ajlm-1434	165	1	acknowledgements	acknowledgement	NOUN
ajlm-1434	165	2	we	we	PRON
ajlm-1434	165	3	acknowledge	acknowledge	VERB
ajlm-1434	165	4	the	the	DET
ajlm-1434	165	5	cooperation	cooperation	NOUN
ajlm-1434	165	6	and	and	CCONJ
ajlm-1434	165	7	support	support	NOUN
ajlm-1434	165	8	of	of	ADP
ajlm-1434	165	9	the	the	DET
ajlm-1434	165	10	blood	blood	NOUN
ajlm-1434	165	11	bank	bank	NOUN
ajlm-1434	165	12	donor	donor	NOUN
ajlm-1434	165	13	section	section	NOUN
ajlm-1434	165	14	staff	staff	NOUN
ajlm-1434	165	15	in	in	ADP
ajlm-1434	165	16	carrying	carry	VERB
ajlm-1434	165	17	out	out	ADP
ajlm-1434	165	18	this	this	DET
ajlm-1434	165	19	study	study	NOUN
ajlm-1434	165	20	.	.	PUNCT
ajlm-1434	166	1	competing	compete	VERB
ajlm-1434	166	2	interests	interest	NOUN
ajlm-1434	166	3	the	the	DET
ajlm-1434	166	4	authors	author	NOUN
ajlm-1434	166	5	declare	declare	VERB
ajlm-1434	166	6	that	that	SCONJ
ajlm-1434	166	7	they	they	PRON
ajlm-1434	166	8	have	have	VERB
ajlm-1434	166	9	no	no	DET
ajlm-1434	166	10	financial	financial	ADJ
ajlm-1434	166	11	or	or	CCONJ
ajlm-1434	166	12	personal	personal	ADJ
ajlm-1434	166	13	relationships	relationship	NOUN
ajlm-1434	166	14	that	that	PRON
ajlm-1434	166	15	may	may	AUX
ajlm-1434	166	16	have	have	AUX
ajlm-1434	166	17	inappropriately	inappropriately	ADV
ajlm-1434	166	18	influenced	influence	VERB
ajlm-1434	166	19	them	they	PRON
ajlm-1434	166	20	in	in	ADP
ajlm-1434	166	21	writing	write	VERB
ajlm-1434	166	22	this	this	DET
ajlm-1434	166	23	article	article	NOUN
ajlm-1434	166	24	.	.	PUNCT
ajlm-1434	167	1	authors	author	NOUN
ajlm-1434	167	2	’	’	PART
ajlm-1434	167	3	contributions	contribution	NOUN
ajlm-1434	167	4	f.a.f	f.a.f	ADV
ajlm-1434	167	5	.	.	PROPN
ajlm-1434	167	6	was	be	AUX
ajlm-1434	167	7	involved	involve	VERB
ajlm-1434	167	8	in	in	ADP
ajlm-1434	167	9	the	the	DET
ajlm-1434	167	10	conception	conception	NOUN
ajlm-1434	167	11	and	and	CCONJ
ajlm-1434	167	12	design	design	NOUN
ajlm-1434	167	13	of	of	ADP
ajlm-1434	167	14	the	the	DET
ajlm-1434	167	15	study	study	NOUN
ajlm-1434	167	16	,	,	PUNCT
ajlm-1434	167	17	analysis	analysis	NOUN
ajlm-1434	167	18	and	and	CCONJ
ajlm-1434	167	19	interpretation	interpretation	NOUN
ajlm-1434	167	20	of	of	ADP
ajlm-1434	167	21	data	datum	NOUN
ajlm-1434	167	22	,	,	PUNCT
ajlm-1434	167	23	drafting	drafting	NOUN
ajlm-1434	167	24	of	of	ADP
ajlm-1434	167	25	the	the	DET
ajlm-1434	167	26	article	article	NOUN
ajlm-1434	167	27	,	,	PUNCT
ajlm-1434	167	28	and	and	CCONJ
ajlm-1434	167	29	final	final	ADJ
ajlm-1434	167	30	manuscript	manuscript	NOUN
ajlm-1434	167	31	review	review	NOUN
ajlm-1434	167	32	.	.	PUNCT
ajlm-1434	168	1	f.a.f	f.a.f	PROPN
ajlm-1434	168	2	.	.	PROPN
ajlm-1434	168	3	,	,	PUNCT
ajlm-1434	168	4	a.a.f	a.a.f	PROPN
ajlm-1434	168	5	.	.	PUNCT
ajlm-1434	168	6	,	,	PUNCT
ajlm-1434	168	7	a.o.f	a.o.f	PROPN
ajlm-1434	168	8	.	.	PUNCT
ajlm-1434	169	1	and	and	CCONJ
ajlm-1434	169	2	a.a	a.a	PROPN
ajlm-1434	169	3	.	.	PROPN
ajlm-1434	169	4	were	be	AUX
ajlm-1434	169	5	involved	involve	VERB
ajlm-1434	169	6	in	in	ADP
ajlm-1434	169	7	laboratory	laboratory	NOUN
ajlm-1434	169	8	analysis	analysis	NOUN
ajlm-1434	169	9	.	.	PUNCT
ajlm-1434	170	1	a.a.f	a.a.f	PROPN
ajlm-1434	170	2	.	.	PUNCT
ajlm-1434	170	3	was	be	AUX
ajlm-1434	170	4	involved	involve	VERB
ajlm-1434	170	5	in	in	ADP
ajlm-1434	170	6	the	the	DET
ajlm-1434	170	7	design	design	NOUN
ajlm-1434	170	8	of	of	ADP
ajlm-1434	170	9	the	the	DET
ajlm-1434	170	10	study	study	NOUN
ajlm-1434	170	11	.	.	PUNCT
ajlm-1434	171	1	a.o.f	a.o.f	PROPN
ajlm-1434	171	2	.	.	PROPN
ajlm-1434	172	1	was	be	AUX
ajlm-1434	172	2	involved	involve	VERB
ajlm-1434	172	3	in	in	ADP
ajlm-1434	172	4	the	the	DET
ajlm-1434	172	5	analysis	analysis	NOUN
ajlm-1434	172	6	of	of	ADP
ajlm-1434	172	7	data	datum	NOUN
ajlm-1434	172	8	and	and	CCONJ
ajlm-1434	172	9	review	review	NOUN
ajlm-1434	172	10	of	of	ADP
ajlm-1434	172	11	the	the	DET
ajlm-1434	172	12	manuscript	manuscript	NOUN
ajlm-1434	172	13	.	.	PUNCT
ajlm-1434	173	1	a.a	a.a	PROPN
ajlm-1434	173	2	.	.	PROPN
ajlm-1434	173	3	was	be	AUX
ajlm-1434	173	4	involved	involve	VERB
ajlm-1434	173	5	in	in	ADP
ajlm-1434	173	6	the	the	DET
ajlm-1434	173	7	administration	administration	NOUN
ajlm-1434	173	8	of	of	ADP
ajlm-1434	173	9	questionnaires	questionnaire	NOUN
ajlm-1434	173	10	and	and	CCONJ
ajlm-1434	173	11	sample	sample	NOUN
ajlm-1434	173	12	collection	collection	NOUN
ajlm-1434	173	13	.	.	PUNCT
ajlm-1434	174	1	sources	source	NOUN
ajlm-1434	174	2	of	of	ADP
ajlm-1434	174	3	support	support	NOUN
ajlm-1434	174	4	this	this	DET
ajlm-1434	174	5	research	research	NOUN
ajlm-1434	174	6	received	receive	VERB
ajlm-1434	174	7	no	no	DET
ajlm-1434	174	8	specific	specific	ADJ
ajlm-1434	174	9	grant	grant	NOUN
ajlm-1434	174	10	from	from	ADP
ajlm-1434	174	11	any	any	DET
ajlm-1434	174	12	funding	funding	NOUN
ajlm-1434	174	13	agency	agency	NOUN
ajlm-1434	174	14	in	in	ADP
ajlm-1434	174	15	the	the	DET
ajlm-1434	174	16	public	public	ADJ
ajlm-1434	174	17	,	,	PUNCT
ajlm-1434	174	18	commercial	commercial	ADJ
ajlm-1434	174	19	or	or	CCONJ
ajlm-1434	174	20	not	not	PART
ajlm-1434	174	21	-	-	PUNCT
ajlm-1434	174	22	for	for	ADP
ajlm-1434	174	23	-	-	PUNCT
ajlm-1434	174	24	profit	profit	NOUN
ajlm-1434	174	25	sectors	sector	NOUN
ajlm-1434	174	26	.	.	PUNCT
ajlm-1434	175	1	data	datum	NOUN
ajlm-1434	175	2	availability	availability	NOUN
ajlm-1434	175	3	data	datum	NOUN
ajlm-1434	175	4	that	that	PRON
ajlm-1434	175	5	support	support	VERB
ajlm-1434	175	6	the	the	DET
ajlm-1434	175	7	findings	finding	NOUN
ajlm-1434	175	8	of	of	ADP
ajlm-1434	175	9	this	this	DET
ajlm-1434	175	10	study	study	NOUN
ajlm-1434	175	11	are	be	AUX
ajlm-1434	175	12	available	available	ADJ
ajlm-1434	175	13	from	from	ADP
ajlm-1434	175	14	the	the	DET
ajlm-1434	175	15	corresponding	corresponding	ADJ
ajlm-1434	175	16	author	author	NOUN
ajlm-1434	175	17	,	,	PUNCT
ajlm-1434	175	18	f.f	f.f	PROPN
ajlm-1434	175	19	.	.	PROPN
ajlm-1434	175	20	,	,	PUNCT
ajlm-1434	175	21	upon	upon	SCONJ
ajlm-1434	175	22	reasonable	reasonable	ADJ
ajlm-1434	175	23	request	request	NOUN
ajlm-1434	175	24	.	.	PUNCT
ajlm-1434	176	1	disclaimer	disclaimer	VERB
ajlm-1434	176	2	the	the	DET
ajlm-1434	176	3	views	view	NOUN
ajlm-1434	176	4	and	and	CCONJ
ajlm-1434	176	5	opinions	opinion	NOUN
ajlm-1434	176	6	expressed	express	VERB
ajlm-1434	176	7	in	in	ADP
ajlm-1434	176	8	this	this	DET
ajlm-1434	176	9	article	article	NOUN
ajlm-1434	176	10	are	be	AUX
ajlm-1434	176	11	those	those	PRON
ajlm-1434	176	12	of	of	ADP
ajlm-1434	176	13	the	the	DET
ajlm-1434	176	14	authors	author	NOUN
ajlm-1434	176	15	and	and	CCONJ
ajlm-1434	176	16	do	do	AUX
ajlm-1434	176	17	not	not	PART
ajlm-1434	176	18	necessarily	necessarily	ADV
ajlm-1434	176	19	reflect	reflect	VERB
ajlm-1434	176	20	the	the	DET
ajlm-1434	176	21	official	official	ADJ
ajlm-1434	176	22	policy	policy	NOUN
ajlm-1434	176	23	or	or	CCONJ
ajlm-1434	176	24	position	position	NOUN
ajlm-1434	176	25	of	of	ADP
ajlm-1434	176	26	any	any	DET
ajlm-1434	176	27	affiliated	affiliated	ADJ
ajlm-1434	176	28	agency	agency	NOUN
ajlm-1434	176	29	of	of	ADP
ajlm-1434	176	30	the	the	DET
ajlm-1434	176	31	authors	author	NOUN
ajlm-1434	176	32	.	.	PUNCT
ajlm-1434	177	1	references	reference	NOUN
ajlm-1434	177	2	calderon	calderon	PROPN
ajlm-1434	178	1	gm	gm	PROPN
ajlm-1434	178	2	,	,	PUNCT
ajlm-1434	178	3	gonzález	gonzález	PROPN
ajlm-1434	178	4	-	-	PUNCT
ajlm-1434	178	5	velázquez	velázquez	NOUN
ajlm-1434	178	6	f	f	PROPN
ajlm-1434	178	7	,	,	PUNCT
ajlm-1434	178	8	gonzález	gonzález	PROPN
ajlm-1434	178	9	-	-	PUNCT
ajlm-1434	178	10	bonilla	bonilla	PROPN
ajlm-1434	178	11	cr	cr	PROPN
ajlm-1434	178	12	,	,	PUNCT
ajlm-1434	178	13	et	et	PROPN
ajlm-1434	178	14	al	al	PROPN
ajlm-1434	178	15	.	.	PUNCT
ajlm-1434	179	1	prevalence	prevalence	NOUN
ajlm-1434	179	2	and	and	CCONJ
ajlm-1434	179	3	risk	risk	NOUN
ajlm-1434	179	4	factors	factor	NOUN
ajlm-1434	179	5	of	of	ADP
ajlm-1434	179	6	hepatitis	hepatitis	PROPN
ajlm-1434	179	7	c	c	PROPN
ajlm-1434	179	8	virus	virus	NOUN
ajlm-1434	179	9	,	,	PUNCT
ajlm-1434	179	10	hepatitis	hepatitis	PROPN
ajlm-1434	179	11	b	b	PROPN
ajlm-1434	179	12	virus	virus	NOUN
ajlm-1434	179	13	,	,	PUNCT
ajlm-1434	179	14	and	and	CCONJ
ajlm-1434	179	15	human	human	ADJ
ajlm-1434	179	16	immunodeficiency	immunodeficiency	NOUN
ajlm-1434	179	17	virus	virus	NOUN
ajlm-1434	179	18	in	in	ADP
ajlm-1434	179	19	multiply	multiply	NOUN
ajlm-1434	179	20	transfused	transfused	ADJ
ajlm-1434	179	21	recipients	recipient	NOUN
ajlm-1434	179	22	in	in	ADP
ajlm-1434	179	23	mexico	mexico	PROPN
ajlm-1434	179	24	.	.	PUNCT
ajlm-1434	180	1	transfusion	transfusion	NOUN
ajlm-1434	180	2	.	.	PUNCT
ajlm-1434	181	1	2009;49(10):2200–2207	2009;49(10):2200–2207	NOUN
ajlm-1434	181	2	.	.	PUNCT
ajlm-1434	182	1	https://doi.org/10.1111/j.1537-2995.2009.02248.x	https://doi.org/10.1111/j.1537-2995.2009.02248.x	VERB
ajlm-1434	182	2	jayaraman	jayaraman	NOUN
ajlm-1434	182	3	s	s	PROPN
ajlm-1434	182	4	,	,	PUNCT
ajlm-1434	182	5	chalabi	chalabi	PROPN
ajlm-1434	182	6	z	z	PROPN
ajlm-1434	182	7	,	,	PUNCT
ajlm-1434	182	8	perel	perel	NOUN
ajlm-1434	182	9	p	p	NOUN
ajlm-1434	182	10	,	,	PUNCT
ajlm-1434	182	11	guerriero	guerriero	PROPN
ajlm-1434	182	12	c	c	PROPN
ajlm-1434	182	13	,	,	PUNCT
ajlm-1434	182	14	roberts	roberts	PROPN
ajlm-1434	182	15	i.	i.	PROPN
ajlm-1434	182	16	the	the	DET
ajlm-1434	182	17	risk	risk	NOUN
ajlm-1434	182	18	of	of	ADP
ajlm-1434	182	19	transfusion	transfusion	NOUN
ajlm-1434	182	20	-	-	PUNCT
ajlm-1434	182	21	transmitted	transmit	VERB
ajlm-1434	182	22	infections	infection	NOUN
ajlm-1434	182	23	in	in	ADP
ajlm-1434	182	24	sub	sub	ADJ
ajlm-1434	182	25	-	-	ADJ
ajlm-1434	182	26	saharan	saharan	ADJ
ajlm-1434	182	27	africa	africa	PROPN
ajlm-1434	182	28	.	.	PUNCT
ajlm-1434	183	1	transfusion	transfusion	NOUN
ajlm-1434	183	2	.	.	PUNCT
ajlm-1434	184	1	2010;50(2):433–442	2010;50(2):433–442	X
ajlm-1434	184	2	.	.	PUNCT
ajlm-1434	184	3	https://doi.org/10.1111/j.1537-2995.2009.002402.x	https://doi.org/10.1111/j.1537-2995.2009.002402.x	PROPN
ajlm-1434	184	4	allain	allain	VERB
ajlm-1434	184	5	j	j	PROPN
ajlm-1434	184	6	-	-	PROPN
ajlm-1434	184	7	p	p	PROPN
ajlm-1434	184	8	,	,	PUNCT
ajlm-1434	184	9	cox	cox	PROPN
ajlm-1434	184	10	l.	l.	PROPN
ajlm-1434	184	11	challenges	challenge	NOUN
ajlm-1434	184	12	in	in	ADP
ajlm-1434	184	13	hepatitis	hepatitis	PROPN
ajlm-1434	184	14	b	b	PROPN
ajlm-1434	184	15	detection	detection	NOUN
ajlm-1434	184	16	among	among	ADP
ajlm-1434	184	17	blood	blood	NOUN
ajlm-1434	184	18	donors	donor	NOUN
ajlm-1434	184	19	.	.	PUNCT
ajlm-1434	185	1	curr	curr	PROPN
ajlm-1434	185	2	opin	opin	PROPN
ajlm-1434	185	3	hematol	hematol	NOUN
ajlm-1434	185	4	.	.	PUNCT
ajlm-1434	186	1	2011;18(6):461–466	2011;18(6):461–466	NUM
ajlm-1434	186	2	.	.	PROPN
ajlm-1434	186	3	https://doi.org/10.1097/moh.0b013e32834bac10	https://doi.org/10.1097/moh.0b013e32834bac10	PROPN
ajlm-1434	186	4	world	world	PROPN
ajlm-1434	186	5	health	health	PROPN
ajlm-1434	186	6	organization	organization	NOUN
ajlm-1434	186	7	.	.	PUNCT
ajlm-1434	187	1	global	global	ADJ
ajlm-1434	187	2	health	health	NOUN
ajlm-1434	187	3	sector	sector	NOUN
ajlm-1434	187	4	strategy	strategy	NOUN
ajlm-1434	187	5	on	on	ADP
ajlm-1434	187	6	viral	viral	ADJ
ajlm-1434	187	7	hepatitis	hepatitis	NOUN
ajlm-1434	187	8	2016	2016	NUM
ajlm-1434	187	9	–	–	PUNCT
ajlm-1434	187	10	2021	2021	NUM
ajlm-1434	187	11	towards	towards	ADP
ajlm-1434	187	12	ending	end	VERB
ajlm-1434	187	13	viral	viral	ADJ
ajlm-1434	187	14	hepatitis	hepatitis	NOUN
ajlm-1434	187	15	.	.	PUNCT
ajlm-1434	188	1	geneva	geneva	PROPN
ajlm-1434	188	2	:	:	PUNCT
ajlm-1434	188	3	world	world	PROPN
ajlm-1434	188	4	health	health	NOUN
ajlm-1434	188	5	organization	organization	NOUN
ajlm-1434	188	6	;	;	PUNCT
ajlm-1434	188	7	2016	2016	NUM
ajlm-1434	188	8	.	.	PUNCT
ajlm-1434	189	1	krajden	krajden	PROPN
ajlm-1434	189	2	m	m	PROPN
ajlm-1434	189	3	,	,	PUNCT
ajlm-1434	189	4	mcnabb	mcnabb	PROPN
ajlm-1434	189	5	g	g	PROPN
ajlm-1434	189	6	,	,	PUNCT
ajlm-1434	189	7	art	art	NOUN
ajlm-1434	189	8	b	b	NOUN
ajlm-1434	189	9	,	,	PUNCT
ajlm-1434	189	10	petric	petric	ADJ
ajlm-1434	189	11	m.	m.	NOUN
ajlm-1434	189	12	the	the	DET
ajlm-1434	189	13	laboratory	laboratory	NOUN
ajlm-1434	189	14	diagnosis	diagnosis	NOUN
ajlm-1434	189	15	of	of	ADP
ajlm-1434	189	16	hepatitis	hepatitis	PROPN
ajlm-1434	189	17	b	b	PROPN
ajlm-1434	189	18	virus	virus	NOUN
ajlm-1434	189	19	diagnostic	diagnostic	ADJ
ajlm-1434	189	20	l’hépatite	l’hépatite	PROPN
ajlm-1434	189	21	b	b	PROPN
ajlm-1434	189	22	en	en	X
ajlm-1434	189	23	laboratoire	laboratoire	PROPN
ajlm-1434	189	24	.	.	PUNCT
ajlm-1434	190	1	can	can	AUX
ajlm-1434	190	2	j	j	PROPN
ajlm-1434	190	3	infect	infect	VERB
ajlm-1434	190	4	dis	dis	PROPN
ajlm-1434	190	5	med	med	PROPN
ajlm-1434	190	6	microbiol	microbiol	NOUN
ajlm-1434	190	7	.	.	PUNCT
ajlm-1434	191	1	2005;16(2):450574	2005;16(2):450574	NUM
ajlm-1434	191	2	.	.	PUNCT
ajlm-1434	192	1	https://doi.org/10.1155/2005/450574	https://doi.org/10.1155/2005/450574	PROPN
ajlm-1434	192	2	hoofnagle	hoofnagle	PROPN
ajlm-1434	192	3	jh	jh	PROPN
ajlm-1434	192	4	.	.	PUNCT
ajlm-1434	193	1	posttransfusion	posttransfusion	PROPN
ajlm-1434	193	2	hepatitis	hepatitis	PROPN
ajlm-1434	193	3	b.	b.	PROPN
ajlm-1434	193	4	transfusion	transfusion	NOUN
ajlm-1434	193	5	.	.	PUNCT
ajlm-1434	194	1	1990;30(5):384–386	1990;30(5):384–386	X
ajlm-1434	194	2	.	.	X
ajlm-1434	194	3	zobeiri	zobeiri	PROPN
ajlm-1434	194	4	m.	m.	NOUN
ajlm-1434	194	5	occult	occult	NOUN
ajlm-1434	194	6	hepatitis	hepatitis	PROPN
ajlm-1434	194	7	b	b	PROPN
ajlm-1434	194	8	:	:	PUNCT
ajlm-1434	194	9	clinical	clinical	ADJ
ajlm-1434	194	10	viewpoint	viewpoint	NOUN
ajlm-1434	194	11	and	and	CCONJ
ajlm-1434	194	12	management	management	NOUN
ajlm-1434	194	13	.	.	PUNCT
ajlm-1434	195	1	hepat	hepat	PROPN
ajlm-1434	195	2	res	re	NOUN
ajlm-1434	195	3	treat	treat	NOUN
ajlm-1434	195	4	.	.	PUNCT
ajlm-1434	196	1	2013;2013:259148	2013;2013:259148	NUM
ajlm-1434	196	2	.	.	PUNCT
ajlm-1434	197	1	https://doi.org/10.1155/2013/259148	https://doi.org/10.1155/2013/259148	NOUN
ajlm-1434	197	2	mak	mak	PROPN
ajlm-1434	197	3	ly	ly	PROPN
ajlm-1434	197	4	,	,	PUNCT
ajlm-1434	197	5	wong	wong	PROPN
ajlm-1434	197	6	dkh	dkh	PROPN
ajlm-1434	197	7	,	,	PUNCT
ajlm-1434	197	8	pollicino	pollicino	PROPN
ajlm-1434	197	9	t	t	PROPN
ajlm-1434	197	10	,	,	PUNCT
ajlm-1434	197	11	raimondo	raimondo	PROPN
ajlm-1434	197	12	g	g	PROPN
ajlm-1434	197	13	,	,	PUNCT
ajlm-1434	197	14	hollinger	hollinger	PROPN
ajlm-1434	197	15	fb	fb	PROPN
ajlm-1434	197	16	,	,	PUNCT
ajlm-1434	197	17	yuen	yuen	PROPN
ajlm-1434	197	18	mf	mf	PROPN
ajlm-1434	197	19	.	.	PROPN
ajlm-1434	197	20	occult	occult	NOUN
ajlm-1434	197	21	hepatitis	hepatitis	PROPN
ajlm-1434	197	22	b	b	PROPN
ajlm-1434	197	23	infection	infection	NOUN
ajlm-1434	197	24	and	and	CCONJ
ajlm-1434	197	25	hepatocellular	hepatocellular	ADJ
ajlm-1434	197	26	carcinoma	carcinoma	NOUN
ajlm-1434	197	27	:	:	PUNCT
ajlm-1434	197	28	epidemiology	epidemiology	NOUN
ajlm-1434	197	29	,	,	PUNCT
ajlm-1434	197	30	virology	virology	NOUN
ajlm-1434	197	31	,	,	PUNCT
ajlm-1434	197	32	hepatocarcinogenesis	hepatocarcinogenesis	NOUN
ajlm-1434	197	33	and	and	CCONJ
ajlm-1434	197	34	clinical	clinical	ADJ
ajlm-1434	197	35	significance	significance	NOUN
ajlm-1434	197	36	.	.	PUNCT
ajlm-1434	198	1	j	j	PROPN
ajlm-1434	198	2	hepatol	hepatol	ADJ
ajlm-1434	198	3	.	.	PUNCT
ajlm-1434	199	1	2020;73(4):952–964	2020;73(4):952–964	X
ajlm-1434	199	2	.	.	PUNCT
ajlm-1434	200	1	https://doi.org/10.1016/j.jhep.2020.05.042	https://doi.org/10.1016/j.jhep.2020.05.042	PROPN
ajlm-1434	200	2	esposito	esposito	PROPN
ajlm-1434	200	3	a	a	PRON
ajlm-1434	200	4	,	,	PUNCT
ajlm-1434	200	5	sabia	sabia	PROPN
ajlm-1434	200	6	c	c	PROPN
ajlm-1434	200	7	,	,	PUNCT
ajlm-1434	200	8	iannone	iannone	NOUN
ajlm-1434	200	9	c	c	NOUN
ajlm-1434	200	10	,	,	PUNCT
ajlm-1434	200	11	nicoletti	nicoletti	PROPN
ajlm-1434	200	12	gf	gf	NOUN
ajlm-1434	200	13	,	,	PUNCT
ajlm-1434	200	14	sommese	sommese	PROPN
ajlm-1434	200	15	l	l	NOUN
ajlm-1434	200	16	,	,	PUNCT
ajlm-1434	200	17	napoli	napoli	PROPN
ajlm-1434	200	18	c.	c.	PROPN
ajlm-1434	200	19	occult	occult	NOUN
ajlm-1434	200	20	hepatitis	hepatitis	NOUN
ajlm-1434	200	21	infection	infection	NOUN
ajlm-1434	200	22	in	in	ADP
ajlm-1434	200	23	transfusion	transfusion	NOUN
ajlm-1434	200	24	medicine	medicine	NOUN
ajlm-1434	200	25	:	:	PUNCT
ajlm-1434	200	26	screening	screen	VERB
ajlm-1434	200	27	policy	policy	NOUN
ajlm-1434	200	28	and	and	CCONJ
ajlm-1434	200	29	assessment	assessment	NOUN
ajlm-1434	200	30	of	of	ADP
ajlm-1434	200	31	current	current	ADJ
ajlm-1434	200	32	use	use	NOUN
ajlm-1434	200	33	of	of	ADP
ajlm-1434	200	34	anti	anti	ADJ
ajlm-1434	200	35	-	-	ADJ
ajlm-1434	200	36	hbc	hbc	ADJ
ajlm-1434	200	37	testing	testing	NOUN
ajlm-1434	200	38	.	.	PUNCT
ajlm-1434	201	1	transfus	transfus	PROPN
ajlm-1434	201	2	med	med	PROPN
ajlm-1434	201	3	hemother	hemother	NOUN
ajlm-1434	201	4	.	.	PUNCT
ajlm-1434	202	1	2017;44(4):263–272	2017;44(4):263–272	X
ajlm-1434	202	2	.	.	PUNCT
ajlm-1434	203	1	https://doi.org/10.1159/000460301	https://doi.org/10.1159/000460301	PRON
ajlm-1434	203	2	kupek	kupek	PROPN
ajlm-1434	203	3	e.	e.	PROPN
ajlm-1434	203	4	residual	residual	ADJ
ajlm-1434	203	5	risk	risk	NOUN
ajlm-1434	203	6	of	of	ADP
ajlm-1434	203	7	hepatitis	hepatitis	NOUN
ajlm-1434	203	8	-	-	PUNCT
ajlm-1434	203	9	b	b	NOUN
ajlm-1434	203	10	-	-	PUNCT
ajlm-1434	203	11	infected	infect	VERB
ajlm-1434	203	12	blood	blood	NOUN
ajlm-1434	203	13	donations	donation	NOUN
ajlm-1434	203	14	:	:	PUNCT
ajlm-1434	203	15	estimation	estimation	NOUN
ajlm-1434	203	16	methods	method	NOUN
ajlm-1434	203	17	and	and	CCONJ
ajlm-1434	203	18	perspectives	perspective	NOUN
ajlm-1434	203	19	.	.	PUNCT
ajlm-1434	204	1	int	int	NOUN
ajlm-1434	204	2	sch	sch	PROPN
ajlm-1434	204	3	res	re	NOUN
ajlm-1434	204	4	notices	notice	NOUN
ajlm-1434	204	5	.	.	PUNCT
ajlm-1434	205	1	2013;2013:839896	2013;2013:839896	X
ajlm-1434	205	2	.	.	PUNCT
ajlm-1434	206	1	https://doi.org/10.5402/2013/839896	https://doi.org/10.5402/2013/839896	NOUN
ajlm-1434	206	2	barro	barro	PROPN
ajlm-1434	206	3	l	l	NOUN
ajlm-1434	206	4	,	,	PUNCT
ajlm-1434	206	5	drew	draw	VERB
ajlm-1434	206	6	vj	vj	PROPN
ajlm-1434	206	7	,	,	PUNCT
ajlm-1434	206	8	poda	poda	PROPN
ajlm-1434	206	9	gg	gg	PROPN
ajlm-1434	206	10	,	,	PUNCT
ajlm-1434	206	11	et	et	PROPN
ajlm-1434	206	12	al	al	PROPN
ajlm-1434	206	13	.	.	PUNCT
ajlm-1434	207	1	blood	blood	NOUN
ajlm-1434	207	2	transfusion	transfusion	NOUN
ajlm-1434	207	3	in	in	ADP
ajlm-1434	207	4	sub	sub	ADJ
ajlm-1434	207	5	-	-	ADJ
ajlm-1434	207	6	saharan	saharan	ADJ
ajlm-1434	207	7	africa	africa	PROPN
ajlm-1434	207	8	:	:	PUNCT
ajlm-1434	207	9	understanding	understand	VERB
ajlm-1434	207	10	the	the	DET
ajlm-1434	207	11	missing	miss	VERB
ajlm-1434	207	12	gap	gap	NOUN
ajlm-1434	207	13	and	and	CCONJ
ajlm-1434	207	14	responding	respond	VERB
ajlm-1434	207	15	to	to	ADP
ajlm-1434	207	16	present	present	ADJ
ajlm-1434	207	17	and	and	CCONJ
ajlm-1434	207	18	future	future	ADJ
ajlm-1434	207	19	challenges	challenge	NOUN
ajlm-1434	207	20	.	.	PUNCT
ajlm-1434	208	1	vox	vox	PROPN
ajlm-1434	208	2	sang	sing	VERB
ajlm-1434	208	3	.	.	PUNCT
ajlm-1434	209	1	2018;113(8):726–736	2018;113(8):726–736	X
ajlm-1434	209	2	.	.	PUNCT
ajlm-1434	210	1	https://doi.org/10.1111/vox.12705	https://doi.org/10.1111/vox.12705	PROPN
ajlm-1434	210	2	wang	wang	PROPN
ajlm-1434	210	3	t	t	PROPN
ajlm-1434	210	4	,	,	PUNCT
ajlm-1434	210	5	wang	wang	PROPN
ajlm-1434	210	6	l	l	PROPN
ajlm-1434	210	7	,	,	PUNCT
ajlm-1434	210	8	zhang	zhang	PROPN
ajlm-1434	210	9	j	j	PROPN
ajlm-1434	210	10	,	,	PUNCT
ajlm-1434	210	11	dong	dong	PROPN
ajlm-1434	210	12	w.	w.	PROPN
ajlm-1434	210	13	a	a	DET
ajlm-1434	210	14	simplified	simplified	ADJ
ajlm-1434	210	15	universal	universal	ADJ
ajlm-1434	210	16	genomic	genomic	ADJ
ajlm-1434	210	17	dna	dna	NOUN
ajlm-1434	210	18	extraction	extraction	NOUN
ajlm-1434	210	19	protocol	protocol	NOUN
ajlm-1434	210	20	suitable	suitable	ADJ
ajlm-1434	210	21	for	for	ADP
ajlm-1434	210	22	pcr	pcr	PROPN
ajlm-1434	210	23	.	.	PUNCT
ajlm-1434	211	1	genet	genet	PROPN
ajlm-1434	211	2	mol	mol	ADP
ajlm-1434	211	3	res	re	NOUN
ajlm-1434	211	4	.	.	PUNCT
ajlm-1434	212	1	2011;10(1):519–525	2011;10(1):519–525	NUM
ajlm-1434	212	2	.	.	PUNCT
ajlm-1434	213	1	https://doi.org/10.4238/vol10-1gmr1055	https://doi.org/10.4238/vol10-1gmr1055	PROPN
ajlm-1434	213	2	fiedler	fiedler	PROPN
ajlm-1434	213	3	sa	sa	PROPN
ajlm-1434	213	4	,	,	PUNCT
ajlm-1434	213	5	oberle	oberle	ADJ
ajlm-1434	213	6	d	d	NOUN
ajlm-1434	213	7	,	,	PUNCT
ajlm-1434	213	8	churdy	churdy	NOUN
ajlm-1434	213	9	m	m	PROPN
ajlm-1434	213	10	,	,	PUNCT
ajlm-1434	213	11	et	et	PROPN
ajlm-1434	213	12	al	al	PROPN
ajlm-1434	213	13	.	.	PROPN
ajlm-1434	213	14	effectiveness	effectiveness	NOUN
ajlm-1434	213	15	of	of	ADP
ajlm-1434	213	16	blood	blood	NOUN
ajlm-1434	213	17	donor	donor	NOUN
ajlm-1434	213	18	screening	screening	NOUN
ajlm-1434	213	19	by	by	ADP
ajlm-1434	213	20	hiv	hiv	PROPN
ajlm-1434	213	21	,	,	PUNCT
ajlm-1434	213	22	hcv	hcv	PROPN
ajlm-1434	213	23	,	,	PUNCT
ajlm-1434	213	24	hbv	hbv	NOUN
ajlm-1434	213	25	-	-	PUNCT
ajlm-1434	213	26	nat	nat	NOUN
ajlm-1434	213	27	assays	assay	NOUN
ajlm-1434	213	28	,	,	PUNCT
ajlm-1434	213	29	as	as	ADV
ajlm-1434	213	30	well	well	ADV
ajlm-1434	213	31	as	as	ADP
ajlm-1434	213	32	hbsag	hbsag	NOUN
ajlm-1434	213	33	and	and	CCONJ
ajlm-1434	213	34	anti	anti	ADJ
ajlm-1434	213	35	-	-	ADJ
ajlm-1434	213	36	hbc	hbc	ADJ
ajlm-1434	213	37	immunoassays	immunoassay	NOUN
ajlm-1434	213	38	in	in	ADP
ajlm-1434	213	39	germany	germany	PROPN
ajlm-1434	213	40	(	(	PUNCT
ajlm-1434	213	41	2008–2015	2008–2015	NUM
ajlm-1434	213	42	)	)	PUNCT
ajlm-1434	213	43	.	.	PUNCT
ajlm-1434	214	1	vox	vox	PROPN
ajlm-1434	214	2	sang	sing	VERB
ajlm-1434	214	3	.	.	PUNCT
ajlm-1434	215	1	2019;114(5):443–445	2019;114(5):443–445	NUM
ajlm-1434	215	2	.	.	PUNCT
ajlm-1434	216	1	https://doi.org/10.1111/vox.12770	https://doi.org/10.1111/vox.12770	PROPN
ajlm-1434	216	2	maheswari	maheswari	PROPN
ajlm-1434	216	3	ks	ks	PROPN
ajlm-1434	216	4	,	,	PUNCT
ajlm-1434	216	5	arun	arun	ADJ
ajlm-1434	216	6	r	r	NOUN
ajlm-1434	216	7	,	,	PUNCT
ajlm-1434	216	8	arunugam	arunugam	ADJ
ajlm-1434	216	9	p.	p.	NOUN
ajlm-1434	217	1	the	the	DET
ajlm-1434	217	2	prevalence	prevalence	NOUN
ajlm-1434	217	3	of	of	ADP
ajlm-1434	217	4	the	the	DET
ajlm-1434	217	5	hepatitis	hepatitis	PROPN
ajlm-1434	217	6	b	b	PROPN
ajlm-1434	217	7	core	core	NOUN
ajlm-1434	217	8	antibody	antibody	NOUN
ajlm-1434	217	9	and	and	CCONJ
ajlm-1434	217	10	the	the	DET
ajlm-1434	217	11	occult	occult	NOUN
ajlm-1434	217	12	hepatitis	hepatitis	NOUN
ajlm-1434	217	13	b	b	PROPN
ajlm-1434	217	14	infection	infection	NOUN
ajlm-1434	217	15	among	among	ADP
ajlm-1434	217	16	voluntary	voluntary	ADJ
ajlm-1434	217	17	blood	blood	NOUN
ajlm-1434	217	18	donors	donor	NOUN
ajlm-1434	217	19	in	in	ADP
ajlm-1434	217	20	chennai	chennai	PROPN
ajlm-1434	217	21	,	,	PUNCT
ajlm-1434	217	22	india	india	PROPN
ajlm-1434	217	23	.	.	PUNCT
ajlm-1434	218	1	j.	j.	PROPN
ajlm-1434	218	2	clin	clin	PROPN
ajlm-1434	218	3	.	.	PUNCT
ajlm-1434	219	1	diagnostic	diagnostic	ADJ
ajlm-1434	219	2	res	re	NOUN
ajlm-1434	219	3	.	.	PUNCT
ajlm-1434	220	1	2012	2012	NUM
ajlm-1434	220	2	dec;6(10):1710–1712	dec;6(10):1710–1712	NUM
ajlm-1434	220	3	.	.	PUNCT
ajlm-1434	221	1	https://doi.org/10.7860/jcdr/2012/4826.2636	https://doi.org/10.7860/jcdr/2012/4826.2636	PROPN
ajlm-1434	221	2	mohamed	mohamed	PROPN
ajlm-1434	221	3	s	s	PROPN
ajlm-1434	221	4	,	,	PUNCT
ajlm-1434	221	5	ezzadin	ezzadin	ADJ
ajlm-1434	221	6	f	f	PROPN
ajlm-1434	221	7	,	,	PUNCT
ajlm-1434	221	8	faisal	faisal	PROPN
ajlm-1434	221	9	i	i	PROPN
ajlm-1434	221	10	,	,	PUNCT
ajlm-1434	221	11	nagi	nagi	PROPN
ajlm-1434	221	12	g	g	PROPN
ajlm-1434	221	13	,	,	PUNCT
ajlm-1434	221	14	kamel	kamel	PROPN
ajlm-1434	221	15	a	a	PROPN
ajlm-1434	221	16	,	,	PUNCT
ajlm-1434	221	17	fatma	fatma	PROPN
ajlm-1434	221	18	a.	a.	NOUN
ajlm-1434	221	19	anti	anti	PROPN
ajlm-1434	221	20	-	-	NOUN
ajlm-1434	221	21	hbc	hbc	ADJ
ajlm-1434	221	22	and	and	CCONJ
ajlm-1434	221	23	hbv	hbv	NOUN
ajlm-1434	221	24	-	-	PUNCT
ajlm-1434	221	25	dna	dna	NOUN
ajlm-1434	221	26	among	among	ADP
ajlm-1434	221	27	blood	blood	NOUN
ajlm-1434	221	28	donors	donor	NOUN
ajlm-1434	221	29	in	in	ADP
ajlm-1434	221	30	north	north	PROPN
ajlm-1434	221	31	africa	africa	PROPN
ajlm-1434	221	32	;	;	PUNCT
ajlm-1434	221	33	western	western	ADJ
ajlm-1434	221	34	libya	libya	PROPN
ajlm-1434	221	35	.	.	PUNCT
ajlm-1434	222	1	international	international	ADJ
ajlm-1434	222	2	blood	blood	NOUN
ajlm-1434	222	3	research	research	NOUN
ajlm-1434	222	4	&	&	CCONJ
ajlm-1434	222	5	reviews	review	NOUN
ajlm-1434	222	6	.	.	PUNCT
ajlm-1434	223	1	2015;3:152–159	2015;3:152–159	NUM
ajlm-1434	223	2	.	.	PROPN
ajlm-1434	223	3	https://doi.org/10.9734/ibrr/2015/18364	https://doi.org/10.9734/ibrr/2015/18364	NOUN
ajlm-1434	223	4	arora	arora	PROPN
ajlm-1434	223	5	s	s	PROPN
ajlm-1434	223	6	,	,	PUNCT
ajlm-1434	223	7	doda	doda	PROPN
ajlm-1434	223	8	v	v	PROPN
ajlm-1434	223	9	,	,	PUNCT
ajlm-1434	223	10	kirtania	kirtania	NOUN
ajlm-1434	223	11	t.	t.	NOUN
ajlm-1434	223	12	sensitivity	sensitivity	NOUN
ajlm-1434	223	13	of	of	ADP
ajlm-1434	223	14	individual	individual	ADJ
ajlm-1434	223	15	donor	donor	NOUN
ajlm-1434	223	16	nucleic	nucleic	ADJ
ajlm-1434	223	17	acid	acid	NOUN
ajlm-1434	223	18	testing	testing	NOUN
ajlm-1434	223	19	(	(	PUNCT
ajlm-1434	223	20	nat	nat	PROPN
ajlm-1434	223	21	)	)	PUNCT
ajlm-1434	223	22	for	for	ADP
ajlm-1434	223	23	the	the	DET
ajlm-1434	223	24	detection	detection	NOUN
ajlm-1434	223	25	of	of	ADP
ajlm-1434	223	26	hepatitis	hepatitis	PROPN
ajlm-1434	223	27	b	b	PROPN
ajlm-1434	223	28	infection	infection	NOUN
ajlm-1434	223	29	by	by	ADP
ajlm-1434	223	30	studying	study	VERB
ajlm-1434	223	31	diluted	dilute	VERB
ajlm-1434	223	32	nat	nat	NOUN
ajlm-1434	223	33	yield	yield	NOUN
ajlm-1434	223	34	samples	sample	NOUN
ajlm-1434	223	35	.	.	PUNCT
ajlm-1434	224	1	blood	blood	NOUN
ajlm-1434	224	2	transfus	transfus	PROPN
ajlm-1434	224	3	.	.	PUNCT
ajlm-1434	225	1	2015;13(2):227–232	2015;13(2):227–232	X
ajlm-1434	225	2	.	.	PUNCT
ajlm-1434	225	3	de	de	PROPN
ajlm-1434	225	4	la	la	PROPN
ajlm-1434	225	5	fuente	fuente	PROPN
ajlm-1434	225	6	ra	ra	PROPN
ajlm-1434	225	7	,	,	PUNCT
ajlm-1434	225	8	gutiérrez	gutiérrez	NOUN
ajlm-1434	225	9	ml	ml	PROPN
ajlm-1434	225	10	,	,	PUNCT
ajlm-1434	225	11	garcia	garcia	PROPN
ajlm-1434	225	12	-	-	PUNCT
ajlm-1434	225	13	samaniego	samaniego	PROPN
ajlm-1434	225	14	j	j	PROPN
ajlm-1434	225	15	,	,	PUNCT
ajlm-1434	225	16	fernández	fernández	PROPN
ajlm-1434	225	17	-	-	PUNCT
ajlm-1434	225	18	rodriguez	rodriguez	NOUN
ajlm-1434	225	19	c	c	PROPN
ajlm-1434	225	20	,	,	PUNCT
ajlm-1434	225	21	lledó	lledó	PROPN
ajlm-1434	225	22	jl	jl	PROPN
ajlm-1434	225	23	,	,	PUNCT
ajlm-1434	225	24	castellano	castellano	PROPN
ajlm-1434	225	25	g.	g.	PROPN
ajlm-1434	225	26	pathogenesis	pathogenesis	NOUN
ajlm-1434	225	27	of	of	ADP
ajlm-1434	225	28	occult	occult	NOUN
ajlm-1434	225	29	chronic	chronic	ADJ
ajlm-1434	225	30	hepatitis	hepatitis	PROPN
ajlm-1434	225	31	b	b	PROPN
ajlm-1434	225	32	virus	virus	NOUN
ajlm-1434	225	33	infection	infection	NOUN
ajlm-1434	225	34	.	.	PUNCT
ajlm-1434	226	1	world	world	PROPN
ajlm-1434	226	2	j	j	PROPN
ajlm-1434	226	3	gastroenterol	gastroenterol	PROPN
ajlm-1434	226	4	.	.	PUNCT
ajlm-1434	227	1	2011;17(12):1543–1548	2011;17(12):1543–1548	X
ajlm-1434	227	2	.	.	PUNCT
ajlm-1434	228	1	https://doi.org/10.3748/wjg.v17.i12.1543	https://doi.org/10.3748/wjg.v17.i12.1543	PROPN
ajlm-1434	228	2	akinbami	akinbami	PROPN
ajlm-1434	228	3	aa	aa	PROPN
ajlm-1434	228	4	,	,	PUNCT
ajlm-1434	228	5	oshinaike	oshinaike	NOUN
ajlm-1434	228	6	oo	oo	ADV
ajlm-1434	228	7	,	,	PUNCT
ajlm-1434	228	8	dosunmu	dosunmu	NOUN
ajlm-1434	228	9	oa	oa	PRON
ajlm-1434	228	10	,	,	PUNCT
ajlm-1434	228	11	et	et	PROPN
ajlm-1434	228	12	al	al	PROPN
ajlm-1434	228	13	.	.	PROPN
ajlm-1434	228	14	seroprevalence	seroprevalence	NOUN
ajlm-1434	228	15	of	of	ADP
ajlm-1434	228	16	hepatitis	hepatitis	PROPN
ajlm-1434	228	17	b	b	PROPN
ajlm-1434	228	18	e	e	X
ajlm-1434	228	19	antigen	antigen	NOUN
ajlm-1434	228	20	(	(	PUNCT
ajlm-1434	228	21	hbe	hbe	X
ajlm-1434	228	22	antigen	antigen	ADV
ajlm-1434	228	23	)	)	PUNCT
ajlm-1434	228	24	and	and	CCONJ
ajlm-1434	228	25	b	b	X
ajlm-1434	228	26	core	core	NOUN
ajlm-1434	228	27	antibodies	antibodie	VERB
ajlm-1434	228	28	(	(	PUNCT
ajlm-1434	228	29	igg	igg	NOUN
ajlm-1434	228	30	anti	anti	PROPN
ajlm-1434	228	31	-	-	ADJ
ajlm-1434	228	32	hbcore	hbcore	ADJ
ajlm-1434	228	33	and	and	CCONJ
ajlm-1434	228	34	igm	igm	PROPN
ajlm-1434	228	35	antihbcore	antihbcore	PROPN
ajlm-1434	228	36	)	)	PUNCT
ajlm-1434	228	37	among	among	ADP
ajlm-1434	228	38	hepatitis	hepatitis	PROPN
ajlm-1434	228	39	b	b	PROPN
ajlm-1434	228	40	surface	surface	NOUN
ajlm-1434	228	41	antigen	antigen	ADP
ajlm-1434	228	42	positive	positive	ADJ
ajlm-1434	228	43	blood	blood	NOUN
ajlm-1434	228	44	donors	donor	NOUN
ajlm-1434	228	45	at	at	ADP
ajlm-1434	228	46	a	a	DET
ajlm-1434	228	47	tertiary	tertiary	ADJ
ajlm-1434	228	48	centre	centre	NOUN
ajlm-1434	228	49	in	in	ADP
ajlm-1434	228	50	nigeria	nigeria	PROPN
ajlm-1434	228	51	.	.	PUNCT
ajlm-1434	229	1	bmc	bmc	ADJ
ajlm-1434	229	2	res	re	NOUN
ajlm-1434	229	3	notes	note	NOUN
ajlm-1434	229	4	.	.	PUNCT
ajlm-1434	230	1	2012;5(1):167	2012;5(1):167	X
ajlm-1434	230	2	.	.	PUNCT
ajlm-1434	230	3	https://doi.org/10.1186/1756-0500-5-167	https://doi.org/10.1186/1756-0500-5-167	PROPN
ajlm-1434	230	4	oluyinka	oluyinka	PROPN
ajlm-1434	231	1	oo	oo	PROPN
ajlm-1434	231	2	,	,	PUNCT
ajlm-1434	231	3	tong	tong	PROPN
ajlm-1434	231	4	hv	hv	PROPN
ajlm-1434	231	5	,	,	PUNCT
ajlm-1434	231	6	bui	bui	PROPN
ajlm-1434	231	7	tien	tien	PROPN
ajlm-1434	231	8	s	s	PROPN
ajlm-1434	231	9	,	,	PUNCT
ajlm-1434	231	10	et	et	PROPN
ajlm-1434	231	11	al	al	PROPN
ajlm-1434	231	12	.	.	PROPN
ajlm-1434	232	1	occult	occult	PROPN
ajlm-1434	232	2	hepatitis	hepatitis	PROPN
ajlm-1434	232	3	b	b	PROPN
ajlm-1434	232	4	virus	virus	NOUN
ajlm-1434	232	5	infection	infection	NOUN
ajlm-1434	232	6	in	in	ADP
ajlm-1434	232	7	nigerian	nigerian	ADJ
ajlm-1434	232	8	blood	blood	NOUN
ajlm-1434	232	9	donors	donor	NOUN
ajlm-1434	232	10	and	and	CCONJ
ajlm-1434	232	11	hepatitis	hepatitis	PROPN
ajlm-1434	232	12	b	b	PROPN
ajlm-1434	232	13	virus	virus	NOUN
ajlm-1434	232	14	transmission	transmission	NOUN
ajlm-1434	232	15	risks	risk	NOUN
ajlm-1434	232	16	.	.	PUNCT
ajlm-1434	233	1	plos	plos	PROPN
ajlm-1434	233	2	one	one	NUM
ajlm-1434	233	3	.	.	PUNCT
ajlm-1434	234	1	2015;10(7):e0131912	2015;10(7):e0131912	NUM
ajlm-1434	234	2	.	.	PUNCT
ajlm-1434	234	3	https://doi.org/10.1371/journal.pone.0131912	https://doi.org/10.1371/journal.pone.0131912	PROPN
ajlm-1434	234	4	seo	seo	PROPN
ajlm-1434	234	5	dh	dh	NOUN
ajlm-1434	234	6	,	,	PUNCT
ajlm-1434	234	7	whang	whang	PROPN
ajlm-1434	234	8	dh	dh	PROPN
ajlm-1434	234	9	,	,	PUNCT
ajlm-1434	234	10	song	song	NOUN
ajlm-1434	234	11	ey	ey	PROPN
ajlm-1434	234	12	,	,	PUNCT
ajlm-1434	234	13	han	han	PROPN
ajlm-1434	234	14	ks	ks	PROPN
ajlm-1434	234	15	.	.	PROPN
ajlm-1434	234	16	occult	occult	PROPN
ajlm-1434	234	17	hepatitis	hepatitis	PROPN
ajlm-1434	234	18	b	b	PROPN
ajlm-1434	234	19	virus	virus	NOUN
ajlm-1434	234	20	infection	infection	NOUN
ajlm-1434	234	21	and	and	CCONJ
ajlm-1434	234	22	blood	blood	NOUN
ajlm-1434	234	23	transfusion	transfusion	NOUN
ajlm-1434	234	24	.	.	PUNCT
ajlm-1434	235	1	world	world	NOUN
ajlm-1434	235	2	j	j	PROPN
ajlm-1434	235	3	hepatol	hepatol	ADV
ajlm-1434	235	4	.	.	PUNCT
ajlm-1434	236	1	2015;7(3):600–606	2015;7(3):600–606	X
ajlm-1434	236	2	.	.	X
ajlm-1434	236	3	https://doi.org/10.4254/wjh.v7.i3.600	https://doi.org/10.4254/wjh.v7.i3.600	PROPN
ajlm-1434	236	4	candotti	candotti	NOUN
ajlm-1434	236	5	d	d	NOUN
ajlm-1434	236	6	,	,	PUNCT
ajlm-1434	236	7	laperche	laperche	PROPN
ajlm-1434	236	8	s.	s.	PROPN
ajlm-1434	236	9	hepatitis	hepatitis	PROPN
ajlm-1434	236	10	b	b	PROPN
ajlm-1434	236	11	virus	virus	NOUN
ajlm-1434	236	12	blood	blood	NOUN
ajlm-1434	236	13	screening	screening	NOUN
ajlm-1434	236	14	:	:	PUNCT
ajlm-1434	236	15	need	need	VERB
ajlm-1434	236	16	for	for	ADP
ajlm-1434	236	17	reappraisal	reappraisal	NOUN
ajlm-1434	236	18	of	of	ADP
ajlm-1434	236	19	blood	blood	NOUN
ajlm-1434	236	20	safety	safety	NOUN
ajlm-1434	236	21	measures	measure	NOUN
ajlm-1434	236	22	?	?	PUNCT
ajlm-1434	237	1	front	front	ADJ
ajlm-1434	237	2	med	med	PROPN
ajlm-1434	237	3	(	(	PUNCT
ajlm-1434	237	4	lausanne	lausanne	PROPN
ajlm-1434	237	5	)	)	PUNCT
ajlm-1434	237	6	.	.	PUNCT
ajlm-1434	238	1	2018;5:29	2018;5:29	NOUN
ajlm-1434	238	2	.	.	PUNCT
ajlm-1434	239	1	https://doi.org/10.3389/fmed.2018.00029	https://doi.org/10.3389/fmed.2018.00029	PROPN
ajlm-1434	239	2	japhet	japhet	PROPN
ajlm-1434	239	3	mo	mo	PROPN
ajlm-1434	239	4	,	,	PUNCT
ajlm-1434	239	5	adesina	adesina	PROPN
ajlm-1434	239	6	oa	oa	PROPN
ajlm-1434	239	7	,	,	PUNCT
ajlm-1434	239	8	donbraye	donbraye	VERB
ajlm-1434	239	9	e	e	NOUN
ajlm-1434	239	10	,	,	PUNCT
ajlm-1434	239	11	adewumi	adewumi	PROPN
ajlm-1434	239	12	mo	mo	PROPN
ajlm-1434	239	13	.	.	PROPN
ajlm-1434	240	1	hepatitis	hepatitis	PROPN
ajlm-1434	240	2	b	b	PROPN
ajlm-1434	240	3	core	core	NOUN
ajlm-1434	240	4	igm	igm	NOUN
ajlm-1434	240	5	antibody	antibody	NOUN
ajlm-1434	240	6	(	(	PUNCT
ajlm-1434	240	7	anti	anti	ADJ
ajlm-1434	240	8	-	-	ADJ
ajlm-1434	240	9	hbcigm	hbcigm	NOUN
ajlm-1434	240	10	)	)	PUNCT
ajlm-1434	240	11	among	among	ADP
ajlm-1434	240	12	hepatitis	hepatitis	PROPN
ajlm-1434	240	13	b	b	PROPN
ajlm-1434	240	14	surface	surface	NOUN
ajlm-1434	240	15	antigen	antigen	NOUN
ajlm-1434	240	16	(	(	PUNCT
ajlm-1434	240	17	hbsag	hbsag	NOUN
ajlm-1434	240	18	)	)	PUNCT
ajlm-1434	240	19	negative	negative	ADJ
ajlm-1434	240	20	blood	blood	NOUN
ajlm-1434	240	21	donors	donor	NOUN
ajlm-1434	240	22	in	in	ADP
ajlm-1434	240	23	nigeria	nigeria	PROPN
ajlm-1434	240	24	.	.	PUNCT
ajlm-1434	241	1	virol	virol	PROPN
ajlm-1434	241	2	j.	j.	PROPN
ajlm-1434	241	3	2011;8(1):513	2011;8(1):513	PROPN
ajlm-1434	241	4	.	.	PUNCT
ajlm-1434	242	1	https://doi.org/10.1186/1743-422x-8-513	https://doi.org/10.1186/1743-422x-8-513	NOUN
ajlm-1434	242	2	dhawan	dhawan	PROPN
ajlm-1434	242	3	h	h	NOUN
ajlm-1434	242	4	-	-	PUNCT
ajlm-1434	242	5	k	k	NOUN
ajlm-1434	242	6	,	,	PUNCT
ajlm-1434	242	7	marwaha	marwaha	NOUN
ajlm-1434	242	8	n	n	CCONJ
ajlm-1434	242	9	,	,	PUNCT
ajlm-1434	242	10	sharma	sharma	PROPN
ajlm-1434	242	11	r	r	PROPN
ajlm-1434	242	12	-	-	PUNCT
ajlm-1434	242	13	r	r	NOUN
ajlm-1434	242	14	,	,	PUNCT
ajlm-1434	242	15	et	et	PROPN
ajlm-1434	242	16	al	al	PROPN
ajlm-1434	242	17	.	.	PUNCT
ajlm-1434	243	1	anti	anti	ADJ
ajlm-1434	243	2	-	-	ADJ
ajlm-1434	243	3	hbc	hbc	ADJ
ajlm-1434	243	4	screening	screening	NOUN
ajlm-1434	243	5	in	in	ADP
ajlm-1434	243	6	indian	indian	ADJ
ajlm-1434	243	7	blood	blood	NOUN
ajlm-1434	243	8	donors	donor	NOUN
ajlm-1434	243	9	:	:	PUNCT
ajlm-1434	243	10	still	still	ADV
ajlm-1434	243	11	an	an	DET
ajlm-1434	243	12	unresolved	unresolved	ADJ
ajlm-1434	243	13	issue	issue	NOUN
ajlm-1434	243	14	.	.	PUNCT
ajlm-1434	244	1	world	world	PROPN
ajlm-1434	244	2	j	j	PROPN
ajlm-1434	244	3	gastroenterol	gastroenterol	PROPN
ajlm-1434	244	4	.	.	PUNCT
ajlm-1434	245	1	2008;14(34):5327–5330	2008;14(34):5327–5330	NUM
ajlm-1434	245	2	.	.	PUNCT
ajlm-1434	245	3	https://doi.org/10.3748/wjg.14.5327	https://doi.org/10.3748/wjg.14.5327	PROPN
ajlm-1434	245	4	ogunfemi	ogunfemi	PROPN
ajlm-1434	245	5	mk	mk	PROPN
ajlm-1434	245	6	,	,	PUNCT
ajlm-1434	245	7	olawumi	olawumi	PROPN
ajlm-1434	245	8	ho	ho	PROPN
ajlm-1434	245	9	,	,	PUNCT
ajlm-1434	245	10	olokoba	olokoba	PROPN
ajlm-1434	245	11	ab	ab	PROPN
ajlm-1434	245	12	,	,	PUNCT
ajlm-1434	245	13	et	et	PROPN
ajlm-1434	245	14	al	al	PROPN
ajlm-1434	245	15	.	.	PUNCT
ajlm-1434	246	1	prevalence	prevalence	NOUN
ajlm-1434	246	2	of	of	ADP
ajlm-1434	246	3	antibody	antibody	NOUN
ajlm-1434	246	4	to	to	ADP
ajlm-1434	246	5	hepatitis	hepatitis	PROPN
ajlm-1434	246	6	b	b	PROPN
ajlm-1434	246	7	core	core	NOUN
ajlm-1434	246	8	antigen	antigen	ADV
ajlm-1434	246	9	among	among	ADP
ajlm-1434	246	10	hepatitis	hepatitis	PROPN
ajlm-1434	246	11	b	b	PROPN
ajlm-1434	246	12	surface	surface	NOUN
ajlm-1434	246	13	antigen	antigen	NOUN
ajlm-1434	246	14	-	-	PUNCT
ajlm-1434	246	15	negative	negative	ADJ
ajlm-1434	246	16	blood	blood	NOUN
ajlm-1434	246	17	donors	donor	NOUN
ajlm-1434	246	18	in	in	ADP
ajlm-1434	246	19	ilorin	ilorin	NOUN
ajlm-1434	246	20	,	,	PUNCT
ajlm-1434	246	21	nigeria	nigeria	PROPN
ajlm-1434	246	22	:	:	PUNCT
ajlm-1434	246	23	a	a	DET
ajlm-1434	246	24	cross	cross	ADJ
ajlm-1434	246	25	-	-	ADJ
ajlm-1434	246	26	sectional	sectional	ADJ
ajlm-1434	246	27	study	study	NOUN
ajlm-1434	246	28	.	.	PUNCT
ajlm-1434	247	1	malawi	malawi	PROPN
ajlm-1434	247	2	med	med	PROPN
ajlm-1434	247	3	j.	j.	PROPN
ajlm-1434	247	4	2017;29(1):7	2017;29(1):7	PROPN
ajlm-1434	247	5	.	.	PUNCT
ajlm-1434	248	1	https://doi.org/10.4314/mmj.v29i1.7	https://doi.org/10.4314/mmj.v29i1.7	PROPN
ajlm-1434	248	2	ojo	ojo	PROPN
ajlm-1434	248	3	os	os	PROPN
ajlm-1434	248	4	,	,	PUNCT
ajlm-1434	248	5	thursz	thursz	PROPN
ajlm-1434	248	6	m	m	PROPN
ajlm-1434	248	7	,	,	PUNCT
ajlm-1434	248	8	thomas	thomas	PROPN
ajlm-1434	248	9	hc	hc	PROPN
ajlm-1434	248	10	,	,	PUNCT
ajlm-1434	248	11	et	et	PROPN
ajlm-1434	248	12	al	al	PROPN
ajlm-1434	248	13	.	.	PUNCT
ajlm-1434	249	1	hepatitis	hepatitis	PROPN
ajlm-1434	249	2	b	b	PROPN
ajlm-1434	249	3	virus	virus	NOUN
ajlm-1434	249	4	markers	marker	NOUN
ajlm-1434	249	5	,	,	PUNCT
ajlm-1434	249	6	hepatitis	hepatitis	NOUN
ajlm-1434	249	7	d	d	PROPN
ajlm-1434	249	8	virus	virus	NOUN
ajlm-1434	249	9	antigen	antigen	NOUN
ajlm-1434	249	10	and	and	CCONJ
ajlm-1434	249	11	hepatitis	hepatitis	PROPN
ajlm-1434	249	12	c	c	PROPN
ajlm-1434	249	13	virus	virus	NOUN
ajlm-1434	249	14	antibodies	antibodie	VERB
ajlm-1434	249	15	in	in	ADP
ajlm-1434	249	16	nigerian	nigerian	ADJ
ajlm-1434	249	17	patients	patient	NOUN
ajlm-1434	249	18	with	with	ADP
ajlm-1434	249	19	chronic	chronic	ADJ
ajlm-1434	249	20	liver	liver	NOUN
ajlm-1434	249	21	disease	disease	NOUN
ajlm-1434	249	22	.	.	PUNCT
ajlm-1434	250	1	east	east	PROPN
ajlm-1434	250	2	afr	afr	PROPN
ajlm-1434	250	3	med	med	PROPN
ajlm-1434	250	4	j.	j.	PROPN
ajlm-1434	250	5	1995;72(11):719–721	1995;72(11):719–721	PROPN
ajlm-1434	250	6	.	.	PROPN
ajlm-1434	251	1	niederhauser	niederhauser	PROPN
ajlm-1434	251	2	c.	c.	PROPN
ajlm-1434	251	3	reducing	reduce	VERB
ajlm-1434	251	4	the	the	DET
ajlm-1434	251	5	risk	risk	NOUN
ajlm-1434	251	6	of	of	ADP
ajlm-1434	251	7	hepatitis	hepatitis	PROPN
ajlm-1434	251	8	b	b	PROPN
ajlm-1434	251	9	virus	virus	NOUN
ajlm-1434	251	10	transfusion	transfusion	NOUN
ajlm-1434	251	11	-	-	PUNCT
ajlm-1434	251	12	transmitted	transmit	VERB
ajlm-1434	251	13	infection	infection	NOUN
ajlm-1434	251	14	.	.	PUNCT
ajlm-1434	252	1	j	j	PROPN
ajlm-1434	252	2	blood	blood	NOUN
ajlm-1434	252	3	med	me	VERB
ajlm-1434	252	4	.	.	PUNCT
ajlm-1434	253	1	2011;2:91–102	2011;2:91–102	NUM
ajlm-1434	253	2	.	.	PUNCT
ajlm-1434	254	1	https://doi.org/10.2147/jbm.s12899	https://doi.org/10.2147/jbm.s12899	X
ajlm-1434	254	2	houareau	houareau	PROPN
ajlm-1434	254	3	c	c	PROPN
ajlm-1434	254	4	,	,	PUNCT
ajlm-1434	254	5	offergeld	offergeld	VERB
ajlm-1434	254	6	r.	r.	PROPN
ajlm-1434	254	7	anti	anti	ADJ
ajlm-1434	254	8	-	-	ADJ
ajlm-1434	254	9	hbc	hbc	ADJ
ajlm-1434	254	10	screening	screening	NOUN
ajlm-1434	254	11	is	be	AUX
ajlm-1434	254	12	it	it	PRON
ajlm-1434	254	13	worth	worth	ADJ
ajlm-1434	254	14	the	the	DET
ajlm-1434	254	15	effort	effort	NOUN
ajlm-1434	254	16	?	?	PUNCT
ajlm-1434	255	1	results	result	NOUN
ajlm-1434	255	2	of	of	ADP
ajlm-1434	255	3	a	a	DET
ajlm-1434	255	4	10	10	NUM
ajlm-1434	255	5	-	-	PUNCT
ajlm-1434	255	6	year	year	NOUN
ajlm-1434	255	7	surveillance	surveillance	NOUN
ajlm-1434	255	8	programme	programme	NOUN
ajlm-1434	255	9	covering	cover	VERB
ajlm-1434	255	10	more	more	ADJ
ajlm-1434	255	11	than	than	ADP
ajlm-1434	255	12	30	30	NUM
ajlm-1434	255	13	million	million	NUM
ajlm-1434	255	14	donations	donation	NOUN
ajlm-1434	255	15	in	in	ADP
ajlm-1434	255	16	germany	germany	PROPN
ajlm-1434	255	17	.	.	PUNCT
ajlm-1434	256	1	vox	vox	PROPN
ajlm-1434	256	2	sang	sing	VERB
ajlm-1434	256	3	.	.	PUNCT
ajlm-1434	257	1	2019;114(5):459–466	2019;114(5):459–466	X
ajlm-1434	257	2	.	.	PUNCT
ajlm-1434	258	1	https://doi.org/10.1111/vox.12781	https://doi.org/10.1111/vox.12781	PROPN
ajlm-1434	258	2	jeremiah	jeremiah	PROPN
ajlm-1434	258	3	za	za	PROPN
ajlm-1434	258	4	,	,	PUNCT
ajlm-1434	258	5	idris	idris	PROPN
ajlm-1434	258	6	h	h	PROPN
ajlm-1434	258	7	,	,	PUNCT
ajlm-1434	258	8	ajayi	ajayi	NOUN
ajlm-1434	258	9	bb	bb	NOUN
ajlm-1434	258	10	,	,	PUNCT
ajlm-1434	258	11	ezimah	ezimah	PROPN
ajlm-1434	258	12	acu	acu	PROPN
ajlm-1434	258	13	,	,	PUNCT
ajlm-1434	258	14	malah	malah	PROPN
ajlm-1434	258	15	mb	mb	PROPN
ajlm-1434	258	16	,	,	PUNCT
ajlm-1434	258	17	baba	baba	PROPN
ajlm-1434	258	18	mm	mm	INTJ
ajlm-1434	258	19	.	.	PUNCT
ajlm-1434	259	1	isolated	isolate	VERB
ajlm-1434	259	2	antihbc	antihbc	PROPN
ajlm-1434	259	3	-	-	PUNCT
ajlm-1434	259	4	igm	igm	NOUN
ajlm-1434	259	5	antibody	antibody	NOUN
ajlm-1434	259	6	among	among	ADP
ajlm-1434	259	7	blood	blood	NOUN
ajlm-1434	259	8	donors	donor	NOUN
ajlm-1434	259	9	in	in	ADP
ajlm-1434	259	10	the	the	DET
ajlm-1434	259	11	semi	semi	ADJ
ajlm-1434	259	12	-	-	ADJ
ajlm-1434	259	13	arid	arid	ADJ
ajlm-1434	259	14	region	region	NOUN
ajlm-1434	259	15	of	of	ADP
ajlm-1434	259	16	nigeria	nigeria	PROPN
ajlm-1434	259	17	.	.	PUNCT
ajlm-1434	260	1	hum	hum	PROPN
ajlm-1434	260	2	antibodies	antibodie	VERB
ajlm-1434	260	3	.	.	PUNCT
ajlm-1434	261	1	2011;20(3–4):77–82	2011;20(3–4):77–82	X
ajlm-1434	261	2	.	.	X
ajlm-1434	261	3	https://doi.org/10.3233/hab-2011-0242	https://doi.org/10.3233/hab-2011-0242	PROPN
ajlm-1434	261	4	salawu	salawu	VERB
ajlm-1434	261	5	l	l	PROPN
ajlm-1434	261	6	,	,	PUNCT
ajlm-1434	261	7	adegoke	adegoke	VERB
ajlm-1434	261	8	ao	ao	ADP
ajlm-1434	261	9	,	,	PUNCT
ajlm-1434	261	10	aboderin	aboderin	NOUN
ajlm-1434	261	11	ao	ao	PROPN
ajlm-1434	261	12	,	,	PUNCT
ajlm-1434	261	13	huraina	huraina	PROPN
ajlm-1434	261	14	ha	ha	INTJ
ajlm-1434	261	15	.	.	PUNCT
ajlm-1434	262	1	hepatitis	hepatitis	PROPN
ajlm-1434	262	2	b	b	PROPN
ajlm-1434	262	3	viral	viral	ADJ
ajlm-1434	262	4	markers	marker	NOUN
ajlm-1434	262	5	in	in	ADP
ajlm-1434	262	6	surface	surface	NOUN
ajlm-1434	262	7	antigen	antigen	ADP
ajlm-1434	262	8	negative	negative	ADJ
ajlm-1434	262	9	blood	blood	NOUN
ajlm-1434	262	10	donors	donor	NOUN
ajlm-1434	262	11	:	:	PUNCT
ajlm-1434	262	12	the	the	DET
ajlm-1434	262	13	need	need	NOUN
ajlm-1434	262	14	to	to	PART
ajlm-1434	262	15	look	look	VERB
ajlm-1434	262	16	beyond	beyond	ADP
ajlm-1434	262	17	antibody	antibody	NOUN
ajlm-1434	262	18	negativity	negativity	NOUN
ajlm-1434	262	19	.	.	PUNCT
ajlm-1434	263	1	west	west	PROPN
ajlm-1434	263	2	afr	afr	PROPN
ajlm-1434	263	3	j	j	PROPN
ajlm-1434	263	4	med	med	PROPN
ajlm-1434	263	5	.	.	PUNCT
ajlm-1434	264	1	2011;30(4):292–295	2011;30(4):292–295	X
ajlm-1434	264	2	.	.	NUM
ajlm-1434	264	3	shil	shil	PROPN
ajlm-1434	264	4	n	n	CCONJ
ajlm-1434	264	5	,	,	PUNCT
ajlm-1434	264	6	biswas	biswas	PROPN
ajlm-1434	264	7	j	j	PROPN
ajlm-1434	264	8	,	,	PUNCT
ajlm-1434	264	9	khatun	khatun	PROPN
ajlm-1434	264	10	a	a	X
ajlm-1434	264	11	,	,	PUNCT
ajlm-1434	264	12	et	et	PROPN
ajlm-1434	264	13	al	al	PROPN
ajlm-1434	264	14	.	.	PROPN
ajlm-1434	264	15	incidence	incidence	NOUN
ajlm-1434	264	16	of	of	ADP
ajlm-1434	264	17	anti	anti	ADJ
ajlm-1434	264	18	-	-	ADJ
ajlm-1434	264	19	hbc	hbc	ADJ
ajlm-1434	264	20	antibody	antibody	NOUN
ajlm-1434	264	21	(	(	PUNCT
ajlm-1434	264	22	igg	igg	PROPN
ajlm-1434	264	23	and	and	CCONJ
ajlm-1434	264	24	igm	igm	PROPN
ajlm-1434	264	25	)	)	PUNCT
ajlm-1434	264	26	among	among	ADP
ajlm-1434	264	27	hbsag	hbsag	NOUN
ajlm-1434	264	28	negative	negative	ADJ
ajlm-1434	264	29	apparently	apparently	ADV
ajlm-1434	264	30	healthy	healthy	ADJ
ajlm-1434	264	31	blood	blood	NOUN
ajlm-1434	264	32	donors	donor	NOUN
ajlm-1434	264	33	.	.	PUNCT
ajlm-1434	265	1	bangabandhu	bangabandhu	NOUN
ajlm-1434	265	2	sheikh	sheikh	NOUN
ajlm-1434	265	3	mujib	mujib	PROPN
ajlm-1434	265	4	med	med	PROPN
ajlm-1434	265	5	univ	univ	PROPN
ajlm-1434	265	6	j.	j.	PROPN
ajlm-1434	265	7	2016;9(4):201–204	2016;9(4):201–204	PROPN
ajlm-1434	265	8	.	.	PUNCT
ajlm-1434	266	1	https://doi.org/10.3329/bsmmuj.v9i4.30241	https://doi.org/10.3329/bsmmuj.v9i4.30241	X
ajlm-1434	266	2	romanò	romanò	PROPN
ajlm-1434	266	3	l	l	NOUN
ajlm-1434	266	4	,	,	PUNCT
ajlm-1434	266	5	velati	velati	NOUN
ajlm-1434	266	6	c	c	PROPN
ajlm-1434	266	7	,	,	PUNCT
ajlm-1434	266	8	cambiè	cambiè	NOUN
ajlm-1434	266	9	g	g	NOUN
ajlm-1434	266	10	,	,	PUNCT
ajlm-1434	266	11	fomiatti	fomiatti	ADJ
ajlm-1434	266	12	l	l	NOUN
ajlm-1434	266	13	,	,	PUNCT
ajlm-1434	266	14	galli	galli	NOUN
ajlm-1434	266	15	c	c	NOUN
ajlm-1434	266	16	,	,	PUNCT
ajlm-1434	266	17	zanetti	zanetti	PROPN
ajlm-1434	266	18	ar	ar	PROPN
ajlm-1434	266	19	.	.	PUNCT
ajlm-1434	266	20	hepatitis	hepatitis	PROPN
ajlm-1434	266	21	b	b	PROPN
ajlm-1434	266	22	virus	virus	NOUN
ajlm-1434	266	23	infection	infection	NOUN
ajlm-1434	266	24	among	among	ADP
ajlm-1434	266	25	first	first	ADJ
ajlm-1434	266	26	-	-	PUNCT
ajlm-1434	266	27	time	time	NOUN
ajlm-1434	266	28	blood	blood	NOUN
ajlm-1434	266	29	donors	donor	NOUN
ajlm-1434	266	30	in	in	ADP
ajlm-1434	266	31	italy	italy	PROPN
ajlm-1434	266	32	:	:	PUNCT
ajlm-1434	266	33	prevalence	prevalence	NOUN
ajlm-1434	266	34	and	and	CCONJ
ajlm-1434	266	35	correlates	correlate	VERB
ajlm-1434	266	36	between	between	ADP
ajlm-1434	266	37	serological	serological	ADJ
ajlm-1434	266	38	patterns	pattern	NOUN
ajlm-1434	266	39	and	and	CCONJ
ajlm-1434	266	40	occult	occult	NOUN
ajlm-1434	266	41	infection	infection	NOUN
ajlm-1434	266	42	.	.	PUNCT
ajlm-1434	267	1	blood	blood	NOUN
ajlm-1434	267	2	transfus	transfus	PROPN
ajlm-1434	267	3	.	.	PUNCT
ajlm-1434	268	1	2013;11(2	2013;11(2	NUM
ajlm-1434	268	2	):	):	PUNCT
ajlm-1434	268	3	281–288	281–288	NUM
ajlm-1434	268	4	.	.	PUNCT
ajlm-1434	269	1	lim	lim	PROPN
ajlm-1434	269	2	ya	ya	PROPN
ajlm-1434	269	3	,	,	PUNCT
ajlm-1434	269	4	yoon	yoon	PROPN
ajlm-1434	269	5	s.	s.	PROPN
ajlm-1434	269	6	an	an	DET
ajlm-1434	269	7	experience	experience	NOUN
ajlm-1434	269	8	of	of	ADP
ajlm-1434	269	9	use	use	NOUN
ajlm-1434	269	10	of	of	ADP
ajlm-1434	269	11	anti	anti	ADJ
ajlm-1434	269	12	-	-	ADJ
ajlm-1434	269	13	hbc	hbc	ADJ
ajlm-1434	269	14	and	and	CCONJ
ajlm-1434	269	15	anti	anti	PROPN
ajlm-1434	269	16	hbs	hbs	PROPN
ajlm-1434	269	17	for	for	ADP
ajlm-1434	269	18	blood	blood	NOUN
ajlm-1434	269	19	donor	donor	NOUN
ajlm-1434	269	20	screening	screen	VERB
ajlm-1434	269	21	tests	test	NOUN
ajlm-1434	269	22	at	at	ADP
ajlm-1434	269	23	a	a	DET
ajlm-1434	269	24	tertiary	tertiary	ADJ
ajlm-1434	269	25	hospital	hospital	NOUN
ajlm-1434	269	26	blood	blood	NOUN
ajlm-1434	269	27	center	center	NOUN
ajlm-1434	269	28	in	in	ADP
ajlm-1434	269	29	korea	korea	PROPN
ajlm-1434	269	30	.	.	PUNCT
ajlm-1434	270	1	korean	korean	PROPN
ajlm-1434	270	2	j	j	PROPN
ajlm-1434	270	3	lab	lab	PROPN
ajlm-1434	270	4	med	me	VERB
ajlm-1434	270	5	.	.	PUNCT
ajlm-1434	271	1	2009;(1):59–65	2009;(1):59–65	X
ajlm-1434	271	2	.	.	PUNCT
ajlm-1434	272	1	https://doi.org/10.3343/kjlm.2009.29.1.59	https://doi.org/10.3343/kjlm.2009.29.1.59	PROPN
ajlm-1434	272	2	olayinka	olayinka	PROPN
ajlm-1434	272	3	at	at	ADP
ajlm-1434	272	4	,	,	PUNCT
ajlm-1434	272	5	oyemakinde	oyemakinde	ADP
ajlm-1434	272	6	a	a	PRON
ajlm-1434	272	7	,	,	PUNCT
ajlm-1434	272	8	balogun	balogun	VERB
ajlm-1434	272	9	ms	ms	PROPN
ajlm-1434	272	10	,	,	PUNCT
ajlm-1434	272	11	et	et	PROPN
ajlm-1434	272	12	al	al	PROPN
ajlm-1434	272	13	.	.	PROPN
ajlm-1434	273	1	seroprevalence	seroprevalence	NOUN
ajlm-1434	273	2	of	of	ADP
ajlm-1434	273	3	hepatitis	hepatitis	PROPN
ajlm-1434	273	4	b	b	PROPN
ajlm-1434	273	5	infection	infection	NOUN
ajlm-1434	273	6	in	in	ADP
ajlm-1434	273	7	nigeria	nigeria	PROPN
ajlm-1434	273	8	:	:	PUNCT
ajlm-1434	273	9	a	a	DET
ajlm-1434	273	10	national	national	ADJ
ajlm-1434	273	11	survey	survey	NOUN
ajlm-1434	273	12	.	.	PUNCT
ajlm-1434	274	1	am	be	AUX
ajlm-1434	274	2	j	j	PROPN
ajlm-1434	274	3	trop	trop	X
ajlm-1434	274	4	med	med	PROPN
ajlm-1434	274	5	hyg	hyg	PROPN
ajlm-1434	274	6	.	.	PUNCT
ajlm-1434	275	1	2016;95(4):902–907	2016;95(4):902–907	NUM
ajlm-1434	275	2	.	.	PUNCT
ajlm-1434	276	1	https://doi.org/10.4269/ajtmh.15-0874	https://doi.org/10.4269/ajtmh.15-0874	PROPN
ajlm-1434	276	2	musa	musa	PROPN
ajlm-1434	276	3	bm	bm	PROPN
ajlm-1434	276	4	,	,	PUNCT
ajlm-1434	276	5	bussell	bussell	VERB
ajlm-1434	276	6	s	s	NOUN
ajlm-1434	276	7	,	,	PUNCT
ajlm-1434	276	8	borodo	borodo	PROPN
ajlm-1434	276	9	mm	mm	PROPN
ajlm-1434	276	10	,	,	PUNCT
ajlm-1434	276	11	samaila	samaila	PROPN
ajlm-1434	276	12	aa	aa	PROPN
ajlm-1434	276	13	,	,	PUNCT
ajlm-1434	276	14	femi	femi	PROPN
ajlm-1434	276	15	ol	ol	PROPN
ajlm-1434	276	16	.	.	PUNCT
ajlm-1434	277	1	prevalence	prevalence	NOUN
ajlm-1434	277	2	of	of	ADP
ajlm-1434	277	3	hepatitis	hepatitis	PROPN
ajlm-1434	277	4	b	b	PROPN
ajlm-1434	277	5	virus	virus	NOUN
ajlm-1434	277	6	infection	infection	NOUN
ajlm-1434	277	7	in	in	ADP
ajlm-1434	277	8	nigeria	nigeria	PROPN
ajlm-1434	277	9	,	,	PUNCT
ajlm-1434	277	10	2000–2013	2000–2013	NUM
ajlm-1434	277	11	:	:	PUNCT
ajlm-1434	277	12	a	a	DET
ajlm-1434	277	13	systematic	systematic	ADJ
ajlm-1434	277	14	review	review	NOUN
ajlm-1434	277	15	and	and	CCONJ
ajlm-1434	277	16	meta	meta	ADJ
ajlm-1434	277	17	-	-	PUNCT
ajlm-1434	277	18	analysis	analysis	NOUN
ajlm-1434	277	19	.	.	PUNCT
ajlm-1434	278	1	niger	niger	PROPN
ajlm-1434	278	2	j	j	PROPN
ajlm-1434	278	3	clin	clin	PROPN
ajlm-1434	278	4	pr	pr	PROPN
ajlm-1434	278	5	.	.	PUNCT
ajlm-1434	279	1	2015;18(2):163–172	2015;18(2):163–172	NUM
ajlm-1434	279	2	.	.	PUNCT
ajlm-1434	280	1	https://doi.org/10.4103/1119-3077.151035	https://doi.org/10.4103/1119-3077.151035	PROPN
ajlm-1434	280	2	fopa	fopa	ADV
ajlm-1434	280	3	d	d	PROPN
ajlm-1434	280	4	,	,	PUNCT
ajlm-1434	280	5	candotti	candotti	NOUN
ajlm-1434	280	6	d	d	NOUN
ajlm-1434	280	7	,	,	PUNCT
ajlm-1434	280	8	tagny	tagny	NOUN
ajlm-1434	280	9	ct	ct	PROPN
ajlm-1434	280	10	,	,	PUNCT
ajlm-1434	280	11	et	et	PROPN
ajlm-1434	280	12	al	al	PROPN
ajlm-1434	280	13	.	.	PROPN
ajlm-1434	281	1	occult	occult	PROPN
ajlm-1434	281	2	hepatitis	hepatitis	PROPN
ajlm-1434	281	3	b	b	PROPN
ajlm-1434	281	4	infection	infection	NOUN
ajlm-1434	281	5	among	among	ADP
ajlm-1434	281	6	blood	blood	NOUN
ajlm-1434	281	7	donors	donor	NOUN
ajlm-1434	281	8	from	from	ADP
ajlm-1434	281	9	yaoundé	yaoundé	PROPN
ajlm-1434	281	10	,	,	PUNCT
ajlm-1434	281	11	cameroon	cameroon	NOUN
ajlm-1434	281	12	.	.	PUNCT
ajlm-1434	282	1	blood	blood	NOUN
ajlm-1434	282	2	transfus	transfus	PROPN
ajlm-1434	282	3	.	.	PUNCT
ajlm-1434	283	1	2019;17(6):403–408	2019;17(6):403–408	X
ajlm-1434	283	2	.	.	X
ajlm-1434	283	3	allain	allain	PROPN
ajlm-1434	283	4	j	j	PROPN
ajlm-1434	283	5	-	-	PUNCT
ajlm-1434	283	6	p	p	PROPN
ajlm-1434	283	7	,	,	PUNCT
ajlm-1434	283	8	candotti	candotti	NOUN
ajlm-1434	283	9	d	d	NOUN
ajlm-1434	283	10	,	,	PUNCT
ajlm-1434	283	11	soldan	soldan	PROPN
ajlm-1434	283	12	k	k	PROPN
ajlm-1434	283	13	,	,	PUNCT
ajlm-1434	283	14	et	et	PROPN
ajlm-1434	283	15	al	al	PROPN
ajlm-1434	283	16	.	.	PUNCT
ajlm-1434	284	1	the	the	DET
ajlm-1434	284	2	risk	risk	NOUN
ajlm-1434	284	3	of	of	ADP
ajlm-1434	284	4	hepatitis	hepatitis	PROPN
ajlm-1434	284	5	b	b	PROPN
ajlm-1434	284	6	virus	virus	NOUN
ajlm-1434	284	7	infection	infection	NOUN
ajlm-1434	284	8	by	by	ADP
ajlm-1434	284	9	transfusion	transfusion	NOUN
ajlm-1434	284	10	in	in	ADP
ajlm-1434	284	11	kumasi	kumasi	PROPN
ajlm-1434	284	12	,	,	PUNCT
ajlm-1434	284	13	ghana	ghana	PROPN
ajlm-1434	284	14	.	.	PUNCT
ajlm-1434	285	1	blood	blood	NOUN
ajlm-1434	285	2	.	.	PUNCT
ajlm-1434	286	1	2003;101(6):2419–2425	2003;101(6):2419–2425	NUM
ajlm-1434	286	2	.	.	PROPN
ajlm-1434	286	3	https://doi.org/10.1182/blood-2002-04-1084	https://doi.org/10.1182/blood-2002-04-1084	PROPN
ajlm-1434	286	4	el	el	PROPN
ajlm-1434	286	5	-	-	PUNCT
ajlm-1434	286	6	zayadi	zayadi	PROPN
ajlm-1434	286	7	ar	ar	PROPN
ajlm-1434	286	8	,	,	PUNCT
ajlm-1434	286	9	ibrahim	ibrahim	PROPN
ajlm-1434	286	10	eh	eh	INTJ
ajlm-1434	286	11	,	,	PUNCT
ajlm-1434	286	12	badran	badran	VERB
ajlm-1434	286	13	hm	hm	INTJ
ajlm-1434	286	14	,	,	PUNCT
ajlm-1434	286	15	et	et	PROPN
ajlm-1434	286	16	al	al	PROPN
ajlm-1434	286	17	.	.	PUNCT
ajlm-1434	287	1	anti	anti	ADJ
ajlm-1434	287	2	-	-	ADJ
ajlm-1434	287	3	hbc	hbc	ADJ
ajlm-1434	287	4	screening	screening	NOUN
ajlm-1434	287	5	in	in	ADP
ajlm-1434	287	6	egyptian	egyptian	ADJ
ajlm-1434	287	7	blood	blood	NOUN
ajlm-1434	287	8	donors	donor	NOUN
ajlm-1434	287	9	reduces	reduce	VERB
ajlm-1434	287	10	the	the	DET
ajlm-1434	287	11	risk	risk	NOUN
ajlm-1434	287	12	of	of	ADP
ajlm-1434	287	13	hepatitis	hepatitis	PROPN
ajlm-1434	287	14	b	b	PROPN
ajlm-1434	287	15	virus	virus	NOUN
ajlm-1434	287	16	transmission	transmission	NOUN
ajlm-1434	287	17	.	.	PUNCT
ajlm-1434	288	1	transfus	transfus	PROPN
ajlm-1434	288	2	med	med	PROPN
ajlm-1434	288	3	.	.	PUNCT
ajlm-1434	289	1	2008;18(1):55–61	2008;18(1):55–61	X
ajlm-1434	289	2	.	.	PUNCT
ajlm-1434	289	3	https://doi.org/10.1111/j.1365-3148.2007.00806.x	https://doi.org/10.1111/j.1365-3148.2007.00806.x	VERB
ajlm-1434	289	4	mahmoud	mahmoud	PROPN
ajlm-1434	289	5	ai	ai	PROPN
ajlm-1434	289	6	,	,	PUNCT
ajlm-1434	289	7	elsherbiny	elsherbiny	PROPN
ajlm-1434	289	8	nm	nm	PROPN
ajlm-1434	289	9	,	,	PUNCT
ajlm-1434	289	10	afifi	afifi	PROPN
ajlm-1434	289	11	na	na	PROPN
ajlm-1434	289	12	,	,	PUNCT
ajlm-1434	289	13	ahmed	ahmed	PROPN
ajlm-1434	289	14	bm	bm	PROPN
ajlm-1434	289	15	,	,	PUNCT
ajlm-1434	289	16	yasin	yasin	VERB
ajlm-1434	289	17	as	as	ADP
ajlm-1434	289	18	.	.	PUNCT
ajlm-1434	290	1	occult	occult	VERB
ajlm-1434	290	2	hepatitis	hepatitis	PROPN
ajlm-1434	290	3	b	b	PROPN
ajlm-1434	290	4	infection	infection	NOUN
ajlm-1434	290	5	among	among	ADP
ajlm-1434	290	6	blood	blood	NOUN
ajlm-1434	290	7	donors	donor	NOUN
ajlm-1434	290	8	in	in	ADP
ajlm-1434	290	9	al	al	PROPN
ajlm-1434	290	10	azhar	azhar	PROPN
ajlm-1434	290	11	university	university	PROPN
ajlm-1434	290	12	hospital	hospital	NOUN
ajlm-1434	290	13	,	,	PUNCT
ajlm-1434	290	14	upper	upper	ADJ
ajlm-1434	290	15	egypt	egypt	PROPN
ajlm-1434	290	16	:	:	PUNCT
ajlm-1434	290	17	the	the	DET
ajlm-1434	290	18	current	current	ADJ
ajlm-1434	290	19	status	status	NOUN
ajlm-1434	290	20	after	after	ADP
ajlm-1434	290	21	25	25	NUM
ajlm-1434	290	22	years	year	NOUN
ajlm-1434	290	23	of	of	ADP
ajlm-1434	290	24	vaccine	vaccine	NOUN
ajlm-1434	290	25	introduction	introduction	NOUN
ajlm-1434	290	26	.	.	PUNCT
ajlm-1434	291	1	egypt	egypt	PROPN
ajlm-1434	291	2	j	j	PROPN
ajlm-1434	291	3	immunol	immunol	NOUN
ajlm-1434	291	4	.	.	PUNCT
ajlm-1434	292	1	2018;25(1):45–56	2018;25(1):45–56	X
ajlm-1434	292	2	.	.	PUNCT